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ABSTRACT 
 
Yersinia enterocolitica is an important foodborne enteric pathogen that causes 
gastroenteritis. There are limited studies on Y. enterocolitica in Malaysia, hence the 
potential complication due to yersiniosis in the country remains unknown. The 
objectives of this study were: (i) to determine the prevalence of Y. enterocolitica from 
raw food and pigs in Malaysia; (ii) to characterize the Malaysian Y. enterocolitica by 
using phenotypic and genotypic methods and; (iii) to study the genetic relatedness of 
Malaysian Y. enterocolitica strains from different food sources and pigs in Malaysia; 
and (iv) to improve the isolation of rate of Y. enterocolitica by modifying the 
composition of Cefsulodin-Irgasan-Novobiocin(CIN) agar.   
Between years 2010 to 2011, 106 raw food samples (58 pork products and 48 
non-porcine food) and 495 swine specimens (from 165 pigs) were analysed for the 
presence of Y. enterocolitica. The pathogen was isolated in 7/58(12.1%) raw pork 
products, in which pork (whole meat) had the highest prevalence 5/21(23.8%), followed 
by liver 1/5(20.0%) and intestine 1/8(12.5%). Y. enterocolitica was not isolated from 
raw non-porcine food. Of 165 pigs, 3(1.8%) were carriers (asymptomatic pigs) for Y. 
enterocolitica. Bioserotyping showed that the isolates were of bioserotypes 3 
variant/O:3(n=92), 1B/O:8(n=3), and 1A/O:5(n=3). The 3 variant/O:3 was the most 
prevalent bioserotype (present in pork products and pigs) and is probably the common 
bioserotype in Malaysia (warm climate region). 
Thirty-two Y. enterocolitica isolates were further subtyped by using pulsed-field 
gel electrophoresis (PFGE) and the antimicrobial profiles and carriage of virulence 
markers were evaluated. Isolates of three different bioserotypes were distinguished into 
three clusters (D value = 0.87, 90% similarity) by using PFGE. However, isolates were 
highly clonal within each bioserotype and exhibited minor variation. Of 29 
ABSTRACT 
 
iv 
 
antimicrobials tested, the 1B/O:8 isolates were only resistant to clindamycin and the 
1A/O:5, resistant to ampicillin, ticarcillin, amoxicillin, and clindamycin. Majority of the 
3 variant/O:3 isolates were resistant to nalidixic acid, clindamycin, ampicillin, 
ticarcillin, tetracycline and amoxicillin.
 
About 90% were multidrug-resistant(MDR) 
with multiple antibiotic resistance(MAR) index for isolates of bioserotype 3 variant/O:3 
the highest, 0.183, followed by 1A/O:5 and 1B/O:8 with MAR indices at 0.121 and 
0.103, respectively. Isolates were examined for the presence of pYV plasmid and 15 
virulence genes. Four reproducible virulence genes patterns obverved and each 
virulotype belonged to a particular bioserotype. The pYV plasmid was only present in 
the 3 variant/O:3 isolates.  
To improve the isolation of Y. enterocolitica, the composition of CIN agar was 
modified. Based on the evaluation on the plating efficiency, detection limit and recovery 
strength for both CIN and modified CIN media, modified CIN provided a better 
discrimination of Y. enterocolitica from five bacteria exhibiting Yersinia-like colonies 
on CIN than the original CIN while retaining similar detection limit and culture 
capability for Y. enterocolitica.  
In conclusion, the occurrence of virulent strains of Y. enterocolitica in pigs and 
raw pork products indicated that pigs are important reservoir of Y. enterocolitica. The 
high incidence of multidrug resistant Y. enterocolitica  is of public health concern and 
possibly reflects the abuse of antimicrobial agents in the animal husbandry. The 
modified CIN might be useful for routine surveillance for Y. enterocolitica.  
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ABSTRAK 
 
Yersinia enterocolitica merupakan patogen enterik bawaan makanan yang 
menyebabkan gastroenteritis. Kekurangan kajian dalam Y. enterocolitica di Malaysia 
menyebabkan potensi komplikasi yersiniosis di Negara ini tidak jelas diketahui. Tujuan-
tujuan kajian ini adalah: (i) mengkaji prevalens Y. enterocolitica daripada makan-
makanan dan khinzir di Malaysia; (ii) mencirikan Y. enterocolitica dengan 
menggunakan kaedah fenotip dan genotip; (iii) mengkaji hubung-kait genetik bagi 
strain Y. enterocolitica Malaysia yang bersumber daripada makanan and khinzir yang 
berlainan; dan (iv) membaikan kadar pengasingan Y. enterocolitica dengan 
mengubahsuai komposisi agar Cefsulodin-Irgasan-Novobiosin (CIN).. 
 Antara tahun 2010 ke 2011, 106 sampel makanan mentah (58 produk khinzir 
dan 48 makanan bukan khinzir) dan 495 spesimen khinzir (daripada 165 khinzir) telah 
diperiksa bagi kehadiran Y. enterocolitica. Y. enterocolitica diasingan daripada 
7/58(12.1%) produk khinzir mentah, di mana daging (daging lengkap) memberikan 
prevalens tertinggi 5/21(23.8%), diikuti dengan hati 1/5(20.0%) dan intestin 
1/8(12.5%). Tiada Y. enterocolitica terasing daripada makanan bukan khinzir mentah. 
Daripada 165 khinzir, 3(1.8%) merupakan pembawa (khinzir yang tidak membawa 
sebarang gejala penyakit) Y. enterocolitica. Bioserotip menunjukkan isolat-isolat terdiri 
daripada bioserotip varian 3/O:3(n=92), 1B/O:8(n=3) dan 1A/O:5(n=3). Bioserotip 
varian 3/O:3 adalah bioserotip yang paling prevalen (hadir dalam kedua-dua makanan 
khinzir dan khinzir) dan barangkali merupakan bioserotip yang biasa di rantau ini. 
Tiga puluh dua isolat Y. enterocolitica dicirikan selanjutnya dengan 
menggunakan kaedah gel elektroforesis medan-berdeyut (PFGE) dan profil antimikrob 
dan pembawaan penanda virulens dinilai. Dengan menggunakan PFGE, isolat-isolat 
daripada tiga bioserotip dibezakan kepada tiga klustur (nilai D=0.87, keserupaan 90%). 
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Akan tetapi, isolat adalah sangat klonal dalam setiap bioserotip dan mempamerkan 
variasi minor. Daripada 29 antimikrob-antimikrob teruji, isolat 1B/O:8 hanya resistan 
terhadap ampisilin, tikarsilin, amoxisilin, dan klindamisin. Kebanyakan isolat varian 
3/O:3 resistan terhadap asid nalidisik, klindamisin, ampisilin, tikarsilin, tetrasiklin dan 
amoxisilin. Kira-kira 90% isolat adalah resistan drug kepelbagaian (MDR) dengan 
indeks resistan kepelbagaian antibiotik (MAR) untuk isolat bioserotip varian 3/O:3 
tertinggi, 0.183, diikuti dengan 1A/O:5 dan 1B/O:8 yang mempunyai indeks MAR 
masing-masing pada 0.121 dan 0.103. Kehadiran plasmid pYV dan 15 gen-gen virulens 
diperiksa. Terdapat empat rupa susunan yang boleh diulang semula dan setiap virulotip 
adalah kepunyaan kepada suatu bioserotip. Plasmid pYV hanya hadir dalam isolat 
varian 3/O:3. 
 Dalam memperbaiki pengasingan Y. enterocolitica, komposisi agar CIN 
diubahsuai. Berdasarkan penilaian kepada kecekapan pemplatan, had pengesanan dan 
kekuatan pemulihan untuk kedua-dua agar CIN dan CIN-diubahsuai, CIN-diubahsuai 
mempunyai keupayaan diskriminasi yang lebih baik berbanding dengan agar CIN dalam 
membezakan Y. enterocolitica daripada lima bakteria bercirian Yersinia atas agar CIN 
dan di samping itu, megekalkan had pengesanan dan keupayaan pengkulturan untuk Y. 
enterocolitica yang sama. 
Kesimpulannya, kejadian strain virulen Y. enterocolitica dalam khinzir dan 
makan khinzir mentah menunjukkan khinzir merupakan reservoir penting untuk Y. 
enterocolitica. Kejadian strain MDR Y. enterocolitica yang tinggi adalah 
membimbangan kesihatan awam dan mungkin mencerminkan penyalahgunaan agen 
antimikrobial dalam industri haiwan. Agar CIN-diubahsuai mungkin berguna dalam 
pengamatan rutin terhadap Y. enterocolitica. 
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Yersinia enterocolitica is a bacterium which belongs to the Enterobactericeae is 
widely found in natural environments. It is psychrotrophic and has the capability to 
survive and multiply at low temperature (Annamalai & Venkitanarayanan, 2005; 
Neuhaus, Francis, Rapposch, Görg, & Scherer, 1999). Y. enterocolitica is considered 
enteropathogenic as it is usually transmitted to through consumption of contaminated 
food and cause gastrointestinal infection in humans. Typical symptoms include acute 
enteritis with fever, bloody diarrhoea and pseudo appendicitis, which frequently leads to 
unnecessary laparotomy in humans (Vlachaki, Tselios, Tsapas, & Klonizakis, 2007). 
Young children and infants are the most susceptible age group (Rosner, Stark, & 
Werber, 2010). In most cases, Y. enterocolitica infection is self-limiting, and no 
antimicrobial therapy is needed. However in rare cases like sepsis, antimicrobials may 
be useful.  
Y. enterocolitica is ubiquitous in the nature and is routinely isolated from 
various animals (swine, cattle, sheep, etc.), food (pork, poultry, ruminant, milk, 
vegetables, etc.) and environment (Dallal et al., 2010; Fredriksson-Ahomaa & Korkeala, 
2003; Fukushima, Hoshina, Itogawa, & Gomyoda, 1997; Novoslavskij et al., 2013; 
Xanthopoulos, Tzanetakis, & Litopoulou-Tzanetaki, 2010). Among the sources, swine 
have been implicated as a major reservoir of Y. enterocolitica associated with human 
infections.  
Yersiniosis outbreaks that involved ingestion of contaminated food have 
occurred in several countries such as China, Norway, United States, Japan, and India 
(Abraham et al., 1997; Ackers et al., 2000; Grahek-Ogden, Schimmer, Cudjoe, Nygard, 
& Kapperud, 2007; Jones, Buckingham, Bopp, Ribot, & Schaffner, 2003; MacDonald et 
al., 2012; Sakai et al., 2005; Zheng & Jiang, 2006). In Europe, Y. enterocolitica is 
notified as the fourth most important foodborne enteric pathogen after 
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campylobacteriosis, salmonellosis and and verotoxigenic E. coli (European Food Safety 
Authority & European Centre for Disease Prevention and Control, 2013).  
Studies concerning the incidence and prevalence of Y. enterocolitica have  
seldom been reported in Malaysia. The first case of human yersiniosis in Malaysia was 
reported by Jegathesan, Paramasivam, Rajagopalan, & Loo (1984) where Y. 
enterocolitica serotype O:3 was isolated from a 34-year-old Indian woman. The only 
food related prevalence report in Malaysia was from unpublished study of Dzomir 
(2005), Y. enterocolitica (bioserotype 1A/O:52, 53 and 1A/O:41, 42) was isolated from 
beef burger patty and chicken burger patty. Due to the limited study of this bacterium in 
Malaysia, the potential complications of yersiniosis in the country remain unknown. 
Therefore it is interesting to investigate the prevalence of Y. enterocolitica in the local 
food and pigs. It is also interesting to investigate the genetic relatedness and 
characteristics of the Y. enterocolitica strains (phenotypic and genotypic) isolated from 
various sources in Malaysia. 
There are numerous isolation schemes available in isolation and detection of Y. 
enterocolitica and the isolation of Y. enterocolitica is considered laborious. Typical 
isolation method involves selective enrichment, post-enrichment alkaline treatment (0.5 
ml enriched broth transferred to 4.5 ml of 0.5% KOH solution and mixed for 20 s) 
(Aulisio, Mehlman, & Sanders, 1980), selective agar isolation, and a series of 
characterization tests. In this study, limitations of the current Cefsulodin-Irgasan-
Novobiocin (CIN) agar in isolating Y. enterocolitica were found. The lack of good 
isolation medium will thus mask and underestimate the actual incidence of yersiniosis. 
Efforts in modifying and improving the current CIN agar will therefore improve the 
isolation rate of Y. enterocolitica. 
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1.1 Objectives of study 
 
The objectives of this research are as follows: 
1. To determine the prevalence of Y. enterocolitica in food and pigs in Malaysia by 
using conventional and molecular methods.  
2. To characterize the Y. enterocolitica isolates in Malaysia by using biotyping, 
serotyping, pulsed field gel electrophoresis, plasmid profiling, virulotyping and 
antimicrobials susceptibility test. 
3. To study the genetic relatedness of Malaysian Y. enterocolitica strains from 
different food sources and pigs in Malaysia. 
4. To modify and improve the composition of the existing Cefsulodin-irgasan-
novobiocin (CIN) agar to improve the differentiation of Y. enterocolitica from other 
natural microbiota.  
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2.1 General background and occurrence of yersiniosis 
Yersinia enterocolitica belongs to the genus of Yersinia in the 
Enterobacteriaceae family. It is Gram-negative, rod-shaped facultative anaerobes, and 
psychrotrophic bacterium which is ubiquitous and widely found in the natural 
environment. Y. enterocolitica was first discovered by Schleifstein and Coleman in 
1939 (Schleifstein & Coleman, 1939). It is an enteropathogenic as it typically causes 
gastrointestinal infection in humans. Y. enterocolitica is usually transmitted to humans 
through contaminated food. It is a notifiable disease in Europe (European Food Safety 
Authority & European Centre for Disease Prevention and Control, 2013). In 2011, the 
incidence rate of yersiniosis was 1.63 cases per 100,000 population in European Union 
(European Food Safety Authority & European Centre for Disease Prevention and 
Control, 2013). In New Zealand, the incidence of yersiniosis is the third most frequently 
reported disease, 11.5 cases per 100,000 population (Heffernan, 2012). In Malaysia, Y. 
enterocolitica is not routinely isolated as it is not a notifiable disease and therefore, not 
much is known about its economic importance. The first case of human yersiniosis in 
Malaysia was reported by Jegathesan, et al. (1984) in which Y. enterocolitica serotype 
O:3 was isolated from a 34-year-old Indian woman. 
 
2.2 Yersiniosis and clinical characteristics 
Human yersiniosis occurs when Y. enterocolitica enters the gastrointestinal tract 
after ingestion of contaminated food or water. Y. enterocolitica that survive through the 
barrier of first line of body's defense (stomach acid) will adhere to mucosal cells in the 
Peyer’s patches (adhesion), invade (invasion) phagocytic cells, extracellular 
multiplication, and produce a local inflammatory response. The damage to the 
absorptive epithelial cells results in mal-absorption and fluid loss that characterized as 
diarrhea (Fàbrega & Vila, 2012).  
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In developed countries, yersiniosis commonly occurs in infants and young 
children. Approximately 75% of patients with Y enterocolitica infection are children 
aged 5-15 years (Ackers, et al., 2000; Gómez-Duarte, et al., 2010). Yersiniosis usually 
causes self-limiting diarrhea with symptoms including abdominal pain, fever and 
diarrhea, sometimes nausea and vomiting, is often indistinguishable from those of acute 
appendicitis. In some cases, it causes extraintestinal sequelae, septicemia and fatal 
systematic infection. 
 
2.3 Mode of transmission 
2.3.1 Foodborne Transmission 
Majority of the incidence of yersiniosis is foodborne transmitted. Human 
yersiniosis is usually sporadic and the source of infection is unknown. Infection is 
generally caused by the ingestion of contaminated foods that usually raw or 
inadequately cooked. Outbreaks of yersiniosis that involved ingestion of contaminated 
food have occurred in several countries such as China, Norway, United States, Japan, 
and India (Abraham, et al., 1997; Ackers, et al., 2000; Grahek-Ogden, et al., 2007; 
Jones, et al., 2003; MacDonald, et al., 2012; Sakai, et al., 2005; Zheng & Jiang, 2006).  
 
2.3.2 Human-to-Human Transmission 
Another possible route of transmission is human-human transmission. Human-
to-human transmission was reported in a familial outbreak of Y. enterocolitica 
bioserotype 2/O:9 in Japan, where the bacterium is transmitted from a infected carrier to 
the family members through food and direct human contact (Moriki, et al., 2010). 
Besides that, another person-to-person Y. enterocolitica transmission was reported in an 
outbreak of diarrheal disease due to Y. enterocolitica serotype 0:5, biotype 1 that 
involved nine hospitalized patients (Ratnam, Mercer, Picco, Parsons, & Butler, 1982). 
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2.3.3 Animal-to-Human Transmission 
Y. enterocolitica infection can occur after the contact with infected or carrier 
animals. Transmission is possible through direct contact between farm workers and the 
life stocks (i.e. animal bits or saliva) or indirectly through animal feces or water 
contaminated by animals. Infected dogs and cats (companion animals or stray pets) can 
cause human yersiniosis when they are in contact with humans, i.e. through contact with 
animals’ excreta such as saliva and faeces (Fenwick, Madie, & Wilks, 1994; Stamm, 
Hailer, Depner, Kopp, & Rau, 2013; Wang et al., 2010). 
  
2.3.4 Direct Transmission 
Direct transmission is extra-intestinal disease. It is normally transmitted through 
skin injuries such as cut wound to a person. Many studies showed the infected persons 
did not show any symptoms of gastrointestinal disease but suffering abscesses (i.e. thigh 
abscess, axillary abscess, etc) (Gumaste, Boppana, Garcha, & Blair, 2012; Kelesidis, 
Balba, & Worthington, 2008; Menzies, 2010).  
 
2.3.5 Blood Transfusion-Associated Transmission 
Y. enterocolitica that occurs occasionally in blood of a healthy donor 
(asymptomatic, with diarrhea history) is transmitted to a recipient during blood 
transfusion. Following a blood transfusion, infected recipients could develop 
transfusion-associated sepsis or septicemia (Hoelen, Tjan, Schouten, Dujardin, & van 
Zanten, 2007; Leclercq, et al., 2005). Blood transfusion-associated septicemia is rare, 
however, the overall fatality rate calculated is about 55% (from the 55 published case 
reports over the year 1975-2007) (Guinet, Carniel, & Leclercq, 2011).  
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2.4 Classification and typing of Y. enterocolitica 
According to Bergey s´ Manual of Systematic Bacteriology, the Y. enterocolitica 
belongs to the phylum Proteobacteria, class Gammaproteobacteria, order 
Enterobacteriales, family Enterobacteriaceae, genus Yersinia, species enterocolitica 
(Kreig, et al., 1984). Strains of Y. enterocolitica are biotyped into six biovars, which 
include biotypes 1A, 1B, 2, 3, 4, and 5 based on their biochemical reactions (Wauters, 
Kandolo, & Janssens, 1987), and more than 50 serotypes according to their composition 
of lipopolysaccharide (LPS) antigens. Strains of Y. enterocolitica are further separated 
into three main pathotypes based on pathogenicity: high pathogenicity biotype 1B; 
moderate pathogenicity biotype 2, 3, 4, and 5; and no pathogenicity biotype 1A (Bari, 
Hossain, Isshiki, & Ukuku, 2011; Lamps, Havens, Gilbrech, Dube, & Scott, 2006). 
 
2.5 Geographical distribution of biotypes of Y. enterocolitica strains 
The geographical distribution of Y. enterocolitica is diverse. The bioserotype 
1B/O:8 is referred as the American strain, is mainly found in North America followed 
by Japan but is extremely rare in Europe (Fukushima, Shimizu, & Inatsu, 2011). It can 
be found in the environment (including water) and responsible for human outbreaks. 
Biotypes 2, 3, 4, and 5 are referred to as the European strains or non-American strains 
and are mainly isolated from animals (pig and cattle) and humans and are very seldom 
reported to be isolated from environment (Fukushima, et al., 2011). Strains of 
bioserotype 3/O:3 have been frequently reported in many Asian countries like Japan, 
Taiwan, Korea and China  (Fukushima, et al., 1997; Fukushima, et al., 2011; Lee, et al., 
2004; Zheng & Xie, 1996). Members of biotype 1A (NP Y. enterocolitica) are widely 
isolated from the environment, animal and also food (Fukushima, et al., 2011; Paixão, et 
al., 2013).  
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2.6 Reservoirs of Y. enterocolitica 
Y. enterocolitica is widely spread in nature and it has been routinely isolated 
from various natural sources such as animals, foods, and environment (Fredriksson-
Ahomaa & Korkeala, 2003; Paixão, et al., 2013). Numerous studies have been carried 
out in isolating Y. enterocolitica from various animals from farms, wildlife, and pet 
animals. These animals are swine (Liang et al., 2012; Van Damme, et al., 2013), cattle 
(McNally, et al., 2004), sheep (Chenais, Bagge, Lambertz, & Artursson, 2012; 
Söderqvist, Boqvist, Wauters, Vågsholm, & Thisted-Lambertz, 2012), goats (Arnold, et 
al., 2006), rats (Kaneko & Hashimoto, 1981), wild boars (Fredriksson-Ahomaa, 
Wacheck, Bonke, & Stephan, 2011), dogs (Wang, et al., 2010), cats  (Fredriksson-
Ahomaa, Korte, & Korkeala, 2001), birds (Niskanen, Waldenstrom, Fredriksson-
Ahomaa, Olsen, & Korkeala, 2003) and many other animals. Among them, swine is 
considered as a major reservoir of Y. enterocolitica.   
Pigs are often reported to be asymptomatic carriers for strains of bioserotype 
4/O:3. The prevalence of this bioserotype in pigs from farms or slaughterhouses in 
different countries is as follows: Belgium (11.0%) (Van Damme, et al., 2013), Italy 
(20.9%) (Bonardi, et al., 2013), Finland (56%)  (Korte, Fredriksson-Ahomaa, Niskanen, 
& Korkeala, 2004), Swiss (96%) (Fredriksson-Ahomaa, Stolle, & Stephan, 2007), and 
southern Germany (60%) (Fredriksson-Ahomaa, Bucher, Hank, Stolle, & Korkeala, 
2001). In China, the most prevalent bioserotype in pigs is 3/O:3 (844/850 strains) 
(Liang, et al., 2012). Other bioserotypes of Y. enterocolitica isolated from pigs are 
2/O:9, 2/O:5,27,  1B/O:8, and biotype 1A  (Fredriksson-Ahomaa, et al., 2007; Liang, et 
al., 2012; Paixão, et al., 2013). 
Y. enterocolitica is often present in the oral cavity of pigs especially tonsils and 
throat, feces and lymph nodes (Gutler, Alter, Kasimir, Linnebur, & Fehlhaber, 2005; 
Nesbakken, Eckner, Hřidal, & Rřtterud, 2003; Novoslavskij, et al., 2013; Okwori et al., 
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2009). Strains of Y. enterocolitica have been frequently isolated in raw pork as a result 
of cross contamination of the organisms via oral cavity, feces, and intestinal contents 
during slaughtering, cutting, further processing and distribution of fresh pork and offals 
(Fredriksson-Ahomaa, Bucher, et al., 2001; Fredriksson-Ahomaa, et al., 2007; Grahek-
Ogden, et al., 2007; Ortiz Martínez, 2010; Terentjeva & Berzins, 2010). Due to the 
psychrotrophic behavior of Y. enterocolitica, it might survive and further multiply 
during the storage of the pork meat and other porcine products. 
Other vehicles of yersiniosis include ruminant and ruminant products 
(Fukushima, et al., 1997), poultry (Dallal, et al., 2010), vegetables (Lee, et al., 2004; 
Xanthopoulos, et al., 2010), milk and dairy products  (Ackers, et al., 2000; Harakeh, 
Saleh, Barbour, & Shaib, 2012; Yucel & Ulusoy, 2006), ready-to-eat food (MacDonald, 
et al., 2012; Xanthopoulos, et al., 2010) and chitterlings (Lee, et al., 1990). 
In Malaysia, there is limited study on Y. enterocolitica. The only food related 
prevalence report in Malaysia was from an unpublished study of Dzomir (2005), Y. 
enterocolitica (bioserotype 1A/O:52, 53 and 1A/O:41, 42) was isolated from beef 
burger meat and chicken burger meat. 
 
2.7 Isolation and detection methods for Y. enterocolitica 
2.7.1  Conventional methods for detection of Y. enterocolitica 
 2.7.1.1  Enrichment 
There are numerous enrichment schemes available in isolating Y. enterocolitica 
such as the International Standard Organisation method (ISO 10273:2003) (European 
Food Safety Authority & European Centre for Disease Prevention and Control, 2007), 
and United States Department of Agriculture (USDA) protocol (Johnson, 1998). These 
enrichment procedures include direct selective enrichment at higher temperature 
(normally at ~25°C) for 3 to 5 days incubation or cold enrichment (~4°C) that takes 
time up to one-month incubation.  
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Selective enrichment at higher temperature inhibit the growth of some 
background microflora (the media contain antimicrobial agents) and at the same time 
allow the multiplication of Y. enterocolitica (in low number) present in samples. Cold 
enrichment is useful for enrichment of Y. enterocolitica as psychrophilic bacteria that 
able to grow and multiply at 4°C. Cold enrichment in phosphate buffered saline (PBS) 
or in phosphate buffered saline with sorbitol and bile salts (PSB) has been widely used 
for clinical, environmental, and food samples (Fredriksson-Ahomaa, et al., 2011; 
Rahman, Bonny, Stonsaovapak, & Ananchaipattana, 2011). Some researchers claimed 
that cold enrichment yield better recovery of Y. enterocolitica (Fukushima, et al., 2011). 
However, no single culture protocol which has been described performed equally well 
for the isolation of Y. enterocolitica serotypes from all types of samples. In a recent 
study, Van Damme, et al. (2013) reported that enrichment in PSB at 25°C recovered 
more positive samples than selective enrichment and cold enrichment. Irgasan-
ticarcillin-potassium chlorate (ITC) broth is reportedly better in recovering of Y. 
enterocolitica 4/O:3 from pig tonsils than cold enrichment in PSB  (Van Damme, 
Habib, & De Zutter, 2010). Yersinia selective enrichment broth according to Ossmer 
(YSEO) is also reportedly good in isolation of Y. enterocolitica (Hudson, et al., 2008; 
King & Hudson, 2006). Therefore, combination of several enrichment broths should be 
used concurrently for better isolation rate.  
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2.7.1.2  Selective or isolation agar for Y. enterocolitica 
Following the enrichment steps, the enriched samples will be streaked onto 
selective medium or media for identification of presumptive Y. enterocolitica. Many 
selective agars have been used for isolation of Y. enterocolitica from food, clinical, 
environment and livestock samples. These agars include cellociose-arginine-lysine 
(CAL) agar (Dudley & Shotts Jr, 1979), Congo red brain heart infusion agarose (CR-
BHO) agar (Bhaduri, Turner-Jones, Taylor, & Lachica, 1990), Congo red magnesium 
oxalate (CR-MOX) agar (Riley & Toma, 1989), Statens Serum Institut (SSI) agar 
(Blom, Meyer, Gerner-Smidt, Gaarslev, & Espersen, 1999), pectin agar (Bowen & 
Kominos, 1979), cefsulodin-irgasan-novobiocin (CIN) agar (Schiemann, 1979), 
Salmonella-Shigella-deoxycholate-calcium chloride (SSDC) agar (Wauters, Goossens, 
Janssens, & Vandepitte, 1988), BABY4 agar (Bercovier, et al., 1984), virulent Yersinia 
enterocolitica (VYE) agar (Fukushima, 1987), Yersinia-selective medium (KV202) agar 
(Jiang, Kang, & Fung, 2000), MacConkey (MAC) agar with Tween 80 (Lee, 1977), 
DYS agar (Agbonlahor, Odugbemi, & Dosunmu-Ogunbi, 1982), and MAC with 1% L-
rhamnose and 1% D-arabitol (RAM) agar (Shehee & Sobsey, 2004).  
Among these agars, CIN agar is reportedly to be more specific compared to 
other conventional selective agars such as SS, MAC, CAL, pectin agars and other 
lactose-containing media tested (Head, Whitty, & Ratnam, 1982). One of the 
weaknesses of CIN is that this medium fails to distinguish Y. enterocolitica from several 
other mannitol-fermenting bacterial species such as Serratia liquefaciens, Enterobacter 
agglomerans, Aeromonas spp., Citrobacter spp., and other non-pathogenic Yersinia spp. 
as all of them appear as red “bull’s eye” on CIN plates (Head, et al., 1982). Additional 
biochemical tests such as esculin, phenylalanine deaminase, arginine dihydrolase, 
hydrogen sulphide, urease, or lysine decarboxylase are needed to further differentiate Y. 
enterocolitica from the others (Weagant & Feng, 2001).  
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Chromogenic-based media are increasingly popular in recent years for isolation 
of enterobacteria. To date, two chromogenic media have been developed for the specific 
detection of virulent Y. enterocolitica. These media are named Yersinia enterocolitica 
chromogenic medium (YeCM) (Weagant, 2008) and Yersinia enterocolitica agar 
(YECA) (Denis, Houard, Labbé, Fondrevez, & Salvat, 2011). Both media allow the 
differentiation of virulent Y. enterocolitica from non-virulent Y. enterocolitica and other 
enterobacteria.  
 
2.7.1.3   Identification of Y. enterocolitica by using biochemical tests 
Presumptive Y. enterocolitica isolates from the selective agar plates will be 
picked and identified by biochemical tests either through conventional tube tests such 
as: Gram, urease, motility at 25ºC and 37ºC, arginine dihydrolase, lysine decarboxylase, 
phenylalanine deaminase, H2S production, indole production, Voges-Proskauer, citrate 
utilisation, L-ornithine, mucate, pyrazinamidase, sucrose, cellobiose, L-rhamnose, 
melibiose, L-sorbose, and L-fucose tests or using rapid identification kits such as API 
20E, MICRO-ID, Vitek GNI Card, Gene-trak system and BBL Crystal 
Enteric/Nonfermenter (Archer, Schell, Pennell, & Wick, 1987; European Food Safety 
Authority & European Centre for Disease Prevention and Control, 2007; Linde, 
Neubauer, Meyer, Aleksic, & Lehn, 1999; Manafi & Holzhammer, 1994; Sharma, 
Doyle, Gerbasi, & Jessop, 1990; Varettas, Mukerjee, & Schmidt, 1995). 
 
2.7.2 Polymerase chain reaction (PCR)-based method for detection of Y. 
enterocolitica 
The conventional isolation methods for detection of Y. enterocolitica normally 
take approximately 3-5 days for enrichment at higher temperature (~25°C) and up to 3-4 
weeks for cold enrichment (~4°C) to complete the whole sets of isolation procedures in 
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confirming the identity of isolates. This is laborious and time consuming. PCR-based 
method can be implemented to shorten the analytical process to 1 - 3 days. Besides that, 
PCR-based method is a rapid and sensitive technique that can identify isolates and at the 
same time separates pathogenic and non-pathogenic strains within the same species 
easily. 
For detection of Y. enterocolitica, the Y. enterocolitica 16S rRNA gene region is 
used (Wannet, Reessink, Brunings, & Maas, 2001). For the detection of pathogenic Y. 
enterocolitica, different virulence genes are used. These genes are either plasmid- or 
chromosome-located. Some of the plasmid-located genes are the virF gene (Bhaduri & 
Pickard, 1995; Thoerner, et al., 2003) and yadA gene (Lantz, et al., 1998) that 
responsible for transcriptional activator for many Yersinia outer membrane proteins. 
The chromosome located genes are: the Yersinia heat stable enterotoxin gene (yst) 
(Gómez-Duarte, Bai, & Newell, 2009; Thoerner, et al., 2003), the ail gene for the 
attachment invasion locus (Bhaduri & Pickard, 1995; Wannet, et al., 2001); the invasin 
gene (inv); and the rfbC gene (Weynants, Jadot, Denoel, Tibor, & Letesson, 1996) 
located within the rfb cluster responsible for the biosynthesis of the O-side chain of Y. 
enterocolitica serotype O:3.  
 
2.8 Characterization 
2.8.1 Biotyping and serotyping 
 Biotyping is essential in the differentiation of pathogenic and non-pathogenic Y. 
enterocolitica strains; whereas serotyping is useful in subgrouping the Y. enterocolitica 
strains within each biotype. According to Wauters, et al. (1987) eight biochemical tests 
are applied for biotype of Y. enterocolitica (Table 2.1) and serotyping is done by using 
commercial O-antisera. 
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Table 2.1. Biotyping scheme for Y. enterocolitica 
a
. 
Biochemical tests Biotypes
b
 
1A 1B
c
 2
c
 3
c
 4
c
 5
c
 
Lipase (Tween-esterase) + + - - - - 
Esculine/salicin 24h
d
 +, - - - - - - 
Indole + + (+)
e
 - - - 
Xylose + + + + - V
f
 
Trehalose/NO3
g
 + + + + + - 
Pyrazinamidase + - - - - - 
β-ᴅ-Glucosidase + - - - - - 
Voges-Proskauer(VP) + + + +
h
 + (+) 
DNase - - - - + + 
a Modified from Wauters, et al. (1987); b reactions from tests incubated at 25-28°C, with the exception of β-ᴅ-Glucosidase 
whichwas incubated at 30 °C and salicin which was incubated at 35 °C. Incubation at other temperatures may result in different 
results and biotypings; c biotype contains pathogenic strains; d esculin and salicin reactions for a given strain of Y. enterocolitica are 
nearly always identical so they are listed together in this table; e indicates a delayed positive reaction; f Indicates variable reactions;  g 
trehalose and nitrate reduction reactions for a given strain of Y. enterocolitica are nearly always identical so they are listed together 
in this table; h rarely, a serotype O:3 strain may be negative for VP. 
 
2.8.2  Genotyping 
There are numerous genotyping methods available in comparing the genetic 
relatedness of Y. enterocolitica strains. These methods include restriction endonuclease 
analysis of plasmid (REAP), restriction endonuclease analysis of chromosome (REAC) 
and Southern blotting, ribotyping, ramdomly amplified polymorphic DNA (RAPD), 
pulsed-field gel electrophoresis (PFGE), amplified fragment length polymorphism 
(AFLP), multiple-locus variable number tandem repeat analysis (MLVA), and DNA 
sequencing (Fredriksson-Ahomaa, Stolle, & Korkeala, 2006; Virtanen, et al., 2013). 
Among them, PFGE is the most widely used subtyping method with good 
discriminatory power and excellent typeability and reproducibility (Fredriksson-
Ahomaa, Stolle, Siitonen, & Korkeala, 2006). 
PFGE is a technique used for separation of large-sized DNA fragments of the 
whole bacterial genome (restricted with various rare-cutting restriction enzymes) by 
applying to a agarose gel with electric field that changes periodically in direction. PFGE 
is considered the gold standard in bacterial subtyping because it provides highly 
reproducible restriction profiles as compared to many other genotyping methods. The 
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most frequently used restriction enzyme in PFGE typing of Y. enterocolitica strains is 
NotI, followed by XbaI. Paixão, et al. (2013) compared PFGE with single enzyme (SP)-
AFLP and Enterobacterial Repetitive Intergenic Consensus (ERIC)-PCR, and found that 
PFGE was the most discriminative technique in subtyping the Y. enterocolitica strains. 
Several studies showed that PFGE allows subtyping of strains that belong to the same or 
different bioserotype (Fredriksson-Ahomaa, Cernela, Hächler, & Stephan, 2012; Liang, 
et al., 2012; Lucero Estrada, et al., 2011; Paixão, et al., 2013). 
 
2.8.3 Virulence factors 
The virulence of the pathogenic Y. enterocolitica biotypes (1B and 2 to 5) 
depends on the presence of the  ~70 kb virulence plasmid (pYV plasmid), Ysc-Yop type 
III secretion system (TTSS), chromosomal-encoded virulence genes including ail, myfA, 
ystA, ysa, and the high pathogenicity island- (HPI-) associated iron acquisition system 
(Cornelis, et al., 1998; Revell & Miller, 2001). More than 15 virulence genes have been 
discovered currently that are associated with the virulence of Y. enterocolitica (Table 
2.2). In order to develop a full virulence of pathogenic Y. enterocolitica, the strains 
require the expression of the virulence genes that are located in chromosome and pYV 
plasmid. However, all these virulence genes are not necessarily present and expressed 
simultaneously in the pathogenic strains (Zheng, Sun, Mao, & Jiang, 2008).  
The biotype 1A is considered nonpathogenic primarily due to the loss of 
virulence pYV plasmid and most of the chromosomal virulence genes such as ail, myfA, 
ystA, ysa, and TTSS, and only occasionally carry myfA and ystA (Kot, Piechota, & 
Jakubczak, 2010). Although the biotype 1A strains are nonpathogenic, they are 
frequently reported to cause gastrointestinal disease in humans (Pham, Bell, & 
Lanzarone, 1991; I. Singh, Bhatnagar, & Virdi, 2003; Stephan, et al., 2013). The 
virulence genes such as ail, ystA, ystB, virF and yadA that are normally present in the 
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pathogenic Y. enterocolitica were found in the biotype 1A strains (Paixão, et al., 2013; 
Sihvonen, Hallanvuo, Haukka, Skurnik, & Siitonen, 2011; Stephan, et al., 2013; H. 
Zheng, et al., 2008).  
 
2.8.4 Antimicrobial susceptibility profiles  
In general, the antimicrobial susceptibility patterns for Y. enterocolitica reported 
by researchers world-wide are different. This may because of the impact of 
geographical location, local selective pressure and other factors that causes the deviation 
in the antimicrobial resistance among the strains from different places. However, Y. 
enterocolitica is normally resistant to penicillin, ampicillin and first generation of 
cephalosporins (Fàbrega & Vila, 2012). In Malaysia, there is limited information on the 
resistance status of the indigenous strains of Y. enterocolitica. In other countries, Y. 
enterocolitica strains isolated from pigs are sensitive to aztreonam, cefotaxim, 
ciprofloxacin, chloramphenicol, colistin, gentamicin, nalidixic acid and tetracycline, and 
moderately susceptible to amoxicillin/clavulanic acid. Y. enterocolitica strains 
associated with human infections in Switzerland are sensitive to ceftazidim, 
ciprofloxacin and gentamicin, and resistant to ampicillin and cefalothin (Fredriksson-
Ahomaa, et al., 2012). In China, majority of the Y. enterocolitica strains isolated from 
diarrheal patients are reported susceptible to third-generation cephalosporins, 
aminoglycosides, fluoroquinolones, and trimethoprim-sulfamethoxazole, and only small 
portion is susceptible to the first-generation cephalosporins and penicillins (Zheng, et 
al., 2008). 
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Table 2.2. Virulence-associated determinants of pathogenic Y. enterocolitica. 
Genes Determinant Function References 
pYV plasmid   
yadA
c
 
YadA, a Yersinia outer membrane 
protein adhesin A 
Major adhesion for attachment, being essential for induction of disease and 
protects the bacterium being killed by neutrophils; involved in 
autoagglutination, after growth in tissue culture medium at 37 °C. 
(Cornelis, et al., 1998) 
virF
c
 Transcriptional regulator 
Transcriptional activator controlling the yop regulon and responsible for the 
effect of temperature on the production of the Yops. 
(Rouvroit, Sluiters, & Cornelis, 
1992) 
ysc, ysa 
Yops, a type III protein secretory 
apparatus 
Resistance to phagocytosis, complement-mediated lysis and allow the 
proliferate extracellularly in tissues. 
(Cornelis, Sluiters, De Rouvroit, & 
Michiels, 1989) 
tccC Insecticidal toxin-like protease Virulence expression (Bhagat & Virdi, 2007) 
    
Chromosome   
inv
c
 Invasin, an outer membrane protein For efficient translocation of bacteria across the intestinal epithelium (Miller & Falkow, 1988) 
ail
c
 Ail, an outer membrane protein Contribute to adhesion, invasion, and resistance to complement-mediated lysis 
(Miller & Falkow, 1988; Pierson & 
Falkow, 1993) 
ystA
c
, 
ystB, 
ystC 
Yst, Yersinia 
stable heat-stable enterotoxin 
Contribute to the pathogenesis of diarrhea associated with acute yersiniosis 
(Huang, Yoshino, Nakao, & 
Takeda, 1997; Robins-Browne, 
Still, Miliotis, & Koornhof, 1979; 
Thoerner, et al., 2003) 
myfA
c
 
MyfA protein, the major subunit of Y. 
enterocolitica Myf fimbriae 
Fimbrial antigen and putative adhesin (Zacharczuk & Gierczyński, 2010) 
fepA, 
fepD 
Enterochelin receptor protein and 
enterochelin ABC transporter, 
respectively 
Enterochelin transport 
(Schubert, Fischer, & Heesemann, 
1999) 
fes Enterochelin esterase Release of iron during enterochelin transport (Schubert, et al., 1999) 
ymoA Yersinia modulator Modulating the expression of virulence functions 
(Cornells et al., 1991; Grant, 
Bennett-Wood, & Robins-Browne, 
1998) 
hreP 
Subtilisin/kexin-like protease/ 
invasion protein 
Bacterial invasion 
(Bhagat & Virdi, 2007; Heusipp, 
Young, & Miller, 2001) 
sat Streptogramin acetyltranferase Polypeptide antibiotics inhibiting protein 
(Bhagat & Virdi, 2007; Seoane & 
Lobo, 2000) 
cclassical virulence markers 
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2.8.5 Usage of antimicrobial agents in food-producing animals 
It has been well documented that large amounts of drugs are used in food-
producing animals, either in feeds or medications in the control, prevention and 
treatment of disease or promotion of growth (Cromwell, 2002; Rajić, Reid-Smith, 
Deckert, Dewey, & McEwen, 2006; Rosengren, Gow, Weese, & Waldner, 2010). In 
Malaysia, the most commonly used antimicrobial agents in animal feeds are procaine 
penicillin, streptomycin, chlortetracycline, tylosin, oxytetracycline, neomycin, 
sulphonamides, and spiramycin (Mohamed, Nagaraj, Chua, & Wang, 2000). The 
application of antimicrobials in food production has successfully suppressed or 
inhibited the growth of some pathogens and minimised benefits loss to animal industry. 
However, the indiscriminate use of antimicrobial agents in animals leads to the selection 
of the antimicrobial resistant bacteria. Several reports indicated that the excessive usage 
of antimicrobial agents in food-producing farms caused increment in the resistance rates 
in enteric pathogens and other bacteria (Oliver, Murinda, & Jayarao, 2011; Rajić, et al., 
2006; Varga et al., 2009). The release of drug residues and the selection of “superbug” 
from the food animals to the environment and final consumer (humans) are of a public 
health concern. Therefore, investigation of the antimicrobial profiles of Y. enterocolitica 
isolated in Malaysia is very important in understanding the current resistant trend in this 
country. 
 
2.8.6 Treatment and prevention of yersiniosis in humans 
According the World Health Organization (WHO) and Centre of Disease 
Control and Prevention, USA (CDC)’s recommendations, no antimicrobial treatment 
will be given to normal gasterointestinal infection. Yersiniosis is normally self-limiting, 
and infected personnel will recover by simple medication and proper rest. 
Antimicrobials treatment is normally given to patients who are suffering enterocolitis, 
septicaemia or invasion infection. The recommended antimicrobials given are 
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tetracyclines, chloramphenicol, trimethoprim-sulphamethaxazole, second and third 
generation of cephalosporins, ciprofloxacin, fluoroquinolones and aminoglycosides 
(WHO; CDC). In reducing the emergence of antimicrobial resistant Y. enterocolitica 
strains, the antimicrobial profile of the bacterial strains has to be known in order to 
avoid blind treatment and guarantee effective treatment in patients. 
The prevention of infection with Y. enterocolitica depends mainly on good 
hygiene practices during food processing and food preparation. Poor sanitation and 
improper cooking or sterilization technique by food handlers are known as the main 
reason for yersiniosis outbreak. Food handlers should also prevent cross-contamination 
in the kitchen in using separate cutting boards for meat and other foods. Cutting boards, 
utensil and other dishes should wash with soap and hot water each time after raw meat 
preparation. Good hygiene practices also include washing hands thoroughly with soap 
and water before eating, before and after food preparation and after contact with 
animals. Consumers should avoid eating raw or undercooked pork or other meat 
products, consume only pasteurized milk or milk products. For pet’s owners, animal 
faeces are disposed in a sanitary manner. 
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3.1 Materials 
3.1.1 Media 
 All the media used for isolation, biochemical tests, culturing and 
characterization of Yersinia enterocolitica are listed in Appendix I. 
 
3.1.2 Chemicals and reagents 
 Chemicals and reagents used in this study are listed in Appendix II. 
 
3.1.3 Buffers and solutions 
Buffers and solutions used in this study are listed in Appendix III. 
 
3.2 Isolation and characterization of Y. enterocolitica from raw food samples 
and swine 
3.2.1 Sampling 
3.2.1.1  Raw pork products  
Between June 2010 to March 2011, 58 raw pork samples were sampled from 
wet markets at selected states in Peninsular Malaysia (Kuala Lumpur, Perak and 
Pahang) (Table 3.1). The location of the slaughtering houses from where the raw pork 
samples came from was unknown because the information was disclosed in the 
slaughtering house. Background information of the sampling sites, samples and date of 
sampling is tabulated in Appendix IV. A convenience sampling was performed in 
choosing the sampling locations. Random selection of participating wet markets was not 
possible in this observational study as the distribution and number of wet markets 
selling raw pork and pork products in each state is limited and unknown. 
The raw pork samples were further grouped into three categories as raw pork 
meats (n=25), raw pork internal organs (n=23) and other parts (n=10) (Table 3.2). All 
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samples in this study were transferred in sterile plastic bags and transported in ice box 
to the laboratory.  
Table 3.1. Locations of wet markets and number of samples collected. 
Location No. of samples collected, n 
Kuala Lumpur 48 
    Wet market A 36 
    Wet market B 12 
  
Perak 9 
    Wet market C 4 
    Wet market D 5 
  
Pahang 1 
    Wet market G 1 
  
Total samples collected, N 58 
 
Table 3.2. Sample types collected from wet markets. 
Sample types No. of samples collected, n 
Raw pork meats 25 
    Whole pork 21 
    Minced pork 3 
  
Raw pork internal organs 23 
    Liver 5 
    Intestine 8 
    Heart 5 
    Kidney 4 
    Throat 1 
  
Other parts 10 
    Skin 4 
    Foot 2 
    Fat tissue 1 
    Ear 1 
    Eye tissue 1 
    Nose 1 
  
Total samples collected, N 58 
 
3.2.1.2  Raw non-porcine food 
Forty-eight raw non-porcine food were purchased from wet markets (located in 
Kuala Lumpur, Selangor and Pahang) and examined for the presence of Y. 
enterocolitica (Table 3.3). Background information of the sampling sites, samples and 
date of sampling are tabulated in Appendix V. A convenience sampling was performed 
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in choosing the sampling locations. Random selection of participating wet markets was 
not possible in this observational study as the distribution and number of wet markets in 
each state was unknown. Food types purchased included raw vegetables (n=19), raw 
seafood (n=11), raw poultry products (n=9), raw beef (n=6), tofu (n=2), and pasteurised 
milk (n=1) (Table 3.4).  
Table 3.3. Location of wet markets and number of samples collected. 
Location Number of samples collected, n 
Kuala Lumpur 10 
    Wet market A 7 
    Wet market B 3 
Selangor 18 
    Wet market E 11 
    Wet market F 7 
Pahang 20 
    Wet market G 20 
  
Total samples collected, N 48 
 
Table 3.4. Sample type collected from wet markets. 
Food type No. of samples 
Raw beef 6 
  
Raw poultry products 9 
    Chicken meat 8 
    Chicken claw 1 
  
Raw seafood 11 
    Fish 6 
    Squid 3 
    Prawn 1 
    Cockles 1 
  
Raw vegetables 19 
    Leafy vegetables 11 
    Bitter gourd 3 
    Cowpea 1 
    Root 1 
    Sweet potato 1 
    Brinjal 1 
    Lady’s finger 1 
  
Raw tofu 2 
  
Pasteurised milk 1 
  
Total 48 
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 3.2.1.3  Pigs (Swab specimens) 
The presence of Y. enterocolitica from pigs in selected farms was investigated 
during the period of October 2010 to September 2011. Random selection of 
participating pig farms was not possible in this observational study as farm access and 
selections were limited. The sampling schedules were dependent on the availability of 
the veterinary doctor. A total of nine pig farms located in three states in middle- and 
north- western part of Peninsular Malaysia (Table 3.5), i.e., Selangor (Farms A, B, C), 
Perak (Farms D, E, F), and Penang (Farms G, H, I) were enrolled in this study. Pig 
industry in Malaysia is highly condensed and commercialised in Penang, Perak and 
Selangor and more than 100 farms are located in these area. Background information of 
the sampling sites, number of pigs, samples and date of sampling are tabulated in 
Appendix VI. These three states are important pig-producing states in Malaysia 
(Department of Veterinary Services, Malaysia, 2011).  
A stratified random sampling was performed in categorising the pigs based on 
the general health condition, i.e. healthy (pigs without prominent disease symptoms) 
and unhealthy (sick, weak and runt). A total of 165 pigs were selected (Table 3.5; farms 
A, n=9; B, n=14; C, n=30; D, n=20; E, n=20; F, n=20; G, n=16; H, n=20; I, n=16) and 
three specimens (nasal, oral and rectal swabs) were collected from each pig and 
maintained in Cary-Blair transport medium (Oxoid, UK). Age grouping of pig is 
tabulated in Table 3.6. Pigs with similar age group are fed in the same pens in the farms 
and the age groups were recorded at the time of the sampling. A veterinary doctor 
determined the age group determination during the sampling. 
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Table 3.5. Location of pig farms and number of pigs and samples collected. 
Location Number of pigs Number of samples 
Selangor 53 159 
    Farm A, Tanjung Sepat 9 27 
    Farm B, Tanjung Sepat 14 42 
    Farm C, Tanjung Sepat 30 90 
   
Perak 60 180 
    Farm D, Gopeng 20 60 
    Farm E, Sungai Siput 20 60 
    Farm F, Sungai Siput 20 60 
   
Penang 52 156 
    Farm G, Sungai Jawi 16 48 
    Farm H, Kampung Selamat 20 60 
    Farm I, Kampung Selamat 16 48 
   
Total samples collected, N 165 495 
 
Table 3.6. Age grouping of pig. 
Group Age 
Piglet < 4 weeks 
Weaner 1 –2 months 
Grower 2 – 4 months  
Finisher 4 – 6 months 
Sow Mother pig 
 
 
3.2.2 Isolation methods  
 3.2.2.1  Enrichment methods for raw food samples 
  3.2.2.1.1 Normal enrichment 
Raw food were analysed for the presence of Y. enterocolitica by conventional 
culture methods and post-enrichment PCR screening. Enumeration of Y. enterocolitica 
was performed using a 3 × 3 most probable number (MPN) method. 
Five g of raw food sample was cut into small pieces, added to 45 ml of selective 
enrichment broth in sterile plastic bag and homogenised manually by hand. Enrichment 
broths used were phosphate buffered saline (PBS, Sigma, Germany), Yersinia selective 
enrichment broth according to OSSMER (YSEO, Merck, Germany), and irgasan-
ticarcillin-potassium chlorate (ITC) broth [ITC broth base (Fluka, Germany) 
supplemented with ticarcillin supplement (Fluka) and potassium chlorate supplement 
CHAPTER 3   MATERIALS AND METHODS 
 
28 
 
(Fluka)]. Food homogenates in ITC and PBS were incubated at 25 °C for 2 days and 4 
°C for 3 weeks, respectively, and food homogenate in YSEO was used for MPN 
enrichment for food safety enumeration. The enrichment was followed by plating onto 
selective agars for isolation of presumptive Y. enterocolitica. 
 
3.2.2.1.2 MPN enrichment and MPN calculation 
After the food particles in YSEO settled down, the fluid was dispensed into a 3 
× 3 MPN system consisting of 10 ml of undiluted fluid in each of three 10 ml test tubes 
(level A), 1 ml of fluid in 9 ml YSEO broth in each three 10 ml test tubes (a 1:10 
dilution, level B), and 1 ml of a 1:10 dilution of the fluid in 9 ml YSEO broth in each 
three 10 ml test tubes (a 1:100 dilution, level C), incubated at 25 °C for 18 h (Hudson, et 
al., 2008). The MPN enrichment was followed by plating onto selective agars for 
isolation of presumptive Y. enterocolitica. 
The three digits for each level in the 3 × 3 MPN system were determined based 
on the post-enrichment PCR screening results (the YSEO enriched tubes). One ml of 
each post-enrichment tube was retained in a sterile 1.5 ml microfuge tube after its 
respective incubation period. DNA extraction and PCR screening as described in 
Section 3.2.4.2 were performed. The MPN/g value was calculated using the Microsoft 
Excel spreadsheet provided by Institute of Environment Science and Research (ESR), 
New Zealand (Hudson, et al., 2008). The range over which these nine tubes MPN 
system operates was between 0.30 MPN/g (lower confidence interval, LCI of 0.07 with 
one positive at level A) to 44.84 MPN/g (upper confidence interval, UCI of 198.70). 
The MPN step was not performed for raw non-porcine food and swine specimens. MPN 
determination was not applicable to swine specimens since the specimens were not 
categorized as food samples. 
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3.2.2.2  Enrichment method for swine specimens 
Swine specimens were processed with two methods, i.e. (i) direct streaking on 
selective agar plates and (ii) enrichment in ITC and PBS broths (as described in Section 
3.2.2.1.1) followed by streaking on selective agar plates. Direct streaking was used to 
replace the MPN enrichment method used for raw food samples (swab specimens are 
not categorized as food). The enrichment was followed by plating onto selective agars 
for isolation of presumptive Y. enterocolitica.  
 
3.2.2.3  Plating on selective media 
A loopful of each enriched samples was streaked onto selective agars. Selective 
agars used were cefsulodin-irgasan-novobiocin (CIN) agar [Yersinia Selective Agar 
Base supplemented with Yersinia Selective Supplement (Oxoid, UK)] or modified CIN, 
and incubated at 25 °C for 24-48 h. Modified CIN was made by adding 1% L-arginine 
(Sigma), 0.8 g/l ferric ammonium citrate (BDH Prolabo, UK), 6.8 g/l sodium 
thiosulphate (BDH Prolabo), and 2.0 g/l DL-phenylalanine (Sigma) at pH 7.4 ± 0.02 
into the CIN agar (Appendix I). In parallel, sample was plated onto CIN agar 
immediately after alkaline treatment in which 0.5 ml of enriched culture was transferred 
into 4.5 ml of 0.25% potassium hydroxide (KOH): 0.50% sodium chloride (NaCl) 
solution (Aulisio, et al., 1980; Hudson, et al., 2008).  
 
3.2.3  Preliminary biochemical tests 
At least five typical Y. enterocolitica isolates (red bull’s eyes) were picked from 
each plate and tested with four preliminary biochemical tests, i.e. oxidase test, Gram 
determination, urease and citrate test. All Gram negative, oxidase negative, urease 
positive and citrate negative isolates were further characterized by using the API 20E 
identification kit (bio-Mérieux® SA, France). Details of each preliminary biochemical 
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test and API identification kit are tabulated in Appendix VII and VIII, respectively. The 
strips were inoculated according to the manufacturer’s recommendations with the minor 
modification of incubation at 28 °C (Archer, et al., 1987). The 7-digit API 20E 
numerical profile obtained was read by using the online APIweb™ identification 
software.  
 
3.2.4  PCR confirmation 
 3.2.4.1  Identification of Y. enterocolitica isolates 
Identity of Y. enterocolitica isolates was confirmed by using a duplex PCR 
targeting Y. enterocolitica-specific 16S rRNA and ail genes. PCR mixes and the cycling 
conditions are tabulated in Tables 3.7 and 3.8. PCR amplicons were electrophoresed on 
1.5% agarose gel subjected in 0.5× TBE buffer at 100 V for 30 min. The gel was stained 
in 3× GelRed™ (Biotium, USA) staining solution for 30 min and gel photo was 
captured using GelDoc™ XR imaging system (Bio-Rad, USA) under UV light. 
Amplicons of selected PCR products were purified using MEGAquick-spin™ PCR & 
agarose gel DNA extraction system (iNtRON Biotechnology, Korea) and then 
submitted to a company (1st BASE) for sequencing. Sequenced genes were analysed 
using the Basic Local Alignment Search Tool (http://blast.ncbi.nlm.nih.gov/). 
 
Table 3.7. Conditions of PCR mixes for duplex PCR targeting Y. enterocolitica-
specific 16S rRNA and ail genes. 
Materials 
Stock 
conc. 
Working 
conc. 
1× (µl) 
Buffer (×) 5 1 5.000 
MgCl2 (mM) 25 3.50 3.500 
dNTPs (mM) 10 0.10 0.250 
Primers (µM) 
   
   Y. enterocolitica-specific 16S rRNA gene 10 0.08 0.200 
   ail gene 10 0.16 0.400 
Taq polymerase (U/µL) 5 0.50 0.100 
ddH2O - - 12.950 
DNA templates (ng) - ~20 2.000 
Total 
  
25.000 
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3.2.4.2  Post-enrichment PCR screening from enriched food 
homogenates 
One ml of each enriched samples (YSEO, ITC, and PBS) were retained in a sterile 1.5 
ml Eppendorf tube after its respective incubation period. The fluid was centrifuged at 
13,400 g for 15 min, and the supernatant was discarded. Washing steps for the cell 
pellet initiated by re-suspension in 1 ml 1× Tris-EDTA (TE) buffer, and the suspension 
was centrifuged at 13,400 g for 15 min and the supernatant was discarded. The washing 
step was repeated twice by substituting 1 ml 1×TE buffer with 1 ml sterile ddH2O 
water. Finally, the pellet was re-suspended in 100 µl sterile ddH2O and transferred into 
a 0.5 ml PCR tubes. The suspension was boiled at 99 °C for 5 min, snapped-cold in ice 
for 10 min and centrifuged at 13,400 g for 10 min. The supernatant was used as DNA 
template. The presence of Y. enterocolitica was screened by using the duplex PCR as 
stated in Section 3.2.4.1.  
 
3.2.5  API 50CH 
Isolates that were API 20E identified as Y. enterocolitica but negative by using 
the duplex PCR (as in Section 3.2.4.1) were further identified by using API 50CH 
identification kit (bio-Mérieux® SA). The kits were inoculated according to the 
manufacturer’s recommendations with the minor modification of incubation at 28 °C. 
The API 50CH numerical profile obtained was read by using the online APIweb™ 
identification software. 
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Table 3.8. Primers sequences and cycling condition of duplex PCR targeting Y. enterocolitica-specific 16S rRNA and ail genes. 
Gene Primers sequence (5’3’) 
Amplicon 
size (bp) 
PCR conditions References 
Y. enterocolitica-
specific 16S 
rRNA 
Forward (Y1) – 
AATACCGCATAACGTCTTCG  
 
Reverse (Y2) – 
CTTCTTCTGCGAGTAACGTC 
 
330 
Predenaturation: 94 °C, 5 mins 
Denaturation: 94 °C, 45 s 
Annealing: 57 °C, 45 s 
Extension: 72 °C, 30 s 
(30 cycles) 
Final extension: 72 °C, 7 mins 
(Neubauer, Hensel, 
Aleksic, & Meyer, 
2000) 
ail 
Forward (A1)–
TTAATGTGTACGCTGCGAGTG 
 
Reverse (A2) –
GGAGTATTCATATGAAGCGTC 
 
430 (Wannet, et al., 2001) 
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3.2.6 Biotyping of Y. enterocolitica isolates 
The biogroup of Y. enterocolitica was determined by using biochemical tests as 
described by Wauters, et al. (1987). The biochemical tests included lipase test, esculin 
hydrolysis, salicin utilisation, indole test, xylose utilisation, trehalose utilisation, nitrate 
reduction, pyrazinamidase test, β-D-glucosidase test, Voges-Prokauer test, and DNase 
test. Details of each test are tabulated in Appendix IX. Table 2.1 indicates the biotyping 
scheme for Y. enterocolitica. 
 
3.2.7 Serotyping of Y. enterocolitica isolates 
Serotyping was determined based on antigenic variations in cell wall 
lipopolysaccharides (LPS). The serotype of Y. enterocolitica was determined by using 
the O-Antisera "SEIKEN" set purchased (DENKA SEIKEN Co., Ltd, Japan). The kit 
can determine six Y. enterocolitica serotypes (O:1, O:2, O:3, O:5, O:8, and O:9). 
Results were interpreted according to recommendation of manufacturer.  
 
3.2.8 Further characterization of Y. enterocolitica isolates  
3.2.8.1  Cultures selection 
Cultures selection were based on the results of the basic biochemical tests 
(Gram, citrate and oxidase tests), API 20E profiles, biogrouping and serotyping. Isolates 
(with similar sample code) that showed similar results were referred as replicates and 
only one of them was selected for further characterization. In total, 32 Y. enterocolitica 
isolates (pig, n=20; food n=12) were selected for further characterization in this study. 
 
3.2.8.2  PCR-based virulence gene determination  
Crude DNA of the 32 selected Y. enterocolitica isolates were prepared by direct 
cell lysate method. Single well-isolated colony was suspended in 100µl sterile ddH2O 
and boiled at 99 °C for 5 min and cooled immediately in ice for 10 min. This step was 
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the heat-shock step that facilitates the released of DNA from cell lyses. Cell lysate was 
centrifuged at 13,400 rpm for 5 min and the supernatant was used as the DNA template. 
The presence of 15 virulence genes (hreP, virF, rfbC, myfA, fes, sat, fepD, inv, ail, 
ymoA, tccC, yadA, fepA, ystB, and ystA) was detected using five multiplex PCRs. 
Cycling and PCR mix conditions were re-optimised. Y. enterocolitica strains IP102, 
IP11105, IP383, IP135, IP145, and IP178 were used as the positive controls (kind gifts 
of Dr. Elisabeth Carniel from Institute Pasteur, the French Yersinia Reference 
laboratory, France).  
PCR amplicons were electrophoresed on 2% agarose gel subjected in 0.5× Tris-
borated EDTA (TBE) buffer at 100 V for 40 min. The gel was stained in 3× GelRed™ 
(Biotium) staining solution for 20 min and gel photo was captured using GelDoc™ XR 
imaging system (Bio-Rad) under UV light. The validity of the amplicons was 
determined by direct sequencing. Briefly, the PCR products were purified using 
MEGAquick-spin™ PCR & agarose gel DNA extraction system (iNtRON 
Biotechnology) and then submitted to a company (1st BASE) for sequencing. 
Sequenced genes were analysed using the Basic Local Alignment Search Tool 
(http://blast.ncbi.nlm.nih.gov/). 
 
3.2.8.3  Plasmid profiling 
3.2.8.3.1 Phenotypic virulence plasmid tests 
The presence of pYV virulence plasmid of Y. enterocolitica was determined 
phenotypically by the following tests; temperature-dependent auto-agglutination in MR-
VP broth (Oxoid) (Farmer 3rd, Carter, Miller, Falkow, & Wachsmuth, 1992), calcium 
dependency and Congo red absorption using Congo red magnesium oxalate (CR-MOX) 
agar (Riley & Toma, 1989) and crystal violet binding (Bhaduri, Conway, & Lachica, 
1987). Details of each test are tabulated in Appendix XI.  
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3.2.8.3.2 PFGE of unrestricted DNA plugs 
The same DNA plugs prepared in for PFGE genotyping (Section 3.2.8.5.1) were 
used. DNA plug slice (3.5 mm wide × 6 mm length) was cut and loaded onto 1% 
agarose gel (Type 1, Sigma-Aldrich). Genomic DNA (without enzyme restriction) was 
separated using Chef-Mapper system (Bio-Rad) at a ramping time from 1-12 s over 14 h 
at 6 V/cm, 15 °C. Low range PFG marker N0350S (New England Biolabs, USA) was 
used as DNA standard marker. Bacterial strain IP383 (Y. enterocolitica bioserotype 
2/O:9) that carried the pYV (~70kb) plasmid was used as the control strain. 
 
  3.2.8.3.3 Plasmid DNA extraction 
A single bacterial colony of Y. enterocolitica was cultured in 10 ml of Luria 
Bertani (LB) broth, incubated at 28 °C for 16-18 h. Cells were harvested by 
centrifugation at 8000 rpm for 3 min at 4 °C. Plasmid DNA was extracted according to 
the recommendation of manufacture using QIAprep® Spin Miniprep kit (QIAGEN, 
Netherland). Extracted plasmid DNA was electrophoresed on 0.9% agarose gel 
subjected in 0.5× TBE buffer at 90 V for approximately 10 h. Supercoiled DNA marker 
set (8-28 kb, Epicentre® Biotechnologies, USA) and supercoiled DNA ladder (2-10 kb, 
New England Biolabs) were used as plasmid markers.  
 
3.2.8.3.4 Gel staining and imaging 
The gels were stained in 3× GelRed™ (Biotium) staining solution for 40 min 
and gel photos were captured using GelDoc™ XR imaging system (Bio-Rad) under UV 
light. The plasmid sizes were determined by using Quantity One® 1-D Analysis 
software. 
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3.2.8.4  Antimicrobial susceptibility testing 
The antimicrobial susceptibility of the 32 selected Y. enterocolitica isolates was 
tested on Mueller-Hinton II agar (BD, USA) with commercial antimicrobial discs 
(Oxoid, UK) by using the disc diffusion method (Bauer, Kirby, Sherris, & Turck, 1966). 
Antimicrobials representing 11 different classes were tested (cephalosporins, 
quinolones/fluoroquinolones, folate pathway inhibitor, aminoglycosides, penicilins, 
tetracyclines, β-lactam, monobactams, carbapenems, polymixins, phenicol and 
lincosamide). The antimicrobial agents used were: cefuroxime (CXM, 30 μg), 
ceftriaxone (CRO, 30 μg), cefotaxime (CTM, 30 μg), ceftazidime (CAZ, 30 μg), 
nalidixic acid (NAL, 30 μg), ciprofloxacin (CIP, 5 μg), levofloxacin (LVX, 5 μg), 
trimethoprim (TMP, 5 μg), trimethoprim-sulphamethoxazole (TIM, 25 μg), 
streptomycin (STR, 10 μg), kanamycin (KAN, 30 μg), amikacin (AMK, 30 μg), 
gentamicin (GEN, 10 μg), neomycin (N, 10 μg), netilmicin (NET, 30 μg), ampicillin 
(AMP, 10 μg), ticarcillin (TIC, 75 μg), tetracycline (TET, 30 μg), doxycycline (DOX, 
30 μg), amoxicillin-clavulanic acid (AMC, 30 μg), aztreonam (ATM, 30 μg), imipenem 
(IPM, 10 μg), polymyxin B (PB, 300 μg), chloroamphenicol (CHL, 30 μg), and 
clindamycin (CLI, 2 μg).  
Four other commonly used antimicrobials in pig farms were also included 
amoxicillin (AMX, 25 μg), colistin sulphate (CSS, 10 μg), enrofloxacin (ENR, 5 μg) 
and spectinomycin (SPT, 100 μg). All Y. enterocolitica isolates were also 
phenotypically screened for ESBL-production using the modified double-disc synergy 
test (DDST) (Jarlier, Nicolas, Fournier, & Philippon, 1988). All plates were incubated at 
37°C and results were interpreted (16-18h) according to the Clinical and Laboratory 
Standards Institute (CLSI) 2012 guidelines (Cockerill, et al., 2012). 
Escherichia coli ATCC 25922 was used as a control strain. Multiple antibiotic 
resistance (MAR) indexing was calculated by referring to Krumperman (1983). Isolates 
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with MAR index value s a cwere considered originated from high-risk source of 
contamination (Krumperman, 1983). Multidrug-resistant (MDR) was defined as 
resistance to om high-risk source of contami 
 
3.2.8.5  Pulsed-field gel electrophoresis (PFGE)  
The genetic relatedness of the 32 selected Y. enterocolitica isolates was 
compared by using PFGE. 
 
 3.2.8.5.1 DNA plugs preparation 
Colonies of an overnight cell culture (incubated at 28 °C) on Brain Heart 
Infusion (BHI) agar (Oxoid) were picked and suspended into 2 ml cell suspension 
buffer (CSB) and cell density was adjusted to 0.8-0.9 by using Dade Microscan 
turbidity metre (Baxter Diagnostics, Inc., McGraw Park, III). Twenty µl of Proteinase K 
(20 mg/ml stock, Promega) and 120 µl melted 1% Seakem Gold agarose (maintained at 
55-60 °C; Cambrex Bio Science Rockland, Inc, USA) were added and mixed-gently 
into 100 µl of the cell suspension. The suspension was dispensed immediately into well 
of a DNA plug mould and left to solidify at room temperature for 10-15 min. The plugs 
were lysed in 2 ml cell lysis buffer (CLB) and 10 µl Proteinase K (20 mg/ml). The plugs 
were incubated in shaking water bath (54 °C, 175 rpm) for 4 h. 
 The plugs were washed with two times sterile ddH2O (15-20 ml, preheated to 50 
°C) followed by six times 1×TE buffer (15-20 ml, preheated to 50 °C) at room 
temperature for 15 min with agitation at 100-150 rpm. Plugs were kept in 2 ml 1×TE 
buffer at 4 °C while waiting to be used. 
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3.2.8.5.2 Restriction digestion of DNA plugs 
 A slice of the DNA plug (2 mm wide × 8 mm length) was cut and pre-restricted 
in pre-restriction buffer mixture [containing 1× multicore restriction buffers (Promega) 
and 0.1 mg/ml Bovine serum albumin (BSA) (Promega)] at 37 °C for 10 min. Pre-
restriction buffer was removed and restriction master mix [containing 1× multicore 
restriction buffers (Promega) and 0.1 mg/ml BSA (Promega) and 24 U of NotI 
(Promega) restriction enzyme] was added. Sample was incubated in 37 °C overnight. 
 
3.2.8.5.3 DNA standard size marker for PFGE 
 The PulseNet size standard, Salmonella enterica serovar Braenderup H9812 was 
used as standard size marker. The DNA plug was prepared as described in Section 
3.2.8.5.1 and restricted as described in Section 3.2.8.5.2 by replacing the restriction 
enzyme with XbaI. 
 
3.2.8.5.4 Pulse-field electrophoresis condition 
Restricted plug slices were loaded onto 1% agarose gel (Type 1, Sigma-Aldrich, 
Germany). DNA fragments were separated using the Chef-Mapper system (Bio-Rad) at 
a ramping time from 2–20 s over 25 h at 6V/cm, 14 °C (Wang, et. al., 2008). The gel 
was stained in 3× GelRed™ (Biotium) staining solution for 40 min and gel photo was 
captured using GelDoc™ XR imaging system (Bio-Rad) under UV light.  
 
3.2.8.5.5 Data analysis 
PFGE gels were analyzed. The dendrogram was constructed by using the 
BioNumerics 6.0 software (Applied Maths, Kortrijk, Belgium). The Dice coefficient 
and the unweighted pair group method with arithmetic average (UPGMA) were applied, 
with a band position tolerance of 1.5%. The discriminatory power of PFGE was 
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calculated based on the Simpson's index of diversity (D value) (Hunter & Gaston, 
1988). 
 
3.3 Modification and improvement of CIN agar for isolation of Y. enterocolitica 
3.3.1 Media modification 
The CIN agar was modified by adding approximately 1% L-arginine (Sigma), 
0.8 g/l ferric ammonium citrate (BDH Prolabo), 6.8 g/l sodium thiosulfate (BDH 
Prolabo), and 2.0 g/l DL-phenylalanine (Sigma) at pH 7.4 ± 0.02 (Appendix I). 
 
3.3.2 Plating efficiency of CIN and modified CIN  
The plating efficiencies of CIN and modified CIN agar were evaluated using the 
50 bacterial strains listed in Table 3.9. These include Y. enterocolitica, other species of 
Yersinia, other Enterobacteriaceae, and selected Gram-negative and -positive bacteria.  
Bacterial strains retrieved from glycerol stocks at -20 °C were grown overnight 
on BHI agar (BBL). With the help of the needle inoculators, overnight bacterial cultures 
were dotted on CIN or modified CIN agar and incubated under aerobic or 
microaerophilic condition at 25 °C. Microaerophilic conditions were created by placing 
the inoculated agar plates in candle jars to facilitate the visualization of H2S-producing 
bacteria (Cheesbrough, 2006). The plating efficiency was determined by screening for 
the presence of colonies with red centre and colourless translucent rim (red bull’s eye) 
on CIN and modified CIN agar, the expected morphology for Y. enterocolitica strains. 
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Table 3.9. Bacterial strains selected for plating efficiency testing. 
Bacterial species  Strain number 
Yersinia enterocolitica  
bioserotype 1A/O:6,30  IP102 
bioserotype1A/O:5  PC-M16-2 
bioserotype 1B/O:8  IP11105, ATCC 9610, YE036c-CY 
bioserotype 2/O:9  IP383 
bioserotype 3/O:1,2,3  IP135 
bioserotype 3 variant /O:3  PC- M1-K1 
bioserotype 4/O:3  IP134 
bioserotype 5/O:2,3  IP178 
Other Yersinia spp.  
Y. aldovae  IP6005 
Y. bercovieri  IP3443 
Y. frederiksenii  IP3842 
Y. intermedia  IP955 
Y. kristensenii  IP105 
Y. mollaretii  IP33766 
Y. pseudotuberculosis  IP34476 
Other Enterobacteriaceae  
Citrobacter,  
       freundii, H2S-producing YC-K1-3 
       freundii, non-H2S-producing YC-S1-5,  YC-T1-1 
       braakii YC-T1-K1 
       koseri YC-VG2-1 
Providencia rettgeri IC-PP2a-9, IC-PP3a-K1, IC-PP6a-10 
Enterobacter cloacae YC-I1-K1, YC-I1-K2, YC-I1-K3 
Pantoae spp. PI-TSP30a-K1 
Serratia,  
       odorifera PC-TSP36b-3 
       marcescens YC-M2-11 
Morganella morganii YS-TSP7b-1 
Salmonella,  
       Paratyphi A  ATCC 9150 
       Paratyphi B  ATCC 8759 
       Paratyphi C  ATCC 9068 
       Typhimurium  ATCC 13311 
       Typhi  ATCC 6539 
       enterica  ATCC 10376 
Escherichia coli  ATCC25922, O157:H7 
Shigella sonnei  ATCC 11060 
Proteus penneri IS-TSP7b-3 
Other Gram-Negative Bacteria  
Aeromonas hydrophila Ae 20 
Vibrio spp. VSP-C12-1210, VS-A29-0810 
Pseudomonas aeruginosa  ATCC 9027 
Gram-Positive Bacteria  
Enterococcus faecalis  ATCC 29212 
Listeria monocytogenes  ATCC 7644 
Staphylococcus aureus  ATCC 6538, MRSA 0807-1 
The IP strains are a kind gifts of Dr. Elisabeth Carniel from Institute Pasteur, the French Yersinia Reference laboratory, France; 
ATCC 9610 is a kind gift of Dr. Aziah from Makmal Kesihatan Awam Veterinar, Malaysia; other strains are bacteria collection of 
Laboratory of Biomedical Science and Molecular Microbiology, UM (Prof. Dr. Thong Kwai Lin).  
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3.3.3 Limit of detection (LOD) of CIN and modified CIN of Y. enterocolitica 
strains  
The LOD was determined using the method recommended by the 
Microbiological Methods Committee (2011). Y. enterocolitica was chosen as 
representing strain. Overnight Y. enterocolitica cultures were serially diluted to a range 
of 10
8 
to 10
1
 colony forming unit (cfu)/ml and spread onto CIN and modified CIN agar. 
The plating efficiency was replicated 6 times with independent cell suspension. The 
plates were incubated under aerobic condition at 25 °C. In addition, one set of modified 
CIN agar was incubated under microaerophilic condition at 25 °C. The LOD was 
defined as the lowest concentration of Y. enterocolitica with culturable bacteria 
detectable in at least 50% of the replicates (as low as one colony detectable in each 
replicate, and at least three out of six positive replicates). Statistical significance was 
calculated by Student t-test using software R (version 2.12.2). Significant values were 
for P<0.05. 
 
3.3.4 Quantification of Y. enterocolitica growth in CIN and modified CIN with 
that on LBA 
The growth of Y. enterocolitica on CIN and modified CIN was compared to that 
on Luria-Bertani agar (LBA) (Oxoid). Y. enterocolitica suspension was adjusted to 
approximately 10
3 
cfu/ml and plated on LBA, CIN and modified CIN. The mean cfu/ml 
(6 replicates) of Y. enterocolitica on LBA, CIN and modified CIN was calculated after 
incubation at 25 °C for 48 h. The results were expressed as a percentage of mean cfu/ml 
on CIN/LBA and modified CIN/LBA at each incubation condition (Savin, Leclercq, & 
Carniel, 2012). 
  
CHAPTER 3   MATERIALS AND METHODS 
42 
 
 
3.3.5 Limit of detection (LOD) and recovery rate of Y. enterocolitica in artificially 
contaminated raw pork meat on CIN and modified CIN  
The effect of the natural microbiota on the recovery of Y. enterocolitica from 
food matrix (with or without stress treatment, kept at -20°C for three weeks after 
bacterial spiking) was studied (Microbiological Methods Committee, 2011). An 
artificially contaminated raw pork meat was used because yersiniosis is frequently 
associated with the consumption of contaminated pork products. For food matrix 
without stress treatment, approximately 1.5 kg of freshly purchased minced pork meat 
was processed immediately following spiking. Cell suspension of Y. enterocolitica was 
serially diluted as previously described and 250 μl of each Y. enterocolitica suspension 
(10-fold higher than the final concentration) was mixed with 25 g of minced meat 
[homogenised in 24.75 ml PBS (Sigma), final volume = 25 ml, final concentrations of 
Y. enterocolitica were 10
1
 to 10
8
 cfu/ml]. The meat suspensions were homogenized 
manually by hand for 30 s and incubated at 25 °C for 30 min. An aliquot of each 
homogenate was then plated onto CIN and modified CIN plates and incubated under 
aerobic condition at 25 °C for 24 - 48 h. The same procedures were repeated for a set of 
modified CIN agars incubated under microaerophilic condition at 25 °C for 24 - 48 h. 
Six replicates were done for each bacterial concentration. The mean cfu/ml of 
background microbiota in uninoculated pork meat (25 g, homogenised in 25 ml PBS, 6 
replicates) was determined using LBA. 
The LOD of Y. enterocolitica in the artificially contaminated pork meat was 
defined as the lowest cfu/ml of culturable Y. enterocolitica detectable in ≥50% of the 
replicates (as low as 1 colony detectable on each replicate, and as least three out of six 
replicates positive) (Microbiological Methods Committee, 2011). The mean cfu of Y. 
enterocolitica to background microbiota ratio was also determined.  
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The same spiked minced meat was subjected to stress treatment by keeping the 
spiked food samples at -20°C for two weeks after bacterial spiking (to mimic food 
storage conditions) (Microbiological Methods Committee, 2011). The same plating 
procedures were performed. Percentage of true Y. enterocolitica recovered from the 
food food (with and without stress treatment) was determined by picking representative 
colonies from each plate and identified by the duplex PCR targeting Y. enterocolitica-
specific 16S rRNA and ail genes as described in Section 3.2.4.1.  
 
3.3.6 Determination of the recovery of Y. enterocolitica from artificial bacterial 
mixtures 
Overnight cultures of Y. enterocolitica IP135 and bacteria exhibiting Yersinia-
like colonies on CIN agar (H2S-producing C. freundii, C. braakii, A. hydrophila, P. 
rettgeri, and E. cloacae) were adjusted to a concentration of 10
4 
cfu/ml and mixed 
together. Six independent mixed bacterial suspensions were made and directly spread 
on CIN and modified CIN agar, and incubated aerobically at 25 °C for 24 - 48 h. 
Presumptive Y. enterocolitica colonies were isolated from each replicate and subjected 
to PCR confirmation to determine the percentage of true Y. enterocolitica on both 
media. Duplex PCR as stated in Section 3.2.4.1 was used. Statistical significance was 
calculated by Chi-square (χ2) test using software R (version 2.12.2). Significant values 
were for P<0.05. 
 
3.3.7 Determination of the recovery rate of Y. enterocolitica in naturally 
contaminated samples 
 The 52 rectal swabs from swine (from Penang, refer Section 3.2.1.2) were tested 
for the presence of Y. enterocolitica using different enrichment procedures and plating 
on CIN and modified CIN agars. Briefly, all of the swab specimens were (i) directly 
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streaked onto the selective medium (Table 3.10, methods 1 and 2), (ii) subjected to cold 
enrichment (incubation at 4°C for three weeks in PBS) (Table 3.10, methods 3 and 4) 
before being plated on CIN and modified CIN, and (iii) subjected to cold enrichment 
and then alkaline treatment before being plated onto the two selective media (Table 
3.10, methods 5 and 6). Refer Section 3.2.2 for the details of each isolation method. 
Presumptive Y. enterocolitica colonies were isolated and subjected to PCR confirmation 
as described in Section 3.2.4.1.  
 
Table 3.10. Summary methods used for the determination of the recovery rate of 
Y. enterocolitica in naturally contaminated samples. 
Methods Medium used 
1 Direct streaking onto CIN
a
 
2 Direct streaking onto mCIN
b
 
3 PBS
c
-CIN 
4 PBS-mCIN 
5 PBS-KOH
d
-CIN 
6 PBS-KOH-mCIN 
a CIN, Cefsulodin-Irgasan-Novobiocin; b mCIN, modified CIN; c PBS, phosphate buffered saline, a cold enrichment at 4°C for three 
weeks; d KOH, post-enrichment alkaline treatment. 
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This study was conducted on 106 raw food samples (58 raw pork products and 
48 non-porcine food) and 495 swine specimens (from 165 pigs) to investigate the 
presence of Yersinia enterocolitica. Section 4.1 summarise the prevalence of Y. 
enterocolitica from raw pork products, raw non-porcine food and pigs, respectively. 
Section 4.2 shows results for the isolation and detection methods for Y. enterocolitica. 
Section 4.3 reports the results for biotyping and serotyping of Y. enterocolitica isolates. 
Results for further characterization of Y. enterocolitica isolates by using AST, 
virulotyping, PFGE and plasmid profiling are in Section 4.4. The last section, Section 
4.5, presents results for the evaluation of the modified CIN agar in comparing to CIN. 
The raw data for sampling date, location, sample type, biochemical tests, PCR results, 
biotyping and serotyping, virulotyping, antimicrobial profiles and modification and 
improvement of CIN agar are listed in Appendix IV to XIII. 
 
4.1 Prevalence of Y. enterocolitica 
4.1.1 Prevalence and MPN/g of Y. enterocolitica in raw pork products 
The prevalence of Y. enterocolitica from raw pork products was low by the 
cultural method. (Refer Appendix IV for raw data). Out of 58 food tested, seven 
(12.1%) were contaminated by Y. enterocolitica; i.e. raw pork meat (whole meat) 5/21 
(23.8%), raw pork liver 1/5 (20.0%) and raw pork intestine 1/8 (12.5%) (Table 4.1.1) 
Samples involved were M1, M3, M13, M16, YE032, YE036 and YE037 (Appendix 
IV). All positive samples were from the same hawker stall. Table 4.1.1 summarises the 
prevalence of Y. enterocolitica from raw pork products. Twenty-six isolates of Y. 
enterocolitica (API 20E and PCR confirmed) were isolated from the 7 positive samples 
(Appendix VIII). Table 4.1.2 shows the summary results of all 26 PCR-confirmed Y. 
enterocolitica isolates.  
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Post-enrichment PCR detection showed a higher incidence of Y. enterocolitica, 
35/58 (60.3%) as compared to the cultural methods (raw pork meat n=20, raw pork 
internal organs, n=14, skin, n=1) (Table 4.1.1). Raw data are in Appendix IV. 
MPN/g of Y. enterocolitica in raw pork products was determined by using the 
YSEO enriched tubes and the results are tabulated in Table 4.1.3. The results showed 
that the concentration of Y. enterocolitica in the positive samples ranged from <0.30 
MPN/g to >43.84 MPN/g. Although there was no specific requirements for the levels of 
Y. enterocolitica in food under FDA Food Code (Lawley, Curtis, & Davis, 2012), but 
majority of the positive samples had low MPN/g values (≤18.98 MPN/g), except four 
samples (>43.84 MPN/g).  
 
Table 4.1.1. Prevalence of Y. enterocolitica from raw pork products determined by 
cultural method and post-enrichment PCR screening. 
Food type   
No. of 
sample  
No of positives (%)
a
 
 
Isolation rate by strain 
type
b
 (%) 
Post-
enrich
ment 
PCR 
 
Culture 
 
Pathogenic 
 
Non-
pathogenic 
Raw pork meat 
 
25 
 
20 (80.0) 
 
5 (20.0) 
 
4/5 (80.0) 
 
1/5 (20.0) 
     Whole meat 
 
21 
 
18 (85.7) 
 
5 (23.8) 
 
4/5 (80.0) 
 
1/5 (20.0) 
     Minced meat 
 
4 
 
2 
 
0 
 
0 
 
0 
           
Raw pork 
internal organs  
23 
 
14 (60.9) 
 
2 (8.7) 
 
2/2 (100.0) 
 
0 
    Liver 
 
5 
 
3 (60.0) 
 
1 (20.0) 
 
1/1 (100.0) 
 
0 
    Intestine 
 
8 
 
7 (87.5) 
 
1 (12.5) 
 
1/1 (100.0) 
 
0 
    Heart 
 
5 
 
3 (60.0) 
 
0 
 
0 
 
0 
    Kidney 
 
4 
 
1 (25.0) 
 
0 
 
0 
 
0 
    Throat 
 
1 
 
0 
 
0 
 
0 
 
0 
           
Other parts 
 
10 
 
1 (10.0) 
 
0 
 
0 
 
0 
    Skin 
 
4 
 
1 
 
0 
 
0 
 
0 
    Foot 
 
2 
 
0 
 
0 
 
0 
 
0 
    Fat tissue 
 
1 
 
0 
 
0 
 
0 
 
0 
    Ear 
 
1 
 
0 
 
0 
 
0 
 
0 
    Eye tissue 
 
1 
 
0 
 
0 
 
0 
 
0 
    Nose 
 
1 
 
0 
 
0 
 
0 
 
0 
           
Total 
 
58 
 
35 (60.3) 
 
7 (12.1) 
 
6/7 (85.7) 
 
1/7 (14.3) 
a The values are the number of positives detected in either of the enriched samples (YSEO, ITC, and PBS); b The isolation rate refers 
to the number of positive samples determined by cultural methods 
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Table 4.1.2. Summary results of the 26 PCR confirmed Y. enterocolitica isolates isolated from raw pork products. 
No. Isolates Name Date of isolation Sample code
a
 Source  
API 20E  code,  
% of confirmation
a
 
Biotype
b
 Serotype
b
 
1 PC-M1-K1 June 2010 M1 Raw pork meat 1014522, 93.9% 3 variant  O:3 
2 PC-M1-K2 June 2010 M1 Raw pork meat 1014522, 93.9% 3 variant  O:3 
3 PC-M1-K3 June 2010 M1 Raw pork meat 1014522, 93.9% 3 variant  O:3 
4 PC-M1-K4 June 2010 M1 Raw pork meat 1014522, 93.9% 3 variant  O:3 
5 PC-M1-K5 June 2010 M1 Raw pork meat 1014522, 93.9% 3 variant  O:3 
6 PC-M1-K11 June 2010 M1 Raw pork meat 1014522, 93.9% 3 variant  O:3 
7 PC-M1-K12 June 2010 M1 Raw pork meat 1014522, 93.9% 3 variant  O:3 
8 PC-M1-K13 June 2010 M1 Raw pork meat 1014522, 93.9% 3 variant  O:3 
9 PC-M3-6 June 2010 M3 Raw pork meat 1014522, 93.9% 3 variant  O:3 
10 PC-M3-K11 June 2010 M3 Raw pork meat 1014522, 93.9% 3 variant  O:3 
11 PC-M3-K12 June 2010 M3 Raw pork meat 1014522, 93.9% 3 variant  O:3 
12 PC-M13-K13 Oct 2010 M13 Raw pork meat 1014522, 93.9% 3 variant  O:3 
13 S18/1-C-O-6a Jan 2011 YE037 Raw pork intestine 1014523 99.7% 3 variant  O:3 
14 S18/1-C-I-10-4-6a Jan 2011 YE037 Raw pork intestine 1014523 99.7% 3 variant  O:3 
15 S18/1-C-O-6b Jan 2011 YE037 Raw pork intestine 1014523 99.7% 3 variant  O:3 
16 S18/1-C-O-5-6b Jan 2011 YE037 Raw pork intestine 1014523 99.7% 3 variant  O:3 
17 S18/1-C-I-4-6b Jan 2011 YE037 Raw pork intestine 1154523 92.3% 3 variant  O:3 
18 S18/1-C-O-6c Jan 2011 YE037 Raw pork intestine 1014523 99.7% 3 variant  O:3 
19 S18/1-C-O-6d Jan 2011 YE037 Raw pork intestine 1154523 92.3% 3 variant  O:3 
20 S18/1-C-O-5-6e Jan 2011 YE037 Raw pork intestine 1114523 99.7% 3 variant  O:3 
21 S18/1-C-O-1a Jan 2011 YE032 Raw pork liver 1154723, 92.5% 1B O:8 
22 S18/1-C-O-K-5b Jan 2011 YE036 Raw pork meat 1154523, 92.3% 1B O:8 
23 S18/1-C-O-5c Jan 2011 YE036 Raw pork meat 1155523, 98.3% 1B O:8 
24 PC-M16-2 Feb 2011 M16 Raw pork meat 1155723, 98.3% 1A O:5 
25 PC-M16-5 Feb 2011 M16 Raw pork meat 1155723, 98.3% 1A O:5 
26 PC-M16-10 Feb 2011 M16 Raw pork meat 1154723, 92.5% 1A O:5 
aAll samples were from Kuala Lumpur,  wet market A, stall 1; bRaw data refer Appendix VIII; bRaw data refer Appendix IX. 
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Table 4.1.3. The MPN and MPN/g values (calculated using the results of post-
enrichment PCR) and the background information of raw food samples. 
 
Sampling 
time 
Sample 
code 
Food type Location 
Bioseroty
pe 
MPNa, MPN/g UCIb LCIc 
June 2010 M1 Raw pork meat KLd 3 ve/O:3 0-0-0, <0.30 - f 0.07 
June 2010 M2 Raw pork meat KL negg 0-0-0, <0.30 - 0.07 
June 2010 M3 Raw pork meat KL 3 v/O:3 0-0-0, <0.30 - 0.07 
June 2010 I1 Raw pork intestine KL neg 0-0-0, <0.30 - 0.07 
July 2010 M4 Raw pork meat KL neg 0-0-0, <0.30 - 0.07 
July 2010 M5 Raw pork meat KL neg 0-0-1, 0.30 1.36 0.07 
July 2010 M6 Raw pork meat KL neg 0-0-0, <0.30 - 0.07 
July 2010 I2 Raw pork intestine KL neg 0-0-0, <0.30 1.36 0.07 
July 2010 I3 Raw pork intestine KL neg 1-0-0, 0.36  1.63 0.08 
July 2010 D1 Raw pork heart KL neg 0-0-0, <0.30 1.36 0.07 
July 2010 D2 Raw pork heart KL neg 0-0-2, 0.60  2.73 0.13 
July 2010 L1 Raw pork liver KL neg 2-2-2, 3.12  14.14 0.69 
Aug 2010 M9 Raw pork meat KL neg 0-0-1, <0.30 1.36 0.07 
Aug 2010 S2 Raw pork skin KL neg 0-0-0, <0.30 - 0.07 
Aug 2010 D4 Raw pork heart KL neg 3-3-0, 18.98  86.04 4.19 
Sept 2010 M11 Raw pork meat KL neg 0-0-0, <0.30 - 0.07 
Sept 2010 M12 Raw pork meat KL neg 0-3-2, 1.58  7.16 0.35 
Sept 2010 M14 Raw pork meat KL neg 3-2-0, 7.60 34.44 1.68 
Sept 2010 M13 Raw pork meat KL 3 v/O:3 0-3-3, 1.90 8.60 0.42 
Sept 2010 M15 Raw pork meat KL neg 0-2-0, 0.62 2.81 0.14 
Sept 2010 I5 Raw pork intestine KL neg 0-0-1, <0.30 1.36 0.07 
Sept 2010 I6 Raw pork intestine KL neg 0-0-0, <0.30 - 0.07 
Jan 2010 I7 Raw pork intestine KL neg 0-3-3, 1.90  8.60 0.42 
Jan 2011 M16 Raw pork meat KL 1A/O:5 3-3-3, >43.84 198.70 - 
Jan 2011 M17 Raw pork meat KL neg 3-3-3, >43.84 198.70 - 
Jan 2011 M18 Raw pork meat KL neg 3-3-3, >43.84 198.70 - 
Jan 2011 M19 Raw pork meat KL neg 3-3-3, >43.84 198.70 - 
Jan 2011 M20 Raw pork meat KL neg 1-3-3, 2.71  12.29 0.60 
Jan 2011 YE032 Raw pork liver KL 1B/O:8 1-0-0, 0.36 1.63 0.08 
Jan 2011 YE036 Raw pork meat KL 1B/O:8 1-0-0, 0.36 1.63 0.08 
Jan 2011 YE037 Raw pork intestine KL 3 v/O:3 1-0-0, 0.36 1.63 0.08 
Jan 2011 S18-3 Raw pork meat KL neg 0-0-0, <0.30 - 0.07 
Jan 2011 S18-4 Raw pork meat KL neg 0-0-0, <0.30 - 0.07 
Mar 2011 K3 Raw pork kidney Taiping neg 1-1-0, 0.73  3.33 0.16 
Mar 2011 L3 Raw pork liver Taiping neg 3-1-0, 4.57  20.72 1.01 
The MPN/g value was calculated using the Microsoft Excel spreadsheet provided by Institute of Environment Science and Research 
(ESR), New Zealand (Hudson, et al., 2008). a MPN, most probable number; b UCI, upper confidence interval; c LCI, lower 
confidence interval; d KL, Kuala Lumpur; e 3 v, 3 variant; f-, value cannot be calculated or identity cannot be determined; g neg, 
sample was negative by using culture method. For the rest samples which were not mentioned in table, Y. enterocolitica was 
negative in both cultural and post-enrichment PCR method in all nine tubes of the 3 × 3 YSEO enrichment tubes.  
 
 
 
4.1.2  Prevalence of Y. enterocolitica in raw non-porcine food 
Overall, no Y. enterocolitica was isolated via culture methods from the 48 raw 
non-porcine food tested (Table 4.1.4). However, the post-enrichment PCR screening 
indicated Y. enterocolitica was present in 20/48 (41.7%) of raw food; i.e. 4/6 (66.7%) 
raw beef, 5/9 (55.6%) raw poultry products, 5/11 (45.5%) raw seafood, and 6/19 
(31.6%) raw vegetables (Table 4.1.4). Raw data for both cultural and PCR methods are 
tabulated in Appendix V. 
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Table 4.1.4. Prevalence of Y. enterocolitica from raw non-porcine food determined 
by cultural method and post-enrichment PCR screening. 
 
Food type 
 
No. of samples 
 
No of positives
 a 
(%) 
PCR 
 
Cultural 
Raw beef 
 
6 
 
4 (66.7) 
 
0 
       
Raw poultry products 
 
9 
 
5 (55.6) 
 
0 
    Chicken meat 
 
8 
 
5 (62.5) 
 
0 
    Chicken claw 
 
1 
 
0 
 
0 
       
Raw seafood 
 
11 
 
5 (45.5) 
 
0 
    Fish 
 
6 
 
4 (66.7) 
 
0 
    Squid 
 
3 
 
1 (33.3) 
 
0 
    Prawn 
 
1 
 
0 
 
0 
    Cockles 
 
1 
 
0 
 
0 
       
Raw vegetables 
 
19 
 
6 (31.6) 
 
0 
    Leafy vegetables 
 
11 
 
4 (36.4) 
 
0 
    Bitter gourd 
 
3 
 
1 (33.3) 
 
0 
    Cowpea 
 
1 
 
0 
 
0 
    Root 
 
1 
 
0 
 
0 
    Sweet potato 
 
1 
 
0 
 
0 
    Brinjal 
 
1 
 
1 (100.0) 
 
0 
    Lady’s finger 
 
1 
 
0 
 
0 
       
Raw tofu 
 
2 
 
0 
 
0 
       
Pasteurised milk 
 
1 
 
0 
 
0 
       
Total 
 
48 
 
20 (41.7) 
 
0 
a The values are the number of positive detected in either of the enriched samples (YSEO, ITC, and PBS) 
 
 
 
4.1.3 Prevalence of Y. enterocolitica in live pigs 
Based on culture methods, only three out of 165 pigs (1.8%) harboured Y. 
enterocolitica (Tables 4.1.5 and 4.1.6). Raw data are tabulated in Appendix VI. All the 
positive pigs were healthy grower pigs (asymptomatic) fed in the same pen from Farm I 
in Penang (Table 4.1.7; Penang’s pig: no. 53, 55 and 56). A total of 72 Y. enterocolitica 
isolates were isolated from the three pigs (Table 4.1.7). These isolates were isolated 
from seven specimens (Table 4.1.8). The involved specimens are PPN53a, PPN55a, 
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PPN55b, PPN55c, PPN56a, PPN56b, and PPN56c (Appendix VI). Table 4.1.7 shows 
the summary results of all 72 PCR-confirmed Y. enterocolitica isolates. 
On the other hand, PCR detected a higher prevalence of Y. enterocolitica, in 46 
pigs (27.9%), i.e. 11/22 (50.0%) healthy growers, 14/44 (31.8%) unhealthy weaners, 
20/68 (29.4%) healthy weaners, and 1/11 (9.1%) unhealthy growers (Tables 4.1.5 and 
4.1.6). Raw data for the PCR detection are tabulated in Appendix VI. The PCR results 
indicated that Y. enterocolitica was most frequently found in nasal swabs, 29/165 
(17.6%) followed by oral swabs, 25/165 (15.2%) and rectal swabs, 21/165 (12.7%) 
(Table 4.1.8). Overall, Y. enterocolitica was PCR detected in the pigs in three states; i.e. 
Selangor (n=9), Perak (n=20), and Penang (n=17) (Table 4.1.5). 
 
 
Table 4.1.5. Prevalence of Y. enterocolitica in swine according to  
each pig farm and state. 
States Farm n
a
 PCR
b
 
method 
Culture 
method 
Total 
PCR 
method 
(%) 
Culture 
method 
(%) 
Selangor  A 9 3 (33.3) 0 (0) 
9 (17.0) 0 (0) B 14 6 (42.9) 0 (0) 
C 30 0 (0) 0 (0) 
 Total 53   
  
     
  
Perak  D 20 5 (25.0) 0 (0) 
20 (33.3) 0 (0) E 20 1 (5.0) 0 (0) 
F 20 14 (70.0) 0 (0) 
 Total 60   
  
     
  
Penang  G 16 1 (6.3) 0 (0) 
17 (32.7) 3 (5.8) H 20 5 (25.0) 0 (0) 
I 16 11 (68.8) 3 (18.8) 
 Total 52   
  
       
Total (%)  165 46 (27.9) 3 (1.8)   
 an, number of pigs within each farm; bPCR, polymerase chain reaction 
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Table 4.1.6. Prevalence of Y. enterocolitica based on the age and health condition  
of pigs determined by cultural method and post-enrichment PCR screening. 
Health group 
 
n
a
 
 No of positives samples (%) 
  Selangor (n=53)  Perak (n=60) 
 
Penang (n=52) 
 
Total positive 
  PCR C
b
  PCR C  PCR C  PCR C 
H
c
 piglet
d
  4  0 0  -
e
 -  - -  0 0 
UH
f  
piglet  4  0 0  - -  - -  0 0 
H weaner
g
  68  4 (5.9) 0  8 (11.8) 0  8 (11.8) 0  20 (29.4) 0 
UH weaner  44  5 (11.3) 0  8 (18.2) 0  1 (2.3) 0  14 (31.8) 0 
H grower
h
  22  0 0  3 (13.6) 0  8 (36.4) 3 (13.6)  11 (50.0) 3 (13.6) 
UH grower  11  0 0  1 (9.1) 0  - -  1 (9.1) 0 
H finisher
i
  10  0 0  - -  - -  0 0 
H sow  2  - -  0 0  - -  0 0 
N
j
  165  9 (5.5) 0  20 (12.1) 0  17 (10.3) 3 (1.8)  46 (27.88) 3 (1.8) 
a n, number of pigs within each health group; b C, cultural method; c H, healthy; d piglet, < 1 month old; e-, sample not collected from this group ; f UH, unhealthy; g weaner, 1-2 months old; h grower, 2-4 months old;  
 i finisher, 4-6 months old; j N, number of pigs from each state. 
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Table 4.1.7. Summary results of the 72 PCR-confirmed  
Y. enterocolitica isolates isolated from pigs. 
No. Isolates Name Pig No. Source API 20E  code,% of confirmation 
1 PCM-PPN53a-1 53 Pig, nasal swab 1114523, 99.7% 
2 PCM-PPN53a-2 53 Pig, nasal swab 1114523, 99.7% 
3 PCM-PPN53a-3 53 Pig, nasal swab 1014522, 93.9% 
4 PCM-PPN53a-4 53 Pig, nasal swab 1114523, 99.7% 
5 PCM-PPN53a-K1 53 Pig, nasal swab 1014522, 93.9% 
6 PCM-PPN53a-K2 53 Pig, nasal swab 1014522, 93.9% 
7 PCM-PPN53a-K3 53 Pig, nasal swab 1114523, 99.7% 
8 PCM-PPN53a-K4 53 Pig, nasal swab 1014522, 93.9% 
9 DCM-PPN55a-1 55 Pig, nasal swab 1114523, 99.7% 
10 DCM-PPN55a-2 55 Pig, nasal swab 1014522, 93.9% 
11 DCM-PPN55a-3 55 Pig, nasal swab 1114523, 99.7% 
12 DCM-PPN55a-4 55 Pig, nasal swab 1014522, 93.9% 
13 PCM-PPN55a-1 55 Pig, nasal swab 1104523, 95.7% 
14 PCM-PPN55a-2 55 Pig, nasal swab 1014522, 93.9% 
15 PCM-PPN55a-3 55 Pig, nasal swab 1014522, 93.9% 
16 PCM-PPN55a-4 55 Pig, nasal swab 1014522, 93.9% 
17 PCM-PPN55a-K1 55 Pig, nasal swab 1114523, 99.7% 
18 PCM-PPN55a-K2 55 Pig, nasal swab 1014522, 93.9% 
19 PCM-PPN55a-K3 55 Pig, nasal swab 1014522, 93.9% 
20 PCM-PPN55a-K4 55 Pig, nasal swab 1014522, 93.9% 
21 PCM-PPN55b-1 55 Pig, tongue swab 1114522, 99.9% 
22 PCM-PPN55b-2 55 Pig, tongue swab 1114523, 99.7% 
23 PCM-PPN55b-3 55 Pig, tongue swab 1014522, 93.9% 
24 PCM-PPN55b-4 55 Pig, tongue swab 1014522, 93.9% 
25 PCM-PPN55b-K1 55 Pig, tongue swab 1014522, 93.9% 
26 PCM-PPN55b-K2 55 Pig, tongue swab 1014522, 93.9% 
27 PCM-PPN55b-K3 55 Pig, tongue swab 1014522, 93.9% 
28 PCM-PPN55b-K4 55 Pig, tongue swab 1014522, 93.9% 
29 PCM-PPN55c-1 55 Pig, rectal swab 1114523, 99.7% 
30 PCM-PPN55c-2 55 Pig, rectal swab 1014522, 93.9% 
31 PCM-PPN55c-3 55 Pig, rectal swab 1014522, 93.9% 
32 PCM-PPN55c-4 55 Pig, rectal swab 1014522, 93.9% 
33 PCM-PPN55c-K1 55 Pig, rectal swab 1014522, 93.9% 
34 PCM-PPN55c-K2 55 Pig, rectal swab 1114523, 99.7% 
35 PCM-PPN55c-K3 55 Pig, rectal swab 1014522, 93.9% 
36 PCM-PPN55c-K4 55 Pig, rectal swab 1014522, 93.9% 
37 PCM-PPN56a-1 56 Pig, nasal swab 1014523, 96.4% 
38 PCM-PPN56a-2 56 Pig, nasal swab 1014522, 93.9% 
39 PCM-PPN56a-3 56 Pig, nasal swab 1014522, 93.9% 
40 PCM-PPN56a-4 56 Pig, nasal swab 1014522, 93.9% 
41 PCM-PPN56a-K1 56 Pig, nasal swab 1114523, 99.7% 
42 PCM-PPN56a-K2 56 Pig, nasal swab 1114523, 99.7% 
43 PCM-PPN56a-K3 56 Pig, nasal swab 1014522, 93.9% 
44 PCM-PPN56a-K4 56 Pig, nasal swab 1014522, 93.9% 
45 DCM-PPN56b-21 56 Pig, tongue swab 1114522, 99.9% 
46 DCM-PPN56b-22 56 Pig, tongue swab 1014522, 93.9% 
47 DCM-PPN56b-23 56 Pig, tongue swab 1114523, 99.7% 
48 DCM-PPN56b-24 56 Pig, tongue swab 1114523, 99.7% 
49 PCM-PPN56b-1 56 Pig, tongue swab 1014522, 93.9% 
50 PCM-PPN56b-2 56 Pig, tongue swab 1014522, 93.9% 
51 PCM-PPN56b-3 56 Pig, tongue swab 1014522, 93.9% 
52 PCM-PPN56b-4 56 Pig, tongue swab 1014522, 93.9% 
53 PCM-PPN56b-K1 56 Pig, tongue swab 1014522, 93.9% 
54 PCM-PPN56b-K2 56 Pig, tongue swab 1014522, 93.9% 
55 PCM-PPN56b-K3 56 Pig, tongue swab 1004522, 94.9% 
56 PCM-PPN56b-K4 56 Pig, tongue swab 1014522, 93.9% 
57 DCM-PPN56c-21 56 Pig, rectal swab 1114523, 99.7% 
58 DCM-PPN56c-22 56 Pig, rectal swab 1114523, 99.7% 
59 DCM-PPN56c-23 56 Pig, rectal swab 1014522, 93.9% 
60 DCM-PPN56c-24 56 Pig, rectal swab 1014522, 93.9% 
61 PCM-PPN56c-1 56 Pig, rectal swab 1114523, 99.7% 
62 PCM-PPN56c-2 56 Pig, rectal swab 1014522, 93.9% 
63 PCM-PPN56c-3 56 Pig, rectal swab 1014522, 93.9% 
64 PCM-PPN56c-4 56 Pig, rectal swab 1014522, 93.9% 
65 PCM-PPN56c-5 56 Pig, rectal swab 1014522, 93.9% 
66 PCM-PPN56c-6 56 Pig, rectal swab 1014522, 93.9% 
67 PCM-PPN56c-7 56 Pig, rectal swab 1114523, 99.7% 
68 PCM-PPN56c-8 56 Pig, rectal swab 1014522, 93.9% 
69 PCM-PPN56c-K1 56 Pig, rectal swab 1014522, 93.9% 
70 PCM-PPN56c-K2 56 Pig, rectal swab 1014522, 93.9% 
71 PCM-PPN56c-K3 56 Pig, rectal swab 1014522, 93.9% 
72 PCM-PPN56c-K4 56 Pig, rectal swab 1114522, 99.9% 
All isolates were bioserotype 3 variant/O:3, isolated on Oct 2011 from Farm I, Penang. Refer Appendix VI and VIII for raw data.
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Table 4.1.8. Distribution of the number of positive swab samples of pigs from Selangor, 
Perak and Penang using post-enrichment PCR screening and cultural methods. 
Swab type 
 
n
a
 
 No of positives samples (%) 
  Selangor (n=53)  Perak (n=60) 
 
Penang (n=52) 
 
Total positive 
  PCR C
b
  PCR C  PCR C  PCR C 
Nasal  165  5 (9.4) 0  14 (23.3) 0  10 (19.2) 3 (5.8)  29 (17.6) 3 (1.2) 
Rectal   165  5 (9.4) 0  8 (13.3) 0  8 (15.4) 2 (3.8)  21 (12.7) 2 (1.2) 
Oral  165  4 (7.5) 0  13 (21.7) 0  8 (15.4) 2 (3.8)  25 (15.2) 2 (1.2) 
N
c
  495  14 (2.8) 0  35 (7.1) 0  26 (5.3) 7 (1.4)  75 (9.9) 7 (1.4) 
a n, number of samples within each swab type; b C, cultural method; c N, number of pigs from each state 
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4.2 Isolation and detection methods for Y. enterocolitica 
4.2.1 Isolation of Y. entercolitica 
A total of 4706 presumptive Y. enterocolitica isolates were isolated from 106 
raw food samples and 495 swine specimens and all presumptive isolates were recovered 
by using CIN and modified CIN agars. The targeted bacterium, Y. enterocolitica, 
appeared as red bull’s eye (red-centred with colourless rim, Figure 4.2.1) and sometimes 
colourless without red-centred (<0.5mm) on both agars. Table 4.2.1 shows the 
distribution of the number of presumptive Y. enterocolitica isolates according to each 
sample type.  
Table 4.2.1. Number of presumptive Y. enterocolitica isolates according to each 
sample type. 
Samples
*
 No. of presumptive isolates 
Raw pork products 1267 
Raw non-porcine food 496 
Swine specimens
**
 2923 
Total 4706 
*All presumptive Y. enterocolitica isolates were picked from CIN agar except swine specimens from Farm I, modified CIN replaced 
CIN; ** only 52 rectal swabs from Farm I was tested with both CIN and modified CIN media. 
 
 
 
Figure 4.2.1. Colony morphology of Y. enterocolitica bioserotype 2/O:9 (IP383) on 
selective agars- (a) CIN, (b) CIN under 40× light microscope, (c) modified CIN, (d) 
modified CIN under 40× light microscope. 
(a) 
(c) 
(b) 
(d) 
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4.2.2 Biochemical identification for Y. enterocolitica 
The presumptive Y. enterocolitica isolates were then preliminary identified by 
using biochemical tests such as: oxidase test, Gram determination, urease test and 
citrate test. Out of 4706 presumptive Y. enterocolitica isolates, only 248 (5.3%) were 
Gram negative, citrate negative, oxidase negative and urease positive. Appendix VII 
summarises results and representive photos for the preliminary biochemical tests of Y. 
enterocolitica. All 248 presumptive Y. enterocolitica isolates that passed the 
preliminary biochemical tests (Appendix VII) were further identified biochemically by 
using API 20E identification kit. Only 107 isolates were API 20E identified as Y. 
enterocolitica (92.3% < % of confirmation < 99.9%). Appendix VIII summarises the 
results of biochemical reactions (API 20E) and raw data of Y. enterocolitica. Figure 
4.2.2 shows the representative photos of API 20E identified Y. enterocolitica isolates. 
Nearly 94% (4458/4706) of the presumptive isolates that appeared as red bulls’ 
eye on CIN (~96%, 3977/4153) and modified CIN (~87%, 481/553) were screened out 
during the preliminary biochemical tests. A part of these isolates were randomly picked 
and identified as Providencia rettgeri, Serratia spp., Citrobacter freundii, C. braakii, 
Klebsiella ornithinolytica, Enterobacter cloacae, and Pantoea spp. by using API 20E 
identification kit (Figure 4.2.3). About 57% (141/248) isolates that passed preliminary 
biochemical tests were identified as non-Y. enterocolitica (Morganella morganii, Y. 
frederiksenii, etc.) by using API 20E identification kit. Figure 4.2.3 shows the 
representative photos of API 20E identification kit these non-Y. enterocolitica bacteria. 
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 API 20E code, ID, % confirmation 
(a)  
1014522, Y. enterocolitica, 93.7% 
(b)  
1014523, Y. enterocolitica, 93.8% 
(c)  
1014522, Y. enterocolitica, 93.7% 
(d)  
1155723, Y. enterocolitica, 98.3% 
Figure 4.2.2. Representative photos of API 20E identification  
kit for Y. enterocolitica isolates.  
(a) PCM-PPN53a-K1; (b) S18/1 C-O-5-6b; (c) PC-M13-K13; (d) PC-M16-2. 
 
 
 
 API 20E code, ID, % confirmation 
(a)  
0274103, P. rettgeri, 99.9% 
(b)  
5317761, S. marcescens, 99.8% 
(c)  
1404672, C. freundii, 99.9% 
(d)  
1704553, C. braakii, 99.9% 
(f)  
1354773, Klebsiella ornithinolytica, 
98.7% 
(g)  
3305573, E. cloacae, 95.1% 
(h)  
1244553, Pantoea spp.,80.6% 
(e)  
0174000, M. morganii, 99.9% 
(f)  
1155573, Y. frederiksenii, 79.8% 
Figure 4.2.3. Representative photos of API 20E identification  
kit for non-Y. enterocolitica bacteria.  
(a) P. rettgeri (PC-TSP43c-2), (b) S. marcescens (YC-M19-2.6), (c) C. freundii (YC-I7-2.7), 
 (d) C. braakii (YC-T1-K1), (f) K. ornithinolytica (PC-M5-K13), (g) E. cloacae (YC-I1-K1),  
(h) Pantoea spp. (PC-TSP53b-K1), (e) M. morganii (IC-VG2-K1), (f) Y. frederiksenii (YC-I1-K1). 
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4.2.3 Confirmation of API 20E identified Y. enterocolitica isolates by PCR and 
DNA sequencing 
API 20E identified Y. enterocolitica isolates were further confirmed by using a 
duplex PCR targeting Y. enterocolitica-specific 16S rRNA (Neubauer, et al., 2000) and 
ail (Wannet, et al., 2001) genes. Primers Y1/Y2 and A1/A2 amplified the Y. 
enterocolitica-specific 16S rRNA (330bp) and ail (430bp) genes, respectively. The 
presence of the 330bp amplicon indicates positive for Y. enterocolitica. The presence of 
430bp amplicon indicates the presence of virulence ail gene. Out of the 107 API 20E 
identified Y. enterocolitica isolates, only 98 (91.5%) were PCR confirmed as Y. 
enterocolitica (all positive for Y. enterocolitica-specific 16S rRNA gene, Appendix 
VIII). Five isolates lacked the ail gene (refer Appendix VIII). Figure 4.2.4 shows 
representative gel photo for the duplex PCR using Y. enterocolitica isolates. DNA 
sequences of the 330 bp and 430 bp amplicons (Y. enterocolitica 16S rRNA and ail 
genes, respectively) were blast using Basic Local Alignment Search Tool 
(http://blast.ncbi.nlm.nih.gov/). The DNA amplicons gave 99% homology for both Y. 
enterocolitica 16S rRNA and ail genes (refer Appendix X for NCBI blast printscreens). 
 
 
Figure 4.2.4. Representative gel photo for the duplex PCR targeting  
Y. enterocolitica-specific 16S rRNA (330bp) and ail (430bp) genes using  
Y. enterocolitica isolates.  
Lane 1 and 17, 100bp DNA ladder (Promega); lane 2, positive control/ Y. enterocolitica (1992–045); lane 2 to 12, Y. enterocolitica 
(name of isolate starts from left: PC-M1-K1, PC-M1-K2, PC-M1-K3, PC-M1-K4, PC-M1-K5, PC-M1-K11, PC-M1-K12. PC-M1-
K13. PC-M3-6, PC-M3-K11, PC-M3-K12); lane 13 to 16, negative control. 
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4.2.4 Comparison of the recovery power of different isolation methods for Y. 
enterocolitica 
Several methods were performed in isolation and detection of Y. enterocolitica 
(three enrichment broths, two selective media, KOH treatment, and also direct plating). 
Tables 4.2.2 and 4.2.3 summarise the recovery rate of true Y. enterocolitica isolates by 
using different methods. Overall, the recovery rate of true Y. enterocolitica isolates was 
very low by using conventional methods. Only 2.1% (98/4706) presumptive Y. 
enterocolitica isolates (from selective plates) were confirmed as true Y. enterocolitica. 
Among the three enrichment broths, PBS enrichment (cold enrichment) was the best 
broth in recovery true Y. enterocolitica isolates from natural contaminated food, with 
recovery rate 6.5% as compared to YSEO (1.0%) and ITC (0.1%) (Table 4.2.2). 
Recovery rate for direct plating method was 1.6%. In comparing the performance of 
selective plating media, modified CIN was better than CIN, recovery rate for each of 
them was 13.0% and 0.6%, respectively (Table 4.2.3). Post enrichment KOH treatment 
increased the recovery rate of both CIN and modified CIN agars in isolating true Y. 
enterocolitica, increased from 0.5% to 1.1% and 7.7% to 31.2%, respectively (Table 
4.2.3). Detail results for the modification, comparison and evaluation of CIN and 
modified CIN are in Section 4.5. 
 
Table 4.2.2. Recovery rate of true Y. enterocolitica isolates  
by using different methods. 
Methods 
 No. of presumptive 
isolates 
 No. of true Y. 
enterocolitica
a
 
 % of recovery 
 
CIN 
Modified 
CIN 
 
CIN 
Modified 
CIN 
 CIN 
Modified 
CIN 
Total 
Direct 
plating 
 
744 229 
 
4 12  0.5 5.2 1.6 
YSEO  864 -
b
  9 -  1.0 - 1.0 
ITC  1531 246  2 0  0.1 0 0.1 
PBS  1014 78  11 60  1.1 76.9 6.5 
     
  
 
  
 
Total  4153 553  26 72  0.6 13.0 2.1 
aConfirmed by PCR and DNA sequencing; b-, method not performed. 
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Table 4.2.3. Effect of alkaline treatment on the recovery rate  
of true Y. enterocolitica isolates. 
Methods 
 No. of presumptive 
isolates 
 
No. of true Y. 
enterocolitica
a
 
 % of recovery 
 Normal 
plating
a
 
Alkaline 
treatment
b
 
 
Normal 
plating 
Alkaline 
treatment 
 
Normal 
plating 
Alkaline 
treatment 
Total 
CIN  3046 1107  14 12  0.5 1.1 0.6 
Modif-
ied CIN 
 
428 125  33 39  7.7 31.2 13.0 
           
Total  3474 1232  47 51  1.4 4.1 2.1 
aWithout any post-enrichment treatment; bA post enrichment treatment before plating; c-, method not performed. 
 
 
 
4.2.5 Post enrichment PCR detection for Y. enterocolitica 
The same duplex PCR (targeting Y. enterocolitica-specific 16S rRNA and ail 
genes in Section 3.2.4.1) used for Y. enterocolitica isolates confirmation was used. A 
food sample was counted as PCR positive when either one of the three enriched 
homogenates (YSEO, ITC and PSB) showed presence of amplicons (Y. enterocolitica-
specifec 16S rRNA gene, 330bp). Overall, post enrichment PCR detection gave higher 
prevalence rate as compared to the conventional culture methods (Refer Section 4.1).  
Raw data of the post enrichment PCR detection are tabulated in Appendix IV, V 
and VI. Figures 4.2.5 and 4.2.6 are representative gel photos for the post enrichment 
PCR detection. 
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Figure 4.2.5. Representative gel photo for enriched food cultures.  
Lane 1 and 17, 100bp DNA ladder (Promega); lane 2 and 16, positive control (1992-045);  
lane 3, M1 (ITC-enriched); lane 4, M1 (PBS-enriched); lane 5 to 13, M1 (YSEO-enriched MPN tubes);  
lane14, M2 (PBS-enriched); lane 15, negative control. 
 
 
Figure 4.2.6. Representative gel photos for PBS-enriched cultures  
(Perak’s swine specimens).  
Lane 1, 18, 19, and 36, 100bp DNA ladder (Promega); lane 2, 17, 20, and 35, positive control (1992-045);  
lane 3-5, PP49a-c; lane 6-8, PP50a-c; lane 9-11, PP51a-c;  lane 12-14, PP52a-c; lane 15, 16 and 21, PP53a-c;  
lane 22-24, PP54a-c; lane 25-27, PP55a-c; lane 28-30, PP56a-c; lane 31-32, PP57a-b; lane 34, negative control. 
 
4.2.6 API 50CH 
The seven isolates that were identified as Y. enterocolitica by the API 20E but 
failed to be amplified by the duplex PCR were further tested with another kit, the API 
50CH identification kit (refer Appendix VIII). The results showed that these seven 
isolates were either Yersinia intermedia or Y. frederiksenii. Figure 4.2.7 shows 
representative photo for the API 50CH identification for the tested isolates. 
 
 
Figure 4.2.7. Representative photo for API 50CH identification 
kit for Y. intermedia (PC-M5-K11). 
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4.3 Biotyping and serotyping of Y. enterocolitica isolates 
 All 98 PCR-confirmed Y. enterocolitica isolates were biotyped by 11 
biochemical tests according to Wauters, et al. (1987) and serotyped by using 
commercial O-antisera "SEIKEN" set purchased (DENKA SEIKEN Co., Ltd, Japan). 
Results obtained were analyzed by referring to Table 2.1. Y. enterocolitica belongs to 
biotype 1B, 2, 3, 4 and 5 are referred as pathogenic and biotype 1A is non-pathogenic. 
Tables 4.3.1 and 4.3.2 summarise the results of biochemical and antisera reactions of Y. 
enterocolitica. Raw data and representative photos of each test for all 98 Y. 
enterocolitica isolates are tabulated in Appendix XI. Overall, the Y. enterocolitica 
isolates were bioserotyped as 3 variant/O:3 (n=92), 1B/O:8 (n=3) and 1A/O:5 (n=3). 
 
 Table 4.3.1. Summary results for the serotyping of Y. enterocolitica. 
Serotypes 
Antisera 
No. of 
isolates O:3 O:5 O:8 O:9 
O:1 and 
O:2 
O:3 + - - - - 92 
O:8 - - + - - 3 
O:5 - + - - - 3 
  
    
 
Total 98 
+, positive; -, negative. 
 
 
 
Table 4.3.2. Summary results for the biotyping of Y. enterocolitica. 
Biotypes 
Biochemical tests 
No. of 
isolates 
L
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3 variant (VP-) - - - - + + + - - - - 92 
1B + - - + + + + + - - - 3 
1A + + + + + + + + + + - 3 
 
           
 
Total 98 
+, positive; -, negative. 
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4.3.1 Bioserotyping of Y. enterocolitica isolates from raw pork products 
Bioserotyping results revealed that the 26 Y. enterocolitica isolates from raw 
pork products were bioserotyped as 3 variant/O:3 (VP negative variant strain, n=20), 
1B/O:8 (n=3), and 1A/O:5 (n=3) (Table 4.1.2 and Appendix IX). Twenty-three isolates 
were referred as pathogenic (biotypes 3 variant and 1B) and 3 isolates were non-
pathogenic (biotype 1A). 
 
4.3.2 Bioserotyping of Y. enterocolitica isolates from swine 
A total of 72 Y. enterocolitica isolates were isolated from the three pigs and all 
isolates were pathogenic Y. enterocolitica bioserotype 3 variant/O:3 (Table 4.1.7). 
 
 
4.4  Futher characterization of Y. enterocolitica isolates 
Out of 98 isolates from the previous Sections, 66 were replicate isolates and 32 
Y. enterocolitica isolates (raw pork products, n=12; pigs, n=20) were selected for further 
characterization. For each sample, isolates with the same profiles (biochemical tests, 
API 20E, biotype and serotype) were recorded as replicates and only one isolate was 
selected for further characterization. More than one isolate (different profiles) might be 
selected from a sample. Table 4.4.1 summarises the background information of the 
selected isolates. 
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Table 4.4.1. Background information of the selected Y. emterocolitica isolates. 
No. Name of isolates Isolation date Location Pig No. / sample code Source API 20E  (code, %)a Biogroupingb Serotypingb 
1 PCM-PPN53a-1 Sept 2011 Penang, Farm I 53 Pig, nasal swab 1114523, 99.7% 3 variant O:3 
2 PCM-PPN53a-3 Sept 2011 Penang, Farm I 53 Pig, nasal swab 1014522, 93.9% 3 variant O:3 
3 DCM-PPN55a-1 Sept 2011 Penang, Farm I 55 Pig, nasal swab 1114523, 99.7% 3 variant O:3 
4 PCM-PPN55a-1 Sept 2011 Penang, Farm I 55 Pig, nasal swab 1104523, 95.7% 3 variant O:3 
5 PCM-PPN55b-1 Sept 2011 Penang, Farm I 55 Pig, tongue swab 1114522, 99.9% 3 variant O:3 
6 PCM-PPN55b-2 Sept 2011 Penang, Farm I 55 Pig, tongue swab 1114523, 99.7% 3 variant O:3 
7 PCM-PPN55b-4 Sept 2011 Penang, Farm I 55 Pig, tongue swab 1014522, 93.9% 3 variant O:3 
8 PCM-PPN55b-K3 Sept 2011 Penang, Farm I 55 Pig, tongue swab 1014522, 93.9% 3 variant O:3 
9 PCM-PPN55c-1 Sept 2011 Penang, Farm I 55 Pig, rectal swab 1114523, 99.7% 3 variant O:3 
10 PCM-PPN55c-3 Sept 2011 Penang, Farm I 55 Pig, rectal swab 1014522, 93.9% 3 variant O:3 
11 PCM-PPN56a-1 Sept 2011 Penang, Farm I 56 Pig, nasal swab 1014523, 96.4% 3 variant O:3 
12 PCM-PPN56a-4 Sept 2011 Penang, Farm I 56 Pig, nasal swab 1014522, 93.9% 3 variant O:3 
13 PCM-PPN56a-K1 Sept 2011 Penang, Farm I 56 Pig, nasal swab 1114523, 99.7% 3 variant O:3 
14 DCM-PPN56b-21 Sept 2011 Penang, Farm I 56 Pig, tongue swab 1114522, 99.9% 3 variant O:3 
15 DCM-PPN56b-23 Sept 2011 Penang, Farm I 56 Pig, tongue swab 1114523, 99.7% 3 variant O:3 
16 PCM-PPN56b-4 Sept 2011 Penang, Farm I 56 Pig, tongue swab 1014522, 93.9% 3 variant O:3 
17 PCM-PPN56b-K3 Sept 2011 Penang, Farm I 56 Pig, tongue swab 1004522, 94.9% 3 variant O:3 
18 DCM-PPN56c-21 Sept 2011 Penang, Farm I 56 Pig, rectal swab 1114523, 99.7% 3 variant O:3 
19 DCM-PPN56c-23 Sept 2011 Penang, Farm I 56 Pig, rectal swab 1014522, 93.9% 3 variant O:3 
20 PCM-PPN56c-K4 Sept 2011 Penang, Farm I 56 Pig, rectal swab 1114522, 99.9% 3 variant O:3 
21 PC-M1-K1 June 2010 KL, Wet Market A M1 Raw pork meat 1014522, 93.9% 3 variant O:3 
22 PC-M3-6 June 2010 KL, Wet Market A M3 Raw pork meat 1014522, 93.9% 3 variant O:3 
23 PC-M13-K13 Sept 2010 KL, Wet Market A M13 Raw pork meat 1014522, 93.9% 3 variant O:3 
24 S18/1-C-O-6a Jan 2011 KL, Wet Market A YE037 Raw pork intestine 1015523, 93.8% 3 variant O:3 
25 S18/1-C-I-4-6b Jan 2011 KL, Wet Market A YE037 Raw pork intestine 1155523, 98.3% 3 variant O:3 
26 S18/1-C-O-6d Jan 2011 KL, Wet Market A YE037 Raw pork intestine 1154523, 92.3% 3 variant O:3 
27 S18/1-C-O-5-6e Jan 2011 KL, Wet Market A YE037 Raw pork intestine 1115523, 92.3% 3 variant O:3 
28 S18/1-C-O-1a Jan 2011 KL, Wet Market A YE032 Raw pork liver 1354723, 92.5% 1B O:8 
29 S18/1-C-O-K-5b Jan 2011 KL, Wet Market A YE036 Raw pork meat 1354523, 92.3% 1B O:8 
30 S18/1-C-O-5c Jan 2011 KL, Wet Market A YE036 Raw pork meat 1355523, 81.3% 1B O:8 
31 PC-M16-2 Jan 2011 KL, Wet Market A M16 Raw pork meat 1155723, 98.3% 1A O:5 
32 PC-M16-10 Jan 2011 KL, Wet Market A M16 Raw pork meat 1154723, 92.5% 1A O:5 
Refer Appendix aVIII and bIX for raw data
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4.4.1 Virulotypes of Y. enterocolitica isolates 
In this study, the cycling and PCR mix conditions were re-optimised for 13 
virulence genes into four multiplex PCRs (MP1 to MP4) as the original published 
conditions were not appropriate. The involved genes are as follow: hreP, virF, rfbC, 
myfA, fes, sat, fepD, inv, ail. ymoA, tccC, yadA, and fepA. The optimized cycling and 
PCR mix conditions are tabulated in Tables 4.4.2 and 4.4.3. Cycling conditions for 
multiplex MP5 (ystA and ystB genes) was performed according to recommendations in 
the original studies. Figure 4.4.1 shows representative agarose gel photo for the 
multiplexes by using positive control strains. 
 
 
Figure 4.4.1. Representative agarose gel (2%) electrophoresis photo  
of multiplex MP1 to MP5 by using positive control strains.  
Lanes 1, 10, 11 and 14, molecular weight marker (100 bp, Promega, USA); lanes 2 and 3, amplicons of multiplex MP1  
(IP383 + IP135; hreP, 757 bp; virF, 591 bp; rfbC, 405 bp; myfA, 272 bp); lanes 3 and 4, amplicons of multiplex MP2  
(IP135; fes, 561 bp; sat, 456 bp; fepD, 381 bp); lanes 6 and 7, amplicons of multiplex MP4 (IP102 + IP383; tccC, 1035 bp;  
yadA, 849 bp; fepA, 438 bp); lanes 8 and 9, amplicons of multiplex MP5 (IP102 + IP11105; ystB, 146 bp; ystA, 79 bp);  
lanes 12 and 13, amplicons of multiplex MP3 (IP11105 + IP383; inv, 570 bp; ail, 430 bp; ymoA, 330 bp). 
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Table 4.4.2. Primers sequences and PCR cycling conditions for virulence genes determination of Y. enterocolitica. 
Multiplex 
PCR (MP) 
Gene 
Gene product/ 
function 
Primers sequence (5’3’) 
Amplicon 
size (bp) 
PCR conditions (°C, s)a References 
Denaturation Annealing Extension  
MP1 
hreP 
subtilisin/kexin-like 
protease 
Forward – GCCGCTATGGTGCCTCTGGTGTG 
Reverse – CCCGCATTGACTCGCCCGTATC 
757 
95, 30 55, 60 72, 60 
(Bhagat & Virdi, 2007) 
virF 
transcriptional 
activator 
Forward – TCATGGCAGAACAGCAGTCAG  
Reverse – ACTCATCTTACCATTAAGAAG 
590 
(Bhaduri & Pickard, 
1995) 
rfbC 
specific detection to 
YE serotype O:3 
Forward – CGCATCTGGGACACTAATTCG  
Reverse – CCACGAATTCCATCAAACCACC 
405 (Weynants, et al., 1996) 
myfA fimbriae 
Forward – CAGATACACCTGCCTTCCATCT  
Reverse – CTCGACATATTCCTCAACACGC 
272 (Kot & Trafny, 2004) 
MP2 
fes enterochelin esterase 
Forward – GCCGGCAGGCACAGCGTAAT  
Reverse – GGCCAACCCACCCAAAACTT 
561 
95, 30 55, 60 72, 60 
(Schubert, et al., 1999) 
sat 
streptogramin 
acetyltransferase 
Forward – CCGATGGTGGGGTTTTCTCAAG  
Reverse – GGGATTACCGCCGACCACACTA 
456 (Bhagat & Virdi, 2007) 
fepD 
enterochelin ABC 
transporter 
Forward – GTGTGATTGCCTTACTATTG  
Reverse – CGGTCATCCTTTTATTACGG 
381 (Schubert, et al., 1999) 
MP3 
inv invasin 
Forward – CTGTGGGGAGAGTGGGGAAGTTTGG  
Reverse – GAACTGCTTGAATCCCTGAAAACCG 
570 
95, 30 55, 60 72, 60 
(Rasmussen, Rasmussen, 
Andersen, & Olsen, 1994) 
ail adhesin 
Forward – TTAATGTGTACGCTGCGAGTG  
Reverse – GGAGTATTCATATGAAGCGTC 
430 (Wannet, et al., 2001) 
ymoA yersinia modulator 
Forward – GACTTTTCTCAGGGGAATAC  
Reverse – GCTCAACGTTGTGTGTCT 
330 (Grant, et al., 1998) 
MP4 
tccC 
insecticidal toxin 
complex-like protein 
Forward – GGGCAAAAAATGCGTGAAGAGAG  
Reverse – TTTACCGGAATAACGCACAGTTTTA 
1035 
95, 30 51, 90 72, 90 
(Bhagat & Virdi, 2007) 
yadA 
auto agglutination, 
serum resistance, 
adhesion 
Forward – CTTCAGATACTGGTGTCGCTGT  
Reverse – ATGCCTGACTAGAGCGATATCC 
849 
759b 
(Wang, et al., 2008) 
fepA 
enterochelin receptor 
protein 
Forward – TACGCCAAAATACCTTACGAT  
Reverse – TGTAAATACACCCCCACCTGA 
438 (Schubert, et al., 1999) 
MP5 
ystB enterotoxin 
Forward – GTACATTAGGCCAAGAGACG  
Reverse – GCAACATACCTCACAACACC 
146 
95, 5 60, 20 72, 20 
(Thoerner, et al., 2003) 
ystA enterotoxin 
Forward – ATCGACACCAATAACCGCTGAG  
Reverse – CCAATCACTACTGACTTCGGCT 
79 (Thoerner, et al., 2003) 
a PCRs were performed with a pre-denaturation step of 95°C for 10 min, 30 cycles of denaturation, annealing, extension as indicated above and a final extension of 72°C, 10 min 
b amplicon length in pathogenic Y. enterocolitica serotypes O:8
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Table 4.4.3. Conditions of PCR mixes of multiplex PCRs for virulence genes determination for Y. enterocolitica. 
Materials 
 
Stock 
conc. 
 Multiplex MP1  Multiplex MP2  Multiplex MP3  Multiplex MP4  Multiplex MP5 
  
Working 
conc. 
1× (µl)  
Working 
conc. 
1× (µl) 
 Working 
conc. 
1× (µl) 
 Working 
conc. 
1× (µl) 
 Working 
conc. 
1× (µl) 
Buffer (×)  5  1 5.0  1 5.0  1.5 7.5  1 5.0  1 5.0 
MgCl2 (mM)  25  1.5 1.5  1.5 1.5  1.5 1.5  3 1.5  3 3.0 
dNTPs (mM)  10  0.2 0.5  0.2 0.5  0.2 0.5  0.2 0.5  0.2 0.5 
Primers (µM)  10  hreP: 0.2 0.5  fes: 0.2 0.5  inv: 0.2 0.5  tccC: 0.3 0.5  ystB: 0.1 0.25 
 
 10  virF: 0.2 0.5  sat: 0.2 0.5  ail: 0.2 0.5  yadA: 0.3 0.5  ystA: 0.1 0.25 
 
 10  rfbC:0.2 0.5  fepD: 0.2 0.5  ymoA:0.2 0.5  fepA: 0.2 0.5  - - 
 
 10  myfA: 0.2 0.5  - -  - -  - -  - - 
Taq polymerase (U/µL)  5  1 0.2  1 0.2  1 0.2  1 0.2  0.5 0.1 
ddH2O  -  - 13.8  - 13.8  - 11.3  - 13.8  - 13.4 
DNA templates (ng)  -  ~20 2.0  ~20 2.0  ~20 2.0  ~20 2.0  ~20 2.0 
Total  
 
 
 
25.000   25.000   25.000   25.000   25.000 
 
 
 
 
  
            
Positive control strains  
 
 
IP383 
IP135 
 IP135  IP11105 
IP383 
 IP102 
IP383 
 IP102 
IP11105 
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The prevalence of the 15 virulence genes tested are as follows: hreP (100%), sat 
(100%), ymoA (100%), myfA (94%), inv (94%), ystA (94%), yadA (94%), virF (84%), 
rfbC (84%), ail (84%), tccC (84%), fepA (34%), fes (16%), fepD (16%), and ystB (6%) 
(Table 4.4.4). Virulotyping results of the 32 selected Y. enterocolitica isolates are 
tabulated in 4.4.4. Figures 4.4.2 to 4.4.6 show representative agarose gel photos for the 
PCRs of Y. enterocolitica isolates. 
 
Table 4.4.4. Prevalence of virulence genes for 32 selected Y. enterocolitica isolates. 
No. Name of isolates 
Virulence Genes 
Virulotype 
h
re
P
 
vi
rF
 
rf
b
C
 
m
yf
A
 
fe
s 
sa
t 
fe
p
D
 
in
v 
a
il
 
ym
o
A
 
ys
tB
 
ys
tA
 
tc
cC
 
ya
d
A
 
fe
p
A
 
1 PCM-PPN53a-1 + + + + - + - + + + - + + + - YeVi3 
2 PCM-PPN53a-3 + + + + - + - + + + - + + + - YeVi3 
3 DCM-PPN55a-1 + + + + - + - + + + - + + + - YeVi3 
4 PCM-PPN55a-1 + + + + - + - + + + - + + + - YeVi3 
5 PCM-PPN55b-1 + + + + - + - + + + - + + + - YeVi3 
6 PCM-PPN55b-2 + + + + - + - + + + - + + + - YeVi3 
7 PCM-PPN55b-4 + + + + - + - + + + - + + + - YeVi3 
8 PCM-PPN55b-K3 + + + + - + - + + + - + + + + YeVi4 
9 PCM-PPN55c-1 + + + + - + - + + + - + + + - YeVi3 
10 PCM-PPN55c-3 + + + + - + - + + + - + + + - YeVi3 
11 PCM-PPN56a-1 + + + + - + - + + + - + + + - YeVi3 
12 PCM-PPN56a-4 + + + + - + - + + + - + + + - YeVi3 
13 PCM-PPN56a-K1 + + + + - + - + + + - + + + - YeVi3 
14 DCM-PPN56b-21 + + + + - + - + + + - + + + - YeVi3 
15 DCM-PPN56b-23 + + + + - + - + + + - + + + - YeVi3 
16 PCM-PPN56b-4 + + + + - + - + + + - + + + - YeVi3 
17 PCM-PPN56b-K3 + + + + - + - + + + - + + + - YeVi3 
18 DCM-PPN56c-21 + + + + - + - + + + - + + + - YeVi3 
19 DCM-PPN56c-23 + + + + - + - + + + - + + + - YeVi3 
20 PCM-PPN56c-K4 + + + + - + - + + + - + + + - YeVi3 
21 PC-M1-K1 + + + + - + - + + + - + + + - YeVi3 
22 PC-M3-6 + + + + - + - + + + - + + + - YeVi3 
23 PC-M13-K13 + + + + - + - + + + - + + + + YeVi4 
24 S18/1-C-O-6a + + + + - + - + + + - + + + + YeVi4 
25 S18/1-C-I-4-6b + + + + - + - + + + - + + + + YeVi4 
26 S18/1-C-O-6d + + + + - + - + + + - + + + + YeVi4 
27 S18/1-C-O-5-6e + + + + - + - + + + - + + + + YeVi4 
28 S18/1-C-O-1a + - - + + + + + - + - + - + + YeVi1 
29 S18/1-C-O-K-5b + - - + + + + + - + - + - + + YeVi1 
30 S18/1-C-O-5c + - - + + + + + - + - + - + + YeVi1 
31 PC-M16-2 + - - - + + + - - + + - - - + YeVi2 
32 PC-M16-10 + - - - + + + - - + + - - - + YeVi2 
No. of isolates 3
2
 
2
7
 
2
7
 
3
0
 
5
 
3
2
 
5
 
3
0
 
2
7
 
3
2
 
2
 
3
0
 
2
7
 
3
0
 
1
1
 
 
Prevalence (%) 
1
0
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.0
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+, positive; -, negative. 
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Figure 4.4.2. Representative agarose gel (2%) electrophoresis  
photo of multiplex MP1.  
Lane 1 and 9, DNA marker (100bp, Promega); lane 2 and 7, positive control (IP383 + IP135);  
lane 3, PC-M1-K1; lane 4, S18/1 C-O-5c; lane 5, S18/1 C-O-6a; lane 6, S18/1 C-O-5-6e;  
lane 8, negative control. 
 
 
 
Figure 4.4.3. Representative agarose gel (2%) electrophoresis  
photo of multiplex MP2.  
Lane 1 and 18, DNA marker (100bp, Promega); lane 2 and 17, positive control (IP135);  
lane 3, PCM-PPN53a-1; lane 4, PCM-PPN53a-3; lane 5, DCM-PPN55a-1; lane 6, PCM-PPN55a-1;  
lane 7, PCM-PPN55b-1; lane 8, PCM-PPN55b-2; lane 9, PCM-PPN55b-4; lane 10, PCM-PPN55b-K3;  
lane 11, PCM-PPN55c-1; lane 12, PCM-PPN55c-3; lane 13, PCM-PPN56a-1; lane 14, PCM-PPN56a-4;  
lane 15, PCM-PPN56a-K1; lane 16, DCM-PPN56b-21. 
 
 
 
Figure 4.4.4. Representative agarose gel (2%) electrophoresis  
photo of multiplex MP3.  
Lane 1 and 16, DNA marker (100bp, Promega); lane 2 and 14, positive control (IP11105 + IP383);  
lane 3, PCM-PPN53a-1; lane 4, PCM-PPN53a-3; lane 5, DCM-PPN55a-1; lane 6, PCM-PPN55a-1;  
lane 7, PCM-PPN55b-1; lane 8, PCM-PPN55b-2; lane 9, PCM-PPN55b-4; lane 10, PCM-PPN55b-K3;  
lane 11, PCM-PPN55c-1; lane 12, PCM-PPN55c-3; lane 13, PCM-PPN56a-1; lane 15, negative control. 
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Figure 4.4.5. Representative agarose gel (2%) electrophoresis  
photo of multiplex MP4.  
Lane 1 and 15, DNA marker (100bp, Promega); lane 2 and 14, positive control (IP102 + IP383);  
lane 3, PC-M13-K13; lane 4, PC-M16-2; lane 5, PC-M16-5; lane 6, PC-M16-10; lane 7, S18/1 C-O-1a;  
lane 8, S18/1 C-O-K-5b; lane 9, S/18/1 C-O-5c; lane 10, S/18/1 C-O-6a; lane 11, S/18/1 C-I-4-6a;  
lane 12, S/18/1 C-O-6d; lane 12, S/18/1 C-O-5-6e; lane 14, negative control. 
 
 
Figure 4.4.6. Representative agarose gel (2%) electrophoresis  
photo of multiplex MP5.  
Lane 1 and 17, DNA marker (100bp, Promega); lane 2 and 16, positive control (IP102 + IP11105);  
lane 3, PC-M16-2; lane 4, PC-M16-10; lane 5, PC-M1-K1; lane 6, PC-M3-6; lane 7, PC-M13-K13;  
lane 8, negative control; lane 9, S18/1 C-O-1a; lane 10, S18/1 C-O-K-5b; lane 11, S/18/1 C-O-5c;  
lane 12, S/18/1 C-O-6a; lane 13, S/18/1 C-I-4-6a; lane 14, S/18/1 C-O-6d; lane 15, S/18/1 C-O-5-6e. 
 
 
DNA sequences of representative amplicons for all genes were analysed using 
the Basic Local Alignment Search Tool (http://blast.ncbi.nlm.nih.gov/), and results 
showed high similarity to the sequences of genes in Genebank, with 98-100% homology 
(Appendix X). There were four reproducible virulence genes patterns (virulotype) and 
each virulotype associated with a particular bioserotype; i.e. virulotypes YeVi1 (n=3, 
bioserotype 1B/O:8), YeVi2 (n=2, bioserotype 1A/O:5), YeVi (n=6, bioserotype 3 
variant/O:3), YeVi4 (n=21, bioserotype 3 variant/O:3). Table 4.4.5 summarises the 
virulotypes of Y. enterocolitica. 
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Table 4.4.5. Virulotypes of Y. enterocolitica. 
Virulotype Virulence genesa 
Y. enterocolitica 
bioserotype 
No. of 
strains 
YeVi1b hreP, myfA, fes, sat, fepD, inv, ymoA, ystA, yadA, fepA 1B/O:8 3 
YeVi2c hreP, fes, sat, fepD, ymoA, ystB, fepA 1A/O:5 2 
YeVi3d 
hreP, virF, rfbC, myfA, sat, inv, ail, ymoA, ystA, tccC, 
yadA, fepA 
3 variant/O:3 6 
YeVi4e 
hreP, virF, rfbC, myfA, sat, inv, ail, ymoA, ystA, tccC, 
yadA 
3 variant/O:3 21 
Total   32 
aThe 15 virulence genes tested were hreP, virF, rfbC, myfA, fes, sat, fepD, inv, ail, ymoA, ystA, ystB,, tccC, yadA, and fepA; bThe 
absent genes (PCR detection) were virF, rfbC, ail, ystB, and tccC; cThe absent genes (PCR detection) were virF, rfbC, myfA, inv, 
ail, ystA, tccC, and fepA; dThe absent genes (PCR detection) were fes, fepD, ystB, and fepA; eThe absent genes (PCR detection) were 
fes, fepD, and ystB.  
 
 
4.4.2 Phenotypic virulence plasmid tests  
The presence of virulence plasmid was phenotypically determined by three 
biochemical tests as stated in Table 4.4.6. CR-MOX test allows visualization of 
calcium-dependent growth and uptake of Congo red dye (Riley & Toma, 1989). Isolates 
that contain the pYV virulence plasmid are CR-MOX positive. Crystal violet of the 
crystal violet binding test binds to the isolates that contain the pYV virulence plasmid 
(Bhaduri, et al., 1987). Simillarly, isolates that contain the pYV virulence plasmid 
agglutinate at 37°C but not 25°C in the autoagglutination test (Farmer 3rd, et al., 1992). 
Isolates that lack the virulence plasmid do not agglutinate at either temperature. 
Representative photo of each tests are in Appendix XI. 
Isolates that are pYV-plasmidless are negative in all three biochemical. All Y. 
enterocolitica bioserotype 3 variant/O:3 isolates (n=27) showed positive in all three 
biochemical tests, indicating they contained the pYV virulence plasmid. Isolates of 
bioserotypes 1A/O:5 (n=2) and 1B/O:8 (n=3) showed negative in all three tests, 
indicating did not contain the pYV virulence plasmid.  
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Table 4.4.6. Results of the auto-agglutination, CR-MOX, and crystal violet 
binding. 
Bioserotype of Y. 
enterocolitica (N=32) 
Auto-
agglutination 
CR-MOX 
Crystal 
violet 
binding 
P/A of pYV 
plasmid 
3 variant/O:3 (n=27) + + + Present 
1B/O:8 (n=3) - - - Absent 
1A/O:5 (n=2) - - - Absent 
+, positive; -, negative. 
 
 
4.4.3 Plasmid profiles 
In this study, the prevalence of plasmids in the 32 selected Y. enterocolitica 
isolates were determined by two ways: (i) PFGE of unrestricted DNA plugs; (ii) 
electrophoresis of extracted plasmid DNA by using commercial kit. The plasmid sizes 
were estimated by using Quantity One® 1-D Analysis software (Bio-Rad). Table 4.4.7 
shows the plasmid sizes and the plasmid profiles of the 32 selected Y. enterocolitica 
isolates. Gel photos for the PFGE of unrestricted DNA plugs and extracted plasmid 
DNA are shown in Figures 4.4.7, 4.4.8, 4.4.9, and 4.4.10. 
Overall, nine plasmid profiles were observed (Table 4.4.7; YeP1 to YeP9). 
Twenty-eight isolates (87.5%) carried multiple plasmids ranging from ~2.3 kb to ~102 
kb (Table 4.4.7). PFGE of undigested genomic DNA showed the presence of the ~70 kb 
band indicative of the pYV virulence plasmid, in all isolates of bioserotype 3 
variant/O:3 (n=27) (including the control strain, IP383; Figure 4.4.7). In addition, 4-7 
small plasmids with size ranging from ~2.3 kb to ~17.7 kb were found (Table 4.4.7). 
The presence of pYV virulence plasmid (~70 kb) in the 3 variant/O:3  isolates (Table 
4.4.7) concurred with the PCR results as both the yadA and virF genes (pYV plasmid-
encoded genes) were present (Tables 4.4.4 and 4.4.5) and the positive phenotypic 
plasmid detection tests (Table 4.4.6). Two isolates were observed to possess an extra 
~102 kb plasmid (Table 4.4.7 and Figure 4.4.7; isolates: PCM-PPN56a-1 and DCM-
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PPN55a-1). The two 1B/O:8 and all 1A/O:5 strains did not harbour any plasmid (Table 
4.4.7). This is in agreement with the negative results of the phenotypic plasmid 
detection tests (Tables 4.4.6). 
 
Table 4.4.7. Number of plasmids, plasmid profiles, and plasmid  
sizes carried by Y. enterocolitica isolates. 
No. Name of isolates 
Pheno-
typic 
tests 
Plasmid Size (kb)* 
No. of 
plasmid 
Plasmid 
profiles 
1 PCM-PPN53a-1 + 70, 17.7, 10.9, 8.7, 7.4, 5.6, 5.2 7 YeP3 
2 PCM-PPN53a-3 + 70, 25, 8.7, 8.2, 5.6, 5.2 6 YeP1 
3 DCM-PPN55a-1 + 102, 65, 17.7, 10.9, 8.7, 7.4, 5.6, 5.2 8 YeP7 
4 PCM-PPN55a-1 + 70, 17.7, 10.9, 8.7, 7.4, 5.6, 5.2 7 YeP3 
5 PCM-PPN55b-1 + 70, 17.7, 7.4, 5.6, 5.2 5 YeP2 
6 PCM-PPN55b-2 + 70, 17.7, 10.9, 8.7, 7.4, 5.6, 5.2 7 YeP3 
7 PCM-PPN55b-4 + 70, 17.7, 10.9, 8.7, 7.4, 5.6, 5.2 7 YeP3 
8 PCM-PPN55b-K3 + 70, 17.7, 10.9, 8.7, 7.4, 5.6, 5.2 7 YeP3 
9 PCM-PPN55c-1 + 70, 17.7, 10.9, 8.7, 7.4, 5.6, 5.2 7 YeP3 
10 PCM-PPN55c-3 + 70, 17.7, 10.9, 8.7, 7.4, 5.6, 5.2 7 YeP3 
11 PCM-PPN56a-1 + 102, 70, 17.7, 10.9, 8.7, 7.4, 5.6, 5.2 8 YeP8 
12 PCM-PPN56a-4 + 70, 17.7, 10.9, 8.7, 7.4, 5.6, 5.2 7 YeP3 
13 PCM-PPN56a-K1 + 70, 17.7, 10.9, 8.7, 7.4, 5.6, 5.2 7 YeP3 
14 DCM-PPN56b-21 + 70, 17.7, 10.9, 8.7, 7.4, 5.6, 5.2 7 YeP3 
15 DCM-PPN56b-23 + 70, 17.7, 10.9, 8.7, 7.4, 5.6, 5.2 7 YeP3 
16 PCM-PPN56b-4 + 70, 17.7, 10.9, 8.7, 7.4, 5.6, 5.2 7 YeP3 
17 PCM-PPN56b-K3 + 70, 17.7, 10.9, 8.7, 7.4, 5.6, 5.2 7 YeP3 
18 DCM-PPN56c-21 + 70, 17.7, 10.9, 8.7, 7.4, 5.6, 5.2 7 YeP3 
19 DCM-PPN56c-23 + 70, 17.7, 10.9, 8.7, 7.4, 5.6, 5.2 7 YeP3 
20 PCM-PPN56c-K4 + 70, 17.7, 10.9, 8.7, 7.4, 5.6, 5.2 7 YeP3 
21 PC-M1-K1 + 70, 14, 12, 8.5, 3.5, 2.6, 2.5, 2.3 8 YeP5 
22 PC-M3-6 + 70, 17.7, 8.5, 3.5, 2.6, 2.5, 2.3 7 YeP6 
23 PC-M13-K13 + 70, 17.7, 8.5, 3.5, 2.6, 2.5, 2.3 7 YeP6 
24 S18/1-C-O-6a + 70, 17.7, 14.4, 8.5, 3.5, 2.6, 2.5, 2.3 8 YeP4 
25 S18/1-C-I-4-6b + 70, 17.7, 14.4, 8.5, 3.5, 2.6, 2.5, 2.3 8 YeP4 
26 S18/1-C-O-6d + 70, 14, 8.5, 3.5, 2.6, 2.5, 2.3 7 YeP5 
27 S18/1-C-O-5-6e + 70, 14, 8.5, 3.5, 2.6, 2.5, 2.3 7 YeP5 
28 S18/1-C-O-1a - No plasmid 0 No plasmid 
29 S18/1-C-O-K-5b - 25.3, 12 2 YeP9 
30 S18/1-C-O-5c - No plasmid 0 No plasmid 
31 PC-M16-2 - No plasmid 0 No plasmid 
32 PC-M16-10 - No plasmid 0 No plasmid 
*Estimated plasmid size in kilobases (determined by using Quantity One® 1-D Analysis). Refer Figures 4.4.7, 4.4.8, 4.4.9 and 
4.4.10 for gel photos. 
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Figure 4.4.7. PFGE gel photos for unrestricted genomic DNA of Y. enterocolitica isolates.  
Plasmid size was determined by using Quantity One® 1-D Analysis. Lane 1, PCM-PPN53a-3; lane 2, PCM-PPN55c-1; lane 3, PCM-PPN55c-3; lane 4, PCM-PPN56a-4;  
lane 5, PCM-PPN55a-K1; lane 6, PCM-PPN56b-4; lane 7, PCM-PPN53a-1; lane 8, PCM-PPN55a-1; lane 9, PCM-PPN55b-1; lane 10, PCM-PPN55b-2; lane 11, PCM-PPN55b-4;  
lane 12, PCM-PPN55b-K3; lane 13, DCM-PPN56b-21; lane 14, DCM-PPN56b-23; lane 15, PCM-PPN56b-K3; lane 16, DCM-PPN56c-21; lane 17, DCM-PPN56c-23;  
lane 18, PC-M1-K1; lane 19, PC-M3-6; lane 20, PC-M13-K13; lane 21, DCM-PPN55a-1; lane 22, PCM-PPN56a-1; lane 23, PCM-PPN56c-K4; lane 24, S18/1-C-O-6a;  
lane 25, S18/1-C-I-4-6b; lane 26, S18/1-C-O-6d; lane 27, S18/1-C-O-5-6e; lane 28, S18/1-C-O-1a; lane 29, S18/1-C-O-K-5b; lane 30, S18/1-C-O-5c; lane 31, PC-M16-2;  
lane 32, PC-M16-10; Control, Y. enterocolitica bioserotype 2/O:9 (IP383); Marker , low range PFG marker N0350S (New England Biolabs). 
 
Chromosomal DNA 
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Figure 4.4.8. Gel photo for extracted plasmid DNA.  
Plasmid size was determined by using Quantity One® 1-D Analysis. M1, supercoiled DNA marker set  
(8-28 kb, Epicentre® Biotechnologies, USA); M2, supercoiled DNA ladder (2-10 kb, New England Biolabs, USA);  
lane 1, PCM-PPN53a-1; lane 2, DCM-PPN55a-1; lane 3, PCM-PPN55a-1; lane 4, PCM-PPN55b-1;  
lane 5, PCM-PPN55b-2; lane 6, PCM-PPN55b-4; lane 7, PCM-PPN55b-K3; lane 8, PCM-PPN55c-1;  
lane 9, PCM-PPN55c-3; lane 10, PCM-PPN56a-1; lane 11, PCM-PPN56a-K1; lane 12, PCM-PPN56a-4. 
 
 
 
 
 
Figure 4.4.9. Gel photo for extracted plasmid DNA.  
Plasmid size was determined by using Quantity One® 1-D Analysis. M1, supercoiled DNA marker set  
(8-28 kb, Epicentre® Biotechnologies, USA); M2, supercoiled DNA ladder (2-10 kb, New England Biolabs, USA);  
lane 1, DCM-PPN56b-21; lane 2, DCM-PPN56b-23; lane 3, PCM-PPN56b-4; lane 4, PCM-PPN56b-K3;  
lane 5, DCM-PPN56c-21; lane 6, DCM-PPN56c-23; lane 7, PCM-PPN56c-K4; lane 8, PC-M1-K1;  
lane 9, PC-M3-6; lane 10, PC-M13-K13; lane 11, S18/1-C-O-6a; lane 12, S18/1-C-I-4-6b; lane 13,  
S18/1-C-O-6d; lane 14, S18/1-C-O-5-6e. 
 
 
Chromosomal 
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Figure 4.4.10. Gel photo for extracted plasmid DNA.  
Plasmid size was determined by using Quantity One® 1-D Analysis.  
M1, supercoiled DNA marker set (8-28 kb, Epicentre® Biotechnologies, USA);  
M2, supercoiled DNA ladder (2-10 kb, New England Biolabs, USA);  
lane 1, PCM-PPN53a-3; lane 2, S18/1-C-O-1a; lane 3, S18/1-C-O-K-5b;  
lane 4, S18/1-C-O-5c; lane 5, PC-M16-2; lane 6, PC-M16-10. 
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4.4.4 Antibiograms of Y. enterocolitica isolates 
The resistance rates of 32 Y. enterocolitica strains against the 29 antimicrobials 
tested are as follows: CLI (87.5%), AMP (87.5%), AMX (84.4%), TIC (78.1%), NAL 
(62.5%), TET (62.5%), STR (21.9%), AMC (9.4%), TIM (3.1%). Table 4.4.8 
summarises the antimicrobial profiles for each antimicrobials. Detailed antimicrobial 
susceptibility profiles of the 32 Y. enterocolitica isolates are tabulated in Appendix XII.  
Overall, 12 resistotypes were observed, with resistotype 
NAL
R
CLI
R
AMP
R
TIC
R
TET
R
AMX
R
 being predominant (Table 4.4.9; n=15, 46.9%). 
Isolates of different bioserotypes had different resistotypes (Table 4.4.8). All 1B/O:8 
isolates (n=3) were resistant to only one antimicrobial, CLI (Table 4.4.8). All 1A/O:5 
isolates were resistant to AMP, TIC, AMX, and CLI (Table 4.4.8). Majority of the 3 
variant/O:3 isolates were resistant to NAL, AMP, TIC, TET, CLI, and AMX (Table 
4.4.8).  
About 90% of the Y. enterocolitica isolates (n=32) were MDR (resistant to at 
least three classes of antimicrobials) (Appendix XII). Due to the high resistance 
observed for penicillin (AMP, 87.5%; TIC, 78.1%), and β-lactam (amoxicillin, 84.4%), 
phenotypic ESBL-production was tested. However, none of the isolates was an ESBL 
producer. Isolates of bioserotype 3 variant/O:3 had the highest MAR index 0.183, 
followed by bioserotype 1A/O:5 and 1B/O:8 with MAR indices at 0.121 and 0.103, 
respectively (Table 4.4.10). All 32 selected isolates were considered originated from 
low risk contaminated source (MAR index < 0.2) (Krumperman, 1983).  
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Table 4.4.8. Antimicrobial profiles (in percentage) of the 32 Y. enterocolitica isolates from raw pork products and pigs. 
Antimicrobial discs 3 variant/O:3 (n=27)  1B/O:8 (n=3)  1A/O:5 (n=2)  Total (n=32) 
R I S  R I S  R I S  R I S 
CLI, 2 µg  85.2 14.8 0  100 0 0  100 0 0  87.5 12.5 0 
AMP, 10 µg 96.3 3.7 0  0 0 100  100 0 0  87.5 3.1 9.4 
AMX, 25 µg 92.6 7.4 0  0 0 100  100 0 0  84.4 6.3 9.4 
TIC, 75 µg 85.2 14.8 0  0 0 100  100 0 0  78.1 12.5 9.4 
NAL, 30µg 74.1 0 25.9  0 0 100  0 0 0  62.5 0 37.5 
TET, 30µg 74.1 0 44.4  0 0 100  0 0 0  62.5 0 37.5 
STR, 10 µg 25.9 14.8 59.3  0 0 100  0 0 0  21.9 12.5 65.6 
AMC, 30µg 7.4 14.8 40.7  0 0 100  50 0 50  9.4 12.5 78.1 
TIM, 25 µg 3.7 7.4 88.9  0 0 100  0 0 0  3.1 6.3 90.6 
CXM, 30µg 0 0 0  0 0 100  0 0 0  0 6.3 93.8 
TMP, 5 µg 0 3.7 96.3  0 0 100  0 0 0  0 3.1 96.9 
ENR, 5 µg 0 3.7 96.3  0 0 100  0 0 0  0 3.1 96.9 
Other antimicrobials
a
 0 0 100  0 0 100  0 0 0  0 0 100 
aOther antimicrobials are CTM, 30µg; CAZ, 30µg; CRO, 30µg; CIP, 5 µg; LEV, 5 µg; KAN, 30µg; AMK, 30µg; GEN, 10 µg; N, 10 µg; NET, 30µg; DOX, 30µg; ATM, 30µg; IPM, 10 µg; PB, 300 µg; 
CHL, 30µg; SPT, 100 µg; CSS, 10 µg. R, resistant; I, intermediate; R, resistant. 
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Table 4.4.9. MAR indices of Y. enterocolitica according to each resistotype. 
Resistotype MAR index No. of isolates (%) 
NAL
R
CLI
R
AMP
R
TIC
R
TET
R
AMC
R
AMX
R
 0.241 2 (6.3) 
NAL
R
CLI
R
AMP
R
TIC
R
TET
R
AMX
R
 0.207 15 (46.9) 
CLI
R
AMP
R
TIC
R
STR
R
TIM
R
AMX
R
 0.207 1 (3.1) 
CLI
R
AMP
R
TIC
R
STR
R
AMX
R
 0.172 2 (6.3) 
NAL
R
CLI
R
AMP
R
TET
R
AMX
R
 0.172 1 (3.1) 
CLI
R
AMP
R
TIC
R
AMC
R
AMX
R
 0.172 1 (3.1) 
AMP
R
TIC
R
STR
R
AMX
R
 0.138 3 (9.4) 
NAL
R
CLI
R
AMP
R
TET
R
 0.138 1 (3.1) 
CLI
R
AMP
R
TIC
R
AMX
R
 0.138 1 (3.1) 
NAL
R
CLI
R
TET
R
 0.103 1 (3.1) 
AMP
R
STR
R
AMC
R
 0.103 1 (3.1) 
CLI
R
 0.034 3 (9.4) 
   
Total  32 (100) 
R, resistant; NAL, 30 μg; CIP, 5 μg; TIM, 25 μg; STR, 10 μg; AMP, 10 μg; TIC, 75 μg; TET, 30 μg; AMC, 30 μg; CLI, 2 μg. 
 
 
Table 4.4.10. MAR indices of Y. enterocolitica according to each bioserotype. 
Y. enterocolitica bioserotype No. of isolates 
No. of antimicrobials 
resistant to 
MAR 
index 
3 variant/O:3 27 143 0.183 
1B/O:8 3 9 0.103 
1A/O:5 2 7 0.121 
    
Total 32 159 0.171 
 
 
4.4.5  Genotypes of Y. enterocolitica based on PFGE 
The genetic relatedness of the 32 Y. enterocolitica isolates was determined by 
PFGE. The NotI-digested chromosomal DNA of the 32 Y. enterocolitica generated ten 
reproducible unique patterns (0.74 eproducible unique 32 IM, 25 μg; STR, 10 μg; AMP, 
10 μg; TIC, 75 μg; TEbetween 22.3 and 446.7 bp. Gel photos for PFGE are shown in 
Figures 4.4.11, 4.4.12, 4.4.13, and 4.4.14. The dendrogram based on the profiles 
obtained by PFGE is shown in Figure 4.4.15.  
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Figure 4.4.11. PFGE (NotI-digested DNA plugs) gel  
photo for Y. enterocolitica isolates.  
Lane 1, PC-M1-K1; lane 2, PC-M3-6; lane 3, PC-M13-K13; lane 4, S18/6 C-O-6a;  
lane 5, PC-M16-2; lane 6, DCM-PPN56b-23; lane 7, PCM-PPN56c-K4; lane 8, S18/1 C-O-5c;  
lane 9, PCM-PPN53a-1; lane 10, PCM-PPN55a-1; H9812, S. enterica serotype Braenderup  
H9812 (ATCC BAA-664) digested with XbaI. 
 
 
Figure 4.4.12. PFGE (NotI-digested DNA plugs)  
gel photo for Y. enterocolitica isolates.  
Lane 1, PCM-PPN55b-2; lane 2, PCM-PPN55c-1; lane 3, PCM-PPN55c-3;  
lane 4, DCM-PPN55a-1; lane 5, PCM-PPN56a-1; lane 6, DCM-PPN56b-21;  
lane 7, PCM-PPN56b-4; lane 8, PCM-PPN56c-21; lane 9, PCM-PPN55b-K3;  
H9812, S. enterica serotype Braenderup H9812 (ATCC BAA-664) digested with XbaI. 
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Figure 4.4.13. PFGE (NotI-digested DNA plugs)  
gel photo for Y. enterocolitica isolates.  
Lane 1, S18/1 C-O-5-6e; lane 2, S18/1 C-O-6d; lane 3, PCM-PPN55b-1; lane 4, PCM-PPN53a-3;  
lane 5, PCM-PPN55b-4; lane 6, S18/1 C-O-5b; H9812, S. enterica serotype Braenderup H9812  
(ATCC BAA-664) digested with XbaI. 
 
 
 
Figure 4.4.14. PFGE (NotI-digested DNA plugs)  
gel photo for Y. enterocolitica isolates.  
Lane 1, PC-M16-10; lane 2, DCM-PPN56c-23; lane 3, S18/1 C-O-1a; lane 4, PCM-PPN56a-4;  
lane 5, PCM-PPN56a-K1; lane 6, PCM-PPN56b-K3; lane 7,  S18/1 C-I-4-6b; H9812,  
S. enterica serotype Braenderup H9812 (ATCC BAA-664) digested with XbaI. 
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Figure 4.4.15. Dendrogram of PFGE of NotI-digested genomic DNA patterns of Y. 
enterocolitica generated by UPGMA clustering method using Dice coefficient. 
 
 
 PFGE subtyped the isolates into three distinct clusters (N1, N2 and N3), with D 
value of 0.87 based on 90% similarity (Figure 4.4.15). Each cluster contained member 
of the same bioserotype; i.e. N1, bioserotype 3 variant/O:3; N2, bioserotype 1A/O:5; 
and N3, bioserotype 1B/O:8.  
Cluster N1 was represented by 27 Y. enterocolitica isolates (n=7 from food; 
n=20 from pigs) belonging to bioserotype 3 variant/O:3. Within cluster N1, the isolates 
were further subgrouped into another three subtypes, N1a, N1b and N1c (Figure 4.4.15). 
The subtype N1a consisted two indistinguishable isolates isolated from the same nasal 
swab of the same pig (PFGE profile: YeNotI-2) although they were different by two 
biochemical tests (API code: 1114523 and 1014522) and plasmid profiles (YeP3 and 
YeP1) (Figure 4.4.15; Table 4.4.1, pig no. 53 from farm I, Penang). The N1b comprised 
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of 17 isolates which were isolated from nasal, oral and rectal swabs of two pigs raised in 
the same pen (Figure 4.4.15, PFGE profile: YeNotI-3, YeNotI-4 and YeNotI-5; Table 
4.4.1, pig no. 55 and 56 from farm I, Penang). The N1c comprised of seven Y. 
enterocolitica strains (food origin) with two PFGE patterns (YeNotI-6 and YeNotI-7). 
The strains were isolated from four different raw pork samples (Table 4.4.1, sample M1, 
M3 M13 and YE037) purchased at different times from the same hawker stall purchased 
at different time frame from the same hawker stall (Figure 4.4.15, YeNotI-6 and 
YeNotI-7). 
Within cluster N2, both the bioserotype 1A/O:5 strains were from the same raw 
pork meat with indistinguishable PFGE pattern (Figure 4.4.15, YeNotI-8), but had 
different API 20E codes (1155723 and 1154723) and resistant profiles 
(CLI
R
AMP
R
TIC
R
AMC
R
AMX
R
/ CLI
R
AMP
R
TIC
R
AMX
R
). The three bioserotype 1B/O:8 
strains in cluster N3 were highly similar (F=0.98), with similar antibiogram and 
virulence genes profile. Of the three strains, two were isolated from raw pork meat and 
one from raw pork liver, purchased on the same day at the same hawker stall. 
 
 
4.5 Modification and improvement of CIN agar for isolation of Y. enterocolitica 
 Although CIN agar is widely used in the isolation of Y. enterocolitica, however, 
in this study, plenty of false Y. enterocolitica isolates were detected (Refer Section 4.6 
for the recovery power of the CIN). Hence, the CIN agar was modified in order to 
increase the recovery rate of true Y. enterocolitica from food and other environmental 
samples. Results for the evaluation of modified CIN in comparing to CIN are in 
Sections 4.5.1 to 4.5.5. 
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4.5.1  Growth characteristics and colony morphology on CIN and modified CIN 
agar 
The capability of bacteria to grow on CIN and modified CIN agar, and the 
colony morphology of 50 bacterial strains were determined. Both CIN and modified 
CIN allowed the growth of all Yersinia strains tested, except the non-pathogenic strain 
IP102 (Y. enterocolitica bioserotype 1A/O:6,30), which was inhibited on both media. 
Furthermore, all Yersinia colonies displayed the same characteristic, red bull's eye 
aspect (Table 4.5.1 and Figure 4.5.1, Nb2-17). Therefore, the modifications in the CIN 
did not alter the growth and colony shape of Yersinia strains. The characteristic red 
bull's eye morphology of Y. enterocolitica colonies was observed at ≥30 h incubation on 
modified CIN instead of 24 h on CIN, indicating that the plates should be read at or 
after 30 h. 
The CIN and modified CIN exhibited the same growth inhibitory effect for 
various species of Salmonella, Escherichia coli, Shigella, Proteus, Vibrio, 
Pseudomonas, Enterococcus, Listeria and Staphylococcus (Table 4.5.1). The two media 
also gave similar results for non-H2S-producing C. freundii, C. koseri, Serriatia 
odorifera, S. marcescens, and Pantoae spp., which produced colonies with the red bull's 
eye morphology (Figure 4.5.1 and Table 4.5.1). Hence, the modification of CIN did not 
improve the differentiation of these bacteria from Yersinia spp. 
In contrast, the modified CIN but not CIN allowed the differentiation of Yersinia 
spp. from several other Enterobacteriaceae and A. hydrophila. On the modified CIN, 
the colonies of C. braakii and H2S-producing C. freundii exhibited a black centre 
(Figure 4.5.1, Nb 18 and 21), the P. rettgeri colonies were surrounded by a brown 
diffusible pigment (Figure 4.5.1, Nb 27-29), the E. cloacae colonies were light pink 
(Figure 4.5.1, Nb 24-26), Aeromonas hydrophila appeared as pink colonies surrounded 
by a brown pigment (Figure 4.5.1, Nb 23), and M. morganii appeared as tiny colourless 
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colonies surrounded by a brown pigment (Figure 4.5.1, Nb 30). The modified CIN is 
thus more efficient than CIN for the discrimination of Yersinia spp. from these Yersinia-
like bacterial species. 
Changing the incubation conditions for the modified CIN had no effect on the 
colony morphology of the various species tested (Table 4.5.1). However, the formation 
of a black centre in H2S-producing colonies could be observed under microaerophilic 
conditions even when their size was ≤ 1 mm, whereas the black centre appeared when 
the colonies were larger under aerobic conditions. Colonies that did not turn black at 24 
h (aerobic), turned black at 30 h or 48 h when the size of colony grew bigger. Therefore, 
microaerophilic condition could facilitate better visualization for H2S-producing 
bacteria. 
 
 
Figure 4.5.1. Bacteria dotted on CIN (A) and modified CIN (B).  
1, Y. enterocolitica bioserotype 1A/O:6,30 (IP102); 2, Y. enterocolitica bioserotype 1B/O:8 (IP11105);  
3, Y. enterocolitica bioserotype 2/O:9 (IP383); 4, Y. enterocolitica, bioserotype 3/O:1,2,3 (IP135);  
5, Y. enterocolitica bioserotype 4/O:3 (IP134); 6, Y. enterocolitica bioserotype 5/O:2,3 (IP178);  
7, Y. enterocolitica ATCC 9610; 8, Y. enterocolitica bioserotype 3 variant/O:3 (PC-M1-K1);  
9, Y. enterocolitica bioserotype 1A/O:5 (PC-M16-2); 10, Y. aldovae (IP6005); 11, Y. bercovieri (IP3443);  
12, Y. frederiksenii (IP3842); 13, Y. intermedia (IP955); 14, Y. kristensenii (IP105); 15, Y. mollaretii (IP33766);  
16, Y. pseudotuberculosis (IP34476); 17, Y. enterocolitica bioserotype 1B/O:8 (YE036c-CY);  
18, C. freundii, H2S-producing; 19, 20, C. freundii, non-H2S-producing; 21, C. braakii; 22, C. koseri;  
23, A. hydrophila; 24, 25, 26, E. cloacae; 27, 28, 29, P. rettgeri; 30, M. morganii; 31, Pantoae spp.;  
32, S. odorifera; 33, S. marcescens. 
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Table 4.5.1. Comparison of growth and morphology of Y. enterocolitica  
and other bacterial colonies on CIN (aerobic), modified CIN (aerobic)  
and modified CIN (microaerophilic). 
Bacterial species (strain number) 
Colony morphology on: 
CIN (ae
a
) 
Modified 
CIN (ae) 
Modified 
CIN (mic
b
) 
Yersinia enterocolitica    
  bioserotype 1A/O:6,30 (IP102) NG
c
 NG NG 
  bioserotype1A/O:5 (PC-M16-2) Rbe Rbe Rbe 
  bioserotype 1B/O:8 (IP11105, ATCC    
  9610, YE036c-CY)  
Rbe
d
 Rbe Rbe 
 bioserotype 2/O:9 (IP383) Rbe Rbe Rbe 
 bioserotype 3/O:1,2,3 (IP135) Rbe Rbe Rbe 
 bioserotype 3 variant /O:3 (PC-M1-K1) Rbe Rbe Rbe 
 bioserotype 4/O:3 (IP134) Rbe Rbe Rbe 
 bioserotype 5/O:2,3 (IP178) Rbe Rbe Rbe 
Other Yersinia spp.    
Y. aldovae (IP6005)  Rbe Rbe Rbe 
Y. bercovieri (IP3443)  Rbe Rbe Rbe 
Y. frederiksenii (IP3842)  Rbe Rbe Rbe 
Y. intermedia (IP955)  Rbe Rbe Rbe 
Y. kristensenii (IP105)  Rbe Rbe Rbe 
Y. mollaretii (IP33766)  Rbe Rbe Rbe 
Y. pseudotuberculosis (IP34476)  Rbe Rbe Rbe 
Other Enterobacteriaceae    
Citrobacter,    
       freundii, H2S-producing Rbe Rbe + Bc
e
 Rbe + Bc 
       freundii, non-H2S-producing Rbe Rbe Rbe 
       braakii Rbe Rbe + Bc Rbe + Bc 
       koseri Rbe Rbe Rbe 
Providencia rettgeri Rbe Rbe + Bp Rbe + Bp 
Enterobacter cloacae Rbe P P 
Pantoae spp. Rbe Rbe Rbe 
Serratia,    
       odorifera Rbe Rbe Rbe 
       marcescens Rbe Rbe Rbe 
Morganella morganii C
f
 C + Bp C + Bp 
Salmonella,    
       Paratyphi A (ATCC 9150) NG NG NG 
       Paratyphi B (ATCC 8759) NG NG NG 
       Paratyphi C (ATCC 9068) NG NG NG 
       Typhimurium (ATCC 13311) NG NG NG 
       Typhi (ATCC 6539) NG NG NG 
       enterica (ATCC 10376) NG NG NG 
Escherichia coli (ATCC25922 and O157:H7) NG NG NG 
Shigella sonnei (ATCC 11060) NG NG NG 
Proteus penneri NG NG NG 
Other Gram-Negative Bacteria    
Aeromonas hydrophila Rbe P
g
 + Bp
h
 P + Bp 
Vibrio spp. NG NG NG 
Pseudomonas aeruginosa (ATCC 9027) NG NG NG 
Gram-Positive Bacteria    
Enterococcus faecalis (ATCC 29212) NG NG NG 
Listeria monocytogenes (ATCC 7644) NG NG NG 
Staphylococcus aureus (ATCC 6538, MRSA 0807-1) NG NG NG 
a ae, aerobic; b mic, microaerophilic; c NG, no growth; d Rbe, red bull’s eye; e Bc, black centre; f  C, colourless; g P, pink; h Bp, brown 
diffusible pigment; IP, Institut Pasteur, strain collection of the French Yersinia Reference laboratory; ATCC, American Type 
Culture Collection; Others, strain collection of Laboratory of Biomedical Science and Molecular Microbiology, Institute of 
Graduate Studies, University of Malaya, Malaysia 
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4.5.2 Limit of detection (LOD) of CIN and modified CIN agar for Y. 
enterocolitica detection 
The capacities of four Y. enterocolitica strains, which represented non-
pathogenic (PC-M16-2), moderate pathogenic (IP383 and IP135), and highly 
pathogenic (ATCC 9610) strains, to grow on CIN and modified CIN agar were 
evaluated. Various cell suspensions (from 10
1
 to
 
10
8 
cfu/ml) were spread onto CIN and 
modified CIN agar, incubated for 24 - 48 h incubation at 25°C, and then observed. In 
addition, one set of modified CIN agar was incubated under microaerophilic condition 
at 25°C for 24 - 48 h. A score of 100% was recorded for the growth of Y. enterocolitica 
on all six replicates plates; 83% for 5/6 plates and so on. The percentages of plates 
showing positive for each Y. enterocolitica strain are tabulated in Table 4.5.2.  
The LOD for all four Y. enterocolitica strains was 10 cfu/ml on both CIN and 
modified CIN under aerobic conditions (Table 4.5.2). Although the LOD for strain 
ATCC 9610 was slightly higher on the modified CIN under microaerophilic (10
2 
cfu/ml) compared with aerobic conditions (10
1 
cfu/ml), the difference in sensitivity for 
all four strains tested under these different conditions was not significant (Student t-test, 
P>0.05). Therefore, microaerophilic conditions did not improve the growth of Y. 
enterocolitica on modified CIN. 
  
  
8
8
 
C
H
A
P
T
E
R
 4
   R
E
S
U
L
T
S
 
 
 
 
 
 
 
 
Table 4.5.2. Percentage of plates showing positive (seeded with pure cultures of Y. enterocolitica)  
and the limit of detection of Y. enterocolitica on CIN and modified CIN. 
Dilution of  YE
a
 
seeded on plate 
(cfu/ml) 
 Percentage of plates showing positive (%) 
 
YE
 
bioserotype 2/O:9 
(IP383) 
 
YE bioserotype 3/O:1,2,3 
(IP135) 
 
YE bioserotype 1B/O:8 
(ATCC 9610) 
 
YE bioserotype 1A/O:5 
(PC-M16-2) 
 
CIN
b
 
(ae
c
) 
mCIN
d 
(ae) 
mCIN 
(mic
e
) 
 
CIN 
(ae) 
mCIN 
(ae) 
mCIN 
(mic) 
 
CIN 
(ae) 
mCIN 
(ae) 
mCIN 
(mic) 
 
CIN 
(ae) 
mCIN 
(ae) 
mCIN 
(mic) 
10
8
  100 100 100  100 100 100  100 100 100  100 100 100 
10
7
  100 100 100  100 100 100  100 100 100  100 100 100 
10
6
  100 100 100  100 100 100  100 100 100  100 100 100 
10
5
  100 100 100  100 100 100  100 100 100  100 100 100 
10
4
  100 100 100  100 100 100  100 83 83  100 100 100 
10
3
  100 100 100  100 100 100  100 100 67  100 100 100 
10
2
  83 83 100  100 100 100  100 100 50  100 100 100 
10
1
  83 83 100  100 100 100  100 67 33  100 100 100 
                 
LOD
f
 (cfu/ml)  10
1
 10
1
 10
1
  10
1
 10
1
 10
1
  10
1
 10
1
 10
2
  10
1
 10
1
 10
1
 
a YE, Yersinia enterocolitica; b CIN, Cefsulodin-Irgasan-Novobiocin; c ae, aerobic; d mCIN, modified CIN; e mic, microaerophilic; fLOD, limit of detection; Underlined numbers correspond to the scores of 
LOD for each Y. enterocolitica strain. LOD was defined as the lowest cfu/ml of culturable Y. enterocolitica detectable in ica fined as the lowest cfu/ml of cY. enterocolitica
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4.5.3 Quantification of Y. enterocolitica growth on CIN and modified CIN as 
compared with LBA 
The ability of CIN and modified CIN to support growth of Y. enterocolitica as 
compared with that of LBA was evaluated. The growth of four Y. enterocolitica strains 
(IP383, IP135, ATCC 9610 and PC-M1-K1) on LBA, CIN, and modified CIN was 
quantified and is presented as percentages of mean cfu/ml on CIN or modified CIN 
versus LBA. Values between 80% and 120% were considered to indicate growth 
efficiency on CIN or modified CIN similar to that on LBA (100%) (Savin, Leclercq, & 
Carniel, 2012). Table 4.5.3 shows the percentages of mean cfu/ml on CIN or modified 
CIN versus LBA. The cfu counts of IP383, IP135, ATCC 9610 and PC-M16-2 on CIN, 
modified CIN and LBA are tabulated in Appendix XIII.  
As shown in Table 4.5.3, the number of Y. enterocolitica colonies recovered on 
CIN, modified CIN and LBA were similar, whether the bacteria were grown under 
aerobic or microaerophilic conditions (ranged between 80% and 120%). Therefore the 
different media and conditions allowed the growth of Y. enterocolitica colonies with the 
same efficiency. 
 
Table 4.5.3. Growth at different incubation conditions of selected  
Y. enterocolitica strains on CIN and modified CIN, as compared with LBA. 
Strains 
 
Bio 
serotype 
 Percentage of mean cfu/ml (%) 
  
Aerobic  
Microaero- 
philic 
 
Aerobic/ 
Microaero-
philic 
  CIN
a
/ 
LBA
b
 
mCIN
c
/ LBA 
 
mCIN/ 
LBA 
 mCIN 
PC-M16-2  1A/O:5  110.3 108.9  106.8  102.0 
ATCC 9610  1B/O:8  88.5 84.3  84.3  100.0 
IP383  2/O:9  109.6 101  94.5  106.9 
IP135  3/O:1,2,3  96.7 82.1  82.4  99.6 
a CIN, Cefsulodin-Irgasan-Novobiocin; bLBA, Luria-Bertani agar; c mCIN, modified CIN 
 
 
CHAPTER 4   RESULTS 
 
90 
 
4.5.4 Limit of detection (LOD) of Y. enterocolitica from artificially contaminated 
raw pork meat 
The cfu/ml for IP135 prepared (at dilution 10
8
) and microbiota in the meat 
sample was 2.43×10
8
 cfu/ml and 1.00×10
7
 cfu/ml, respectively. Therefore, the initial 
ratio of IP135 to microbiota in the meat sample (IP135:MM) at dilution 10
8
 (at 0 h) was 
1:0.0412. Logically, the IP135:MM at 10
7
, 10
6
, 10
5
, 10
4
, 10
3
, 10
2
, and 10 were 1:0.412, 
1:4.12, 1:41.2, 1:412, 1:4120, 1:41200, and 1:412000, respectively (Table 4.5.4). Raw 
data of cfu counts are tabulated in Appendix XIII.  
The ability of CIN and modified CIN to recover Y. enterocolitica from food 
matrix was determined on raw pork meat (with or without stress treatment, kept at -
20°C, three weeks after bacterial spiking) mixed with various concentrations (from 10
1 
to 10
8
 cfu/ml) of Y. enterocolitica IP135. A score of 100% was recorded for the growth 
of Y. enterocolitica on all six replicates plates; 83% for 5/6 plates and so on. The 
percentages of plates showing positive for each Y. enterocolitica strain are tabulated in 
Table 4.5.4. The ratio of LOD to background microbiota was calculated by dividing the 
mean cfu/ml of LOD to the mean cfu/ml of uninoculated pork meat.  
The LOD of IP135 in in both raw pork meat with and without stress treatment 
was 10
4 
cfu/ml on both media incubated under aerobic conditions (Table 4.5.4), 
indicating that modification of CIN did not impair its capability to recover Y. 
enterocolitica from the studied food matrix. The finding that this LOD was 100-fold 
higher than that of bacteria grown in pure culture (10 cfu/ml) confirms the impact of the 
presence of background microbiota on the recovery of Y. enterocolitica. At the LOD 
value of 10
4 
cfu/ml, the food homogenates contained a ratio of Y. enterocolitica to 
microbiota of 1:412, indicating that Y. enterocolitica colonies cannot be successfully 
identified in the meat sample if it is below this ratio. 
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For the food matrix with stress treatment (kept at -20°C for three weeks after 
bacterial spiking) and incubated under microaerophilic conditions, the LOD dropped to 
10
3 
cfu/ml on modified CIN, which suggests that this incubation condition may slightly 
increase the recovery rate of Y. enterocolitica in food since visualization of H2S-
producing bacteria was improved. 
 
Table 4.5.4. Percentage of plates showing positive [seeded with homogenate of raw 
pork meat spiked with Y. enterocolitica bioserotype 3/O:1,2,3 (IP135)] and the limit 
of detection of IP135 on CIN and modified CIN. 
Dilution of 
IP135 
spiked  
in 25 g of 
pork meat 
(cfu/ml) 
 
Initial 
ratio 
 Without stress treatment  
With stress treatment at  
-20°C for two weeks 
 IP135 
: 
MM
a
 
 
CIN
b
 
(ae
c
) 
mCIN
d
 
(ae) 
mCIN 
(mic
e
) 
 
CIN 
(ae) 
mCIN 
(ae) 
mCIN 
(mic) 
10
8
  1:0.0412  100 100 100  100 100 100 
10
7
  1:0.412  100 100 100  100 100 100 
10
6
  1:4.12  100 100 100  100 100 100 
10
5
  1:41.2  100 100 100  100 100 100 
10
4
  1:412  100 67 67  83 67 83 
10
3
  1:4120  33 17 33  17 17 50 
10
2
  1:41200  0 17 0  0 0 0 
10
1
  1:412000  0 0 0  0 0 0 
           
LOD
f
 (cfu/ml), IP135:MM  
10
4
, 
1:412 
10
4
, 
1:412 
10
4
, 
1:412 
 
10
4
, 
1:412 
10
4
, 
1:412 
10
3
, 
1:4120 
a MM, microbiota in the meat sample; b CIN, Cefsulodin-Irgasan-Novobiocin; c ae, aerobic; d mCIN, modified CIN; e mic, 
microaerophilic; fLOD, limit of detection; Underlined numbers correspond to the LOD scores of LOD for each medium. LOD was 
defined as the lowest cfu/ml of culturable Y. enterocolitica detectable in ≥50% of the replicates 
 
 
4.5.5 Differentiation of Y. enterocolitica colonies from exhibiting Yersinia-like 
morphology on CIN 
Suspensions containing similar concentrations (10
4 
cfu/ml) of Y. enterocolitica IP135 
and other enterobacterial species exhibiting Yersinia-like colonies on CIN agar such as 
H2S-producing C. freundii, C. braakii, E. cloacae, P. rettgeri, and A. hydrophila were 
prepared to compare the number of true Y. enterocolitica recovered on CIN and 
modified CIN. Presumptive colonies of Y. enterocolitica (appeared as red bull’s eye) 
were picked and analyzed by PCR for confirmation.  
CHAPTER 4   RESULTS 
 
92 
 
Modified CIN gave an excellent differentiation of Y. enterocolitica from bacteria 
exhibiting Yersinia-like colonies on CIN agar (H2S-producing C. freundii, C. braakii, E. 
cloacae, P. rettgeri, and A. hydrophila). The percentages of true Y. enterocolitica 
recovered from the bacterial mixtures were 33.3% on CIN and 60.0% on modified CIN 
(Table 4.5.5), and the difference was significant (χ2 test, p<0.05). Therefore, the use of 
modified CIN agar enhanced the differentiation of Yersinia colonies from those of 
Yersinia-like species.  
In artificially contaminated raw pork meat, the percentage of true Y. 
enterocolitica colonies increased from 62.3% on CIN to 72.5% on modified CIN (Table 
4.5.5),  however this difference was not statistically significant (χ2 test, p>0.05). 
 
Table 4.5.5. Recovery of Y. enterocolitica bioserotype 3/O:3 (IP135)  
from artificially prepared bacterial mixture and from spiked food. 
Co-culture bacteria 
type 
 
Agar 
 Number of positive isolates 
  True (%) False (%)  Total  
Bacterial mixture
a
  CIN
b
  20 (33.3) 40 (66.7)  60 
 Modified CIN  36 (60.0) 24 (40.0)  60 
        
Background 
microbiota from food 
 CIN  43 (62.3) 26 (37.7)  69 
 Modified CIN  50 (72.5) 19 (27.5)  69 
        
a Mixture of bacteria exhibiting Yersinia-like colonies on CIN agar (C. freundii, C. braakii, E. cloacae, P. rettgeri, A. hydrophila) 
b CIN, Cefsulodin-Irgasan-Novobiocin 
 
 
4.5.6 Determination of the recovery of Y. enterocolitica from naturally 
contaminated samples 
The efficiency of CIN and modified CIN agars for the recovery of Y. 
enterocolitica from the 52 naturally contaminated samples (rectal swabs from swine) 
was evaluated and compared in three ways: (i) after direct plating on the agars (methods 
1 and 2); (ii) after cold enrichment followed by plating on the agars (methods 3 and 4); 
(iii) after cold enrichment, alkaline treatment, and plating on the agars (methods 5 and 
6) (Table 4.5.6). The detection of Y. enterocolitica by PCR in post-PBS enrichment 
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broths was 2/52 (3.8%). Both modified CIN and CIN did not recover any Y. 
enterocolitica from the samples using the direct plating method (methods 1 and 2). 
After cold enrichment (methods 3 and 4), the modified CIN allowed the recovery of Y. 
enterocolitica from all PCR-positive samples (2/52, 3.8%), while no Y. enterocolitica 
was identified on CIN (Table 4.5.6). Cold enrichment and alkaline treatment followed 
by plating on modified CIN (methods 5 and 6) also allowed the isolation of Y. 
enterocolitica from all PCR-positive samples (2/52, 3.8%), while no Y. enterocolitica 
was detected on CIN (Table 4.5.6). The results showed that modified CIN resulted in 
the detection of a larger number of positive samples than CIN for the recovery of Y. 
enterocolitica from naturally contaminated samples. 
 
Table 4.5.6. Recovery rate of Y. enterocolitica from the 52 naturally  
contaminated rectal swabs from swine. 
Methods No. of positive specimens recovered 
by plating (%) 
Method 1 — Direct streaking onto CINa 0 (0) 
Method 2 — Direct streaking onto mCINb 0 (0) 
Method 3 — PBSc-CIN 0 (0) 
Method 4 — PBS-mCIN 2 (3.8) 
Method 5 — PBS-KOHd-CIN 0 (0) 
Method 6 — PBS-KOH-mCIN  2 (3.8) 
a CIN, Cefsulodin-Irgasan-Novobiocin; b mCIN, modified CIN; c PBS, phosphate buffered saline, a cold enrichment at 4°C for three 
weeks; d KOH, post-enrichment alkaline treatment 
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Yersinia enterocolitica is an important foodborne pathogen that causes human 
yersiniosis worldwide. The presence of Y. enterocolitica in both food and pigs (food 
animal) has public health implications since the primary transmission route of 
pathogenic Y. enterocolitica to humans is through contaminated food. 
 
5.1 Isolation and detection of Y. enterocolitica from food and pigs 
The primary goal of the present study is to investigate the occurrence of Y. 
enterocolitica in raw food and also pigs (food animal). Out of the 106 raw food 
samples (58 pork products and 48 non-porcine food) and 495 swine specimens (from 
165 pigs) collected, Y. enterocolitica was isolated from seven raw pork products 
(12.7%) (Table 4.1.1) and seven specimens of three pigs (1.8%) (Tables 4.1.6 and 
4.1.7). No correlation was made between the prevalence of Y. enterocolitica in the 
farms and  food samples. This was because the location where the raw foods came 
from was unknown. Three Y. enterocolitica bioserotypes were identified, 3 
variant/O:3, 1B/O:8 and 1A/O:5. The results confirmed that Y. enterocolitica was 
present in the local raw pork products and pigs.  
Interestingly, Y. enterocolitica (bioserotype 3 variant/O:3) was isolated from 
three healthy grower pigs (Table 4.1.6). This indicated that the pigs were carrier for 
the bacterium. Similar finding is reported in Jos, Nigeria, where Y. enterocolitica is 
isolated from healthy pigs (Okwori, et al., 2009). Pigs appear asymptomatic due to 
the colonisation of Y. enterocolitica in the lymphoid tissue, particularly in tonsils 
(Horter, Yoon, & Zimmerman, 2003). The colonisation caused the identiﬁcation of 
asymptomatic carrier animals difficult in disease control and/or pathogen 
elimination. These asymptomatic pigs serve as food for humans when they are 
matured to be sold. Cross-contamination of Y. enterocolitica from pigs’ oral cavity, 
intestine and faeces to meat is possible during the slaughtering and dressing 
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operations through the slaughtering tools and containers (Gill & Jones, 1995; 
Nesbakken, 1988; Skjerve, Lium, Nielsen, & Nesbakken, 1998). Besides that, cross 
contamination may happen during food storage. For example, the interior surfaces of 
household refrigerators (Jackson, Blair, McDowell, Kennedy, & Bolton, 2007) or 
surfaces of storage containers. Y. enterocolitica may be transferred from the 
contaminated surfaces to other food items, especially the higher risk ready-to-eat 
foods. Improper food handling, processing and storing practices such as undercooked 
meats or cross contamination of contaminated meats or surfaces to other food or 
water are risk factors for yersiniosis in humans. 
More than 50 serotypes and 6 biogroups of Y. enterocolitica have been 
identified currently and their geographical distributions are diverse. In Europe, Y. 
enterocolitica particularly bioserotype 4/O:3 has been frequently isolated in humans, 
pig husbandry and food, followed by the less common bioserotype, 2/O:9 and 
2/O:5,27 (European Food Safety Authority & European Centre for Disease 
Prevention and Control, 2013; Fondrevez, et al., 2010; Fredriksson-Ahomaa, 
Gerhardt, & Stolle, 2009). In USA, O:8 is the primary infectious serotype, followed 
by O:5,27, O:13a, 13b, O:20, O:9 (Bottone, 1997; Kwaga, Iversen, & Misra, 1992). 
Y. enterocolitica is frequently isolated in pigs from China in which the bioserotypes 
isolated are 2/O:9, 4/O:3, 3/O:3, 1A/O:5, 1A/O:8. Among the three bioserotypes 
identified in this study, Y. enterocolitica bioserotypes 3 variant/O:3 was the most 
common. In the past, the bioserotype 3 variant/O:3 has been reported in imported 
pork and chicken to Japan and food animals (pigs, rats and rabbits) in China 
(Fukushima, et al., 1997; Zheng & Xie, 1996). Y. enterocolitica bioserotype 3/O:3 is 
the major bioserotype in pigs, particularly from Jiangxi and Fujian Provinces with 
warmer climate (Liang, et al., 2012; Wang, et al., 2009). All these reports showed 
that this particular bioserotype 3/O:3 is frequently isolated from the regions with 
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warmer climate. Therefore, Y. enterocolitica bioserotype 3/O:3 or 3 variant/O:3 
strains might be the common strains in warm regions. 
Lim & Tay (1992) attempted to isolate Y. enterocolitica from over 6000 
samples from patients with diarrhoea in Singapore, but no Y. enterocolitica was 
detected. They also suggested that Y. enterocolitica had no clinical importance in this 
region. However, this pathogen is recently isolated from unpacked tofu 
(Ananchaipattana, et al., 2012a), beef and shrimp samples (Ananchaipattana, et al., 
2012b) in Thailand. These recent reports from Thailand indicated that there is a risk 
of human infection. In Malaysia, yersiniosis is rarely reported. The under-reporting 
in Malaysia can be due to several possibilities: (i) Malaysians prefer well cooked 
food to raw or undercooked meats, (ii) Y. enterocolitica is not the routine pathogen 
monitored in the diarrhoeal patients, or (iii) most of the Y. enterocolitica cases are 
self-limiting. Although there is no other official report on yersiniosis in Malaysia 
since 1984, we should be cognisant that this bacterium could be another potential 
agent to contribute to the incidence of food poisoning cases in our country since this 
pathogen was confirmed present in our local food and pigs. Improper food handling 
and processing may cause cross contamination of this pathogen to humans and 
therefore affirms a potential risk for the consumers.  
 
5.2 Comparison of conventional cultural and post-enrichment PCR methods 
in detection of Y. enterocolitica 
In this study, several methods were performed in the isolation and detection 
of Y. enterocolitica; i.e. post-enrichment PCR detection method and conventional 
culturing method (initiated by enrichment steps followed by plating onto selective 
agar plates (with or without KOH treatment, biochemical identification, and finally 
PCR confirmation of presumptive Y. enterocolitica isolates). 
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In comparing between the conventional cultural and post-enrichment PCR 
methods in detection of Y. enterocolitica, results showed that post-enrichment PCR-
based detection method was more sensitive than the conventional cultural method. 
For raw pork products (Section 4.3), about 60% were PCR detected positive, 
compared to 12% detected by cultural methods. For raw non-porcine food (Section 
4.4), PCR detected Y. enterocolitica present in nearly 42% of the food, while no Y. 
enterocolitica was isolated. Besides, Y. enterocolitica was PCR detected in nearly 
28% of the pigs as compared to 1.8% by using cultural methods (Section 4.5). The 
results indicated that conventional method might underestimate the real prevalence 
of this pathogen in the local food and pigs. This result concurred with many other 
reports that the PCR detection are more sensitive than the cultural method (Bhaduri, 
Wesley, & Bush, 2005; Johannessen, Kapperud, & Kruse, 2000; Messelhäusser, et 
al., 2011). For example, Messelhäusser, et al. (2011) reported that 18% of the pork 
samples analysed is PCR- positive as compared to 10% positive by cultural method. 
However, these percentages are not necessarily comparable due to the different 
methods used in the detection of Y. enterocolitica. The primers used in the PCR 
assay are specific, which amplified the targeted gene of Y. enterocolitica. In contrast, 
detection by cultural method is less sensitive as the method is based on the 
physiology and biochemical activities of bacteria. Besides, DNA templates for PCR 
assay were prepared from bacterial cells that were concentrated from 1 ml of 
enriched homogenate, thus increasing the probability in getting more DNA of Y. 
enterocolitica. Moreover, the PCR can detect all kinds of cells in regardless of dead 
cells or viable including non-culturable cells which may not grow on artificial 
medium (Parker & Martel, 2002; A. Singh & McFeters, 1987). 
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5.3 Comparison of the recovery power of different isolation media in 
isolating Y. enterocolitica 
In comparing the recovery power of different enrichment and selective media 
used in the conventional cultural method, PBS enrichment (cold enrichment) was the 
best broth, with recovery rate 6.5% as compared to YSEO (1.0%), ITC (0.1%), and 
direct plating (1.6%) (Table 4.2.2). The results concurred with findings of 
Fukushima, et al. (2011) that reported the PBS (cold enrichment) yields better 
recovery of Y. enterocolitica. Although there are numerous enrichment schemes 
available in isolating Y. enterocolitica such as the ISO 10273:2003 and USDA 
protocol, however, no single culture protocol which has been described performed 
equally well for the isolation of Y. enterocolitica serotypes from all types of samples. 
For example, in a recent study, Van Damme, et al. (2013) reported that enrichment in 
PSB at 25°C recovers more positive samples than selective enrichment and cold 
enrichment. Irgasan-ticarcillin-potassium chlorate (ITC) broth is reportedly better in 
recovering of Y. enterocolitica 4/O:3 from pig tonsils than cold enrichment in PSB 
(Van Damme, et al., 2010). Therefore, combination of several enrichment broths 
should be used concurrently for better isolation rate. 
Following the enrichment steps, the enriched cultures (or samples) were 
plated (by streaking or/and spread plating methods) onto selective agar. During the 
initial investigation of Y. enterocolitica in this study, particularly for all 106 raw food 
samples and swine specimens from Selangor and Perak, CIN was the only selective 
plate used. The recovery power of CIN in isolating true Y. enterocolitica was very 
low (0.6%, Table 4.2.3). Nearly 94% of the presumptive isolates that appeared as red 
bull’s eye on CIN turned out to be Providencia rettgeri, Serratia spp., Citrobacter 
freundii, C. braakii, Klebsiella ornithinolytica, Enterobacter cloacae, and Pantoea 
spp. after the preliminary biochemical tests. (Section 4.2.1, Figure 4.2.3). In addition, 
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about 62% of isolates tht passed the preliminary biochemical tests were then 
identified as Morganella morganii, Y. frederiksenii, etc. by using API 20E 
identification kit. These bacteria clearly increase the workloads, experimental cost 
and also create complicates selection of Y. enterocolitica colonies during the 
isolation that may result in false negative findings. In the later stage of isolation of Y. 
enterocolitica, CIN agar was modified in order to increase the differential power of 
the original CIN in identifying true Y. enterocolitica. Discussion for the modification 
and improvement of CIN agar is in Section 5.6. 
 
5.3 Biochemical tests in identification of presumptive Y. enterocolitica 
 In the identification of presumptive Y. enterocolitica isolates, four 
biochemical tests (preliminary test: Gram, citrate, oxidase, and urease tests) and 20 
biochemical tests in the API 20E identification kit were preformed. The preliminary 
tests were used as the initial screening tests in reducing the amount of non-Y. 
enterocolitica isolates. The results showed the preliminary tests are effective in 
cutting down the number of non-Y. enterocolitica isolates by 94% (Section 4.1.1). 
 In this study, the incubation temperature of API 20E identification kit was 
modified to 28 °C as recommended in Archer, et al. (1987). In their study, the 
decrease of incubation temperature from 37 °C to 28 °C increases the percentage of 
correct identifications for Yersinia spp. from 66 to 93%. By refferring to this 
recommendation, the accuracy of API 20E in identifying Y. enterocolitica in this 
study was 91.5% (Section 4.1.2). Only seven isolates were misidentified as Y. 
enterocolitica when PCR was carried out. API 50CH results revealed that these 
isolates were Y. intermedia and Y. frederiksenii.  
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5.5 Further characterization of Y. enterocolitica isolates 
 In characterizing the isolates of Y. enterocolitica, a total of 32 isolates were 
selected. During the cultures selection, isolates with similar bioserotypes and API 
20E code that originated from a same sample were referred as replicate isolates, and 
only one isolates was selected for further characterization. The virulotypes, plasmid 
profiles, antimicrobial susceptibility profiles and the genotypes (PFGE) of Y. 
enterocolitica were determined.  
 
5.5.1 Virulence profiles of Y. enterocolitica  
The pathogenicity of Y. enterocolitica is associated with specific virulence 
factors that are located in the virulence pYV plasmid (~70kb) and also in the 
chromosomal DNA (Cornelis, et al., 1998; Revell & Miller, 2001). Among the 15 
virulence associated genes tested, the classical virulence genes that are involved in 
establishing gasterointestinal infection are the inv, ail, ystA, myfA, virF and yadA, in 
which, virF and yadA genes are plasmid-borne (pYV virulence plasmid) (Bottone, 
1999). The ail, inv, yadA and myfA genes basically contribute to adhesion, invasion 
and protects the bacterium from being killed by the host defence system (Cornelis, et 
al., 1998; Miller & Falkow, 1988). The yst and virF genes are important for the 
production of Yersinia stable heat-stable enterotoxin and Yops, respectively, and 
cause disease symptoms like diarrhea with fever associated with acute yersiniosis 
(Fàbrega & Vila, 2012). Other genes are associated with the survival and adaptation 
in animals or human hosts. All six classical virulence genes (inv, ail, ystA, myfA, virF 
and yadA) and in addition rfbC, hreP, ymoA and tccC and the pYV virulence plasmid 
were present in all isolates of bioserotypes 3 variant/O:3 (Tables 4.4.4 and 4.4.5). 
Interestingly, the virulence profiles (inv
+
, ail
+
, ystA
+
, virF
+
, yadA
+
 and rfbC
+
) of the 
bioserotype 3 variant/O:3 isolates in this study were similar to the virulence genes 
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profiles of clinical 3/O:3 strains reported from South China (Zheng, et al., 2008), 
indicating that these strains may be potentially virulent to humans. 
Isolates of biotype 1B are attributed as highly pathogenic, like other 
pathogenic strains (biotype 2, 3, 4 and 5) should harbour a highly conserved ~70 kb 
pYV virulence plasmid and also chromosomal virulence genes (Cornelis, et al., 
1998). Surprisingly, the three pathogenic bioserotype 1B/O:8 isolates (isolated from 
raw pork and liver) in this study did not carry the ail, virF, ystA genes and the pYV 
virulence plasmid, which normally present in the pathogenic strains (Tables 4.4.5 
and 4.4.7). According to the studies by Wang, et al. (2008), the loss of four genes ail, 
ystA, yadA and virF in the O:8 strains did not result in death of their artificially 
infected mice model experiments. The reason for the loss of plasmid is unknown. 
The occurrence of plasmid-borne genes (virF and yadA) in plasmid-less Y. 
enterocolitica has also been reported in other studies by Paixão, et al. (2013) and 
Zheng, et al. (2008). Although the stability of pYV plasmid is associated with the 
growth temperature (plasmid loss above 30 °C) and calcium concentration (Cornelis, 
et al., 1998), the growth temperature was maintained at <30 °C in this study, hence 
the loss of plasmid due to temperature was minimised.  
The non-pathogenic bioserotype 1A/O:5 isolates (n=2) carried the virulence 
genes ystB, hreP, fes, sat, fepD, ymoA, and fepA. The findings concurred with several 
reports on the presence of these virulence genes in the biotype 1A strains  (Bhagat & 
Virdi, 2007; Paixão, et al., 2013; Sihvonen, et al., 2011; Stephan, et al., 2013; Zheng, 
et al., 2008). Although the biotype 1A is considered a non-pathogenic strain, it is 
frequently isolated from diarrheic patients despite the absence of the pYV virulence 
plasmid and the classical virulence genes (Singh, et al., 2003; Stephan, et al., 2013). 
Several studies suggested that strains of biotype 1A that possess ystB, hreP, sat and 
myfA genes have a virulence potential of causing infection in humans and animals 
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(Bhagat & Virdi, 2007; Campioni & Falcão, 2013; Stephan, et al., 2013). In this 
study, all the bioserotype 1A/O:5 food isolates had similar virulence genes, 
suggesting their virulence potential.  
 
5.5.2 Antibiograms of Y. enterocolitica isolates  
The antimicrobial susceptibility patterns for Y. enterocolitica reported world-
wide are different. This may because of the impact of geographical location, 
difference in the usage of antimicrobials amongst other factors. In generally the Y. 
enterocolitica is resistant to penicillin, ampicillin and first generation of 
cephalosporins (Fàbrega & Vila, 2012). 
In 2005, majority of Y. enterocolitica strains (from meat and meat products) 
have high percentage of resistance to penicillin, first-generation cephalosporins, and 
bacitracin, and less than 11% were resistant to TET, NAL, STR and cefaporazone, 
and 100% susceptible to CHL and GEN (Dzomir, 2005). Similarly, all Y. 
enterocolitica isolates in present study were susceptible to CHL and GEN and 
resistant to TIC and AMP (penicillin). However, the resistance rates of NAL, TET 
and STR have increased tremendously over the years. Y. enterocolitica with high 
resistance rates to TET, AMP, or AMX are commonly reported in many countries in 
recent years from different sources such as marine marketed fishes, pig’s carcass and 
feces, and humans (Akhila, Priya, Murugn, & Thayumanavan, 2013; Bhaduri & 
Wesley, 2012; Bolton, Ivory, & McDowell, 2013). Nalidixic acid-resistant Y. 
enterocolitica is rarely reported from food and pigs and the reported resistant rate is 
comparably lower than this study; i.e. 31% in Lebanon (dairy food) (Harakeh, et al., 
2012), and 55% in India (marine marketed fish) (Akhila, et al., 2013). High levels of 
NAL, TET and AMX resistance were also reported in verotoxigenic Escherichia coli 
strains from the same pig farms (Ho, Tan, Ooi, Yeo, & Thong, 2013). The increased 
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in antimicrobial resistance rates and the emergence of MDR Y. enterocolitica in the 
livestock industry is of public health concern.  
Selective pressure due to regular usage of antimicrobials at suboptimal 
concentrations in the livestock industry is often cited as a cause of antimicrobial 
resistance (Oliver, et al., 2011; Rajić, et al., 2006; Varga, et al., 2009). In Malaysia, 
the antimicrobials used in pig farms are for prophylactic (in-feed medication), 
therapeutic (injectable) purposes and growth promotion purpose. In this study, the 
antimicrobials used for prophylactic are tetracycline, oxytretracycline, sulphonamide, 
penicillin, tylosin, lincomycin, florfenicol, and neomycin whereas for enroflaxacin, 
amoxicillin, gentamycin, florfenicol, ceftiofur, and tylosin are used as therapeutic. 
The choice of antimicrobials may vary between farms due to the herd health status 
and farmers’ preference. The high resistance in AMX and TET of Y. eneterocolitica 
isolates in this study may be due to the over-usage of antimicrobials in farm disease 
control purpose. The relevant governmental agencies should regulate the usage of 
antimicrobials for disease control and prevention in minimizing the breeding and 
transmission of MDR pathogens that potentially can be transferred to consumers 
through food or direct contact. 
 
5.5.3 Genotyping of Y. enterocolitica by using PFGE  
PFGE of the NotI restricted genomic DNA is a useful technique in 
differentiating Y. enterocolitica of various biotypes and serotypes (Bonardi, et al., 
2013; Fredriksson-Ahomaa, et al., 2007; Liang, et al., 2012; Stephan, et al., 2013). In 
this study, genomic DNA of the 32 Y. enterocolitica isolates was NotI-restricted and 
DNA fragments were separated by PFGE. The NotI was the primary restriction 
enzyme used in this study since the PFGE results yielded discriminating patterns for 
the Y. enterocolitica strains. All isolates of the three different bioserotypes, 3 
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variant/O:3, 1A/O:5 and 1B/O:8 could be distinguished. Nevertheless, the isolates 
were highly clonal within each bioserotype and exhibited minor variation. Isolates of 
bioserotype 3 variant/O:3 were comparably more diverse than the other bioserotype 
and could be further distinguished according to their geographical origin or sources. 
Interestingly, pulsotypes YeNotI-7 and YeNotI-9 (Figure 4.5.1) were found 
consistently in the food strains that were isolated at different times from the same 
vendor.  Cross contamination might have occurred in the slaughtering houses or 
farms before the raw pork products reach the market (Fredriksson-Ahomaa, Bucher, 
et al., 2001; Ortiz Martínez, 2010) or during storage from contaminated interior 
surfaces of refrigerator or surfaces of storage containers (Jackson, et al., 2007). 
Similarly, Y. enterocolitica with indistinguishable PFGE pattern was also observed 
among specimens originated from different pigs (YeNotI-3 and YeNotI-5, Figure 
4.4.15), suggesting transmission of a particular Y. enterocolitica clone from a 
common contaminating source (e.g. feed, water source and breeding environment) 
among the animals at the farm. It is possible that different subtypes of Y. 
enterocolitica exist within a particular animal host. The phenomenon of co-existing 
strains in an animal is possibly due to contamination originated from different 
sources during animal breeding or food processing (Fredriksson-Ahomaa, Korte, et 
al., 2001; Ortiz Martínez, 2010; Wang, et al., 2010).  
Due to the limited research of Y. enterocolitica in Malaysia, the PFGE results 
failed to be compared with other fields in Malaysia. Our PFGE results failed to 
correlate the raw pork from wet markets with the swine farms because the pulsotypes 
were different. Pigs and raw pork products may be a potential source of infection for 
humans in Malaysia and the possible transmissions of Y. enterocolitica are directly 
through pigs to humans via contaminated pork, fecal-oral route, contaminated 
environment and pets (Fredriksson-Ahomaa, Korte, et al., 2001; Wang, et al., 2010). 
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5.6 Modification and improvement of CIN agar 
In the search for a medium that would allow a better discrimination of 
Yersinia colonies from other bacterial spp. while maintaining the selective properties 
of CIN, various chemical components have been added to this medium to detect 
three biochemical activities: phenylalanine deaminase, arginine dihydrolase, and H2S 
production. According to Bergey, Breed, Hitchens, & Murray (1948), C. braakii, 
H2S-producing C. freundii, E. cloacae, Providencia rettgeri, and Aeromonas 
hydrophila can be differentiated from Y. enterocolitica based on their biochemical 
properties in utilizing either of these components.  
Ferric ammonium citrate and sodium thiosulphate are substrates for H2S 
production, which results in the formation of a black centre on bacterial colonies. 
Phenylalanine deaminase converts DL-phenylalanine in phenylpyruvate, in which the 
presence of iron (III) ions and citrate, forms a brown, diffusible pigment in agar 
around the bacterial colonies. The dihydrolysis of L-arginine produces an alkaline 
substrate that gives a yellow colour to bacterial colonies. The addition of these 
substrates did not alter the formation of the red bull’s eye feature of Yersinia 
colonies, although the formation of Y. enterocolitica characteristic morphology was 
slightly delayed on modified CIN compared with CIN. Nevertheless, the plates could 
be read within 48 h (optimal incubation time for Y. enterocolitica) in the normal 
isolation step for Y. enterocolitica. 
The differentiation of Yersinia from other mannitol-fermenting bacteria that 
exhibit Yersinia-like colonies CIN (H2S-producing C. freundii, C. braakii, E. 
cloacae, A. hydrophila, and P. rettgeri) was markedly easier on modified CIN 
compared with CIN. These bacterial species are naturally present in feces, raw food, 
and other environmental samples (Bergey, et al., 1948). Because H2S-producing C. 
freundii and C. braakii ferment mannitol and produce H2S, these appeared as red 
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bull’s eye colonies with a black centre on modified CIN. The capacity of E. cloacae 
and A. hydrophila to ferment mannitol and dihydrolyse arginine resulted in the 
formation of pink colonies. Furthermore, A. hydrophila produces phenylalanine 
deaminase, which generates a diffusible brown pigment around the pink colonies. 
Similarly, P. rettgeri produces a phenylalanine deaminase and therefore appeared as 
red bull’s eye colonies with a diffusible brown pigment. The diffusible brown 
pigment produced will not mask the appearance of non-phenylalanine deaminase-
producing bacteria because this brown pigment has a light colour that is less intense 
than the dark-brown pigment produced in the VYE agar (Fukushima, 1987). Van 
Damme, et al. (2013) reported that Y. enterocolitica forms small white colonies and 
not typical red bull’s eyes colonies on CIN agar in the presence of an abundant 
background flora. Similar results were observed in this study when the colony size of 
Y. enterocolitica was ≤ 0.5 mm on CIN (Chapter 4.2.1, Figure 4.2.1). The tiny 
white/colourless Y. enterocolitica colonies obtained in this case resembled M. 
morganii on CIN, causing false-negative results during colony selection. A bonus 
benefit obtained with the modification of CIN was that M. morganii appeared as 
colourless colonies with a diffusible brown pigment on modified CIN due to their 
capacity to produce phenylalanine deaminase. Based on these differential metabolic 
properties, it was possible to eliminate a large number of bacterial colonies prior 
further biochemical testing. The addition of these chemicals in the modified CIN thus 
reduced the workload and additional costs associated with biochemical testing by 
decreasing the number of colonies to be tested and enhanced the detection rate by 
lowering the risk of selecting non-Yersinia colonies.  
However, the modified CIN still has the limitation of not differentiating 
pathogenic Y. enterocolitica from non-pathogenic Yersinia species and from non-
H2S-producing C. freundii, C. koseri, Pantoea spp., S. odorifera, and S. marcescens. 
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Nevertheless, the combination usage of modified CIN with a chromogenic media, 
such as CHROMagar Yersinia (Renaud, Lecci, Courcol, Simonet, & Gaillot, 2013) 
and YECA (Denis, et al., 2011), and YeCM (Weagant, 2008), may help eliminate 
non-pathogenic Yersinia without the need to conduct additional biochemical tests 
(Fondrevez, et al., 2010). This combination usage may also reduce the false-positive 
results caused by wrong colour interpretations by the user (Denys, Renzi, Koch, & 
Wissel, 2013). 
A better formation of a black centre by H2S-producing C. freundii and C. 
braakii colonies was observed when these were incubated under microaerophilic 
conditions. The reduction of sulphide to H2S gas is an anaerobic respiration and 
normally occurs in the middle of bacterial colonies (Stilinovic & Hrenovic, 2009). 
Tiny colonies may not provide good anaerobic conditions for the production of H2S 
gas, and this phenomenon was observed in the samples (Zone A, Figure 5.1). The 
formation of a black centre could not be detected when the colonies were small and 
clumped together. Therefore, a longer incubation time (30 h to 48 h instead of 24 h) 
was required when the plates were incubated under normal (aerobic) conditions 
because bacteria grew bigger and fulfilled the anaerobic respiration requirement. 
Moreover, we observed that the formation of the brown diffusible pigment due to the 
phenylalanine deaminase reaction was hardly observable when the bacteria grew in 
clumps (Figure 5.1, zone A) because the brown pigment diffused around the colony. 
Bacterial clumping may thus be a limitation of modified CIN for the visualisation of 
these bacteria. However, the clumped bacteria can be re-streaked on modified CIN 
for further identification. 
The addition of chemicals did not inhibit the growth of the Yersinia strains 
tested, indicating that modified CIN has the same capacity as CIN to allow the 
growth of this species. It has been previously reported that CIN inhibits the growth of 
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Y. bercovieri (formerly known as Y. enterocolitica bioserotype 3B/O:3) and some 
strains of Y. pseudotuberculosis due to the presence of cefsulodin in the medium 
(Blom, et al., 1999; Fukushima & Gomyoda, 1986; Renaud, et al., 2013; Schiemann, 
1979). Because the amount of cefsulodin was not changed in the modified CIN, we 
expect similar results on this medium.  
 
 
 
Figure 5.1. Colony morphology on CIN and modified CIN  
of an artificially prepared bacterial mixture.  
1, Y. enterocolitica bioserotype 3/O:1,2,3 (IP135); 2, C. braakii; 3, H2S-producing C. freundii; 4, A. hydrophila;  
5, P. rettgeri; 6, E. cloacae. Zone A was region with heavy bacteria growth (bacteria clumping) and bacteria  
normally grew tiny due to competition. Limitation of modified CIN in Zone A: (i) formation of a black centre  
due to H2S-production could not be detected; (ii) visualization of the brown diffusible pigment produce due  
to phenylalanine deaminase reaction was hardly seen. 
 
In evaluating the limit of detection (LOD) and influence of background 
microbiota of both CIN and modified CIN media, Y. enterocolitica was chosen as the 
representating bacterium. The LOD of the modified CIN for the detection of Y. 
enterocolitica (in pure cultures or in artificially contaminated raw pork meat) was 
comparable to that obtained on CIN. For pure Y. enterocolitica cultures, the LOD 
was 10 cfu/ml (for all four strains tested; IP383, IP135, ATCC 9610 and PC-M16-2) 
(Table 4.5.2). The LOD of IP135 for artificially contaminated pork meat increased to 
10
4
 cfu/ml because the presence of natural microbiota interfered with the recovery of 
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Y. enterocolitica (Table 4.5.4). Bacteria such as C. freundii, C. amalonaticus, C. 
diversus, Hafnia alvei, Klebsiella pneumoniae, E. agglomerans, P. rettgeri, and 
environmental Yersinia species that are naturally present in food may indeed have an 
inhibitory effect on the growth of Y. enterocolitica (Fukushima & Gomyoda, 1986). 
The antagonistic effect of certain Gram-negative bacteria toward the growth of Y. 
enterocolitica could be due to the limited space for cell multiplication too 
(Schiemann & Olson, 1984). In a recent study conducted by Savin et al. (2005), CIN 
was reported to be more efficient (LOD = 3 × 10
3
 cfu/g of faeces) as compared to 
SSI medium (LOD = 3 × 10
6
 cfu/g faeces) in isolating Y. enterocolitica. Therefore, 
we anticipate the modified CIN would be a useful medium in differentiating Y. 
enterocolitica from contaminated samples such as faeces. 
The investigation on the influence of background microbiota was done by 
three tests: (i) pool of bacterial mixture, (ii) artificially contaminated pork and (iii) 
naturally contaminated rectal swabs from swine. We observed that the Y. 
enterocolitica colonies were easily distinguished on modified CIN even when 
surrounded by Yersinia-like bacteria and background microbiota, but on CIN, it was 
much more difficult. The percentage of false-positive Y. enterocolitica recovered on 
CIN (66.7%) from an artificially prepared bacterial mixture can decrease to 40.0% 
on modified CIN, and the corresponding percentage from artificially contaminated 
raw pork meat can decrease from 37.7% on CIN to 27.5% on modified CIN (Table 
4.5.5). At the same time, the true positive Y. enterocolitica isolates increased by 
nearly 27% and 10% on modified CIN compared to CIN in artificially prepared 
bacterial mixture and artificially contaminated pork, respectively CIN (Table 4.5.5). 
The capability of modified CIN in reducing the number of false positive Y. 
enterocolitica isolates, especially in eliminating H2S-producing Citrobacter spp., M. 
morganii, P. rettgeri, A. hydrophila, E. cloacae can shorten the processing time and 
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reduce the workload and costs associated with biochemical assays that were reported 
in many studies (Fondrevez, et al., 2010; Head, et al., 1982; Renaud, et al., 2013; 
Schiemann, 1979; Weagant & Feng, 2001; Zheng & Xie, 1996). Higher recovery 
rates from the modified CIN compared with that of CIN was further demonstrated 
using naturally contaminated samples (rectal swabs from swine, Table 4.5.6), 
indicating the modified CIN improved the recovery of Y. enterocolitica even on 
actual samples. The reason for the failure of CIN in isolating Y. enterocolitica from 
rectal specimens may due to the presence of high amount of Yersinia-like bacteria on 
CIN that caused the visualisation of the Yersinia difficult during plate analysis. In 
this evaluation study, the naturally contaminated samples were only enriched in one 
enrichment medium, PBS and the results indicated that a cold enrichment could help 
in recovering a larger number of positive samples than direct streaking method. A 
post-enrichment alkaline treatment showed no difference for the recovery rates of Y. 
enterocolitica (Table 4.5.6). The modification made on CIN enhanced the 
differentiating power of CIN while retaining the sensitivity (see results of LOD test) 
in isolating Yersinia. Hence, the modified CIN could also increase the recovery rates 
compared to CIN when it is used in combination with any other enrichment or 
isolating media that are reported to be useful in previous studies. For examples the 
irgarsan-ticarcillin-cholate (ITC)-CIN method (Fondrevez, et al., 2010), followed by 
streaking on YeCM and enrichment in peptone-sorbitol-bile (PSB) broth for 2 days 
(Van Damme, et al., 2013) that are reported to be useful in isolation of pathogenic Y. 
enterocolitica.  
Therefore, the use of modified CIN may significantly reduce the percentage 
of false-positive Yersinia recovered from a contaminated sample. The higher 
discriminatory power of the modified CIN compared with that of CIN was further 
demonstrated in artificially prepared bacteria mixture and naturally contaminated 
CHAPTER 5   DISCUSSION 
 
112 
 
samples. The results thus demonstrated that the use of modified CIN may be a 
valuable means to increase the recovery rate of Y. enterocolitica from natural 
samples, which are usually contaminated by multiple types of bacteria. 
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This is the first report on the prevalence and characterization of Yersinia 
enterocolitica in pigs and food from Malaysia. Y. enterocolitica was isolated from raw 
pork products and pigs. The prevalence of Y. enterocolitica in raw pork products and 
pigs were 12.1% and 1.8%, respectively. The most common bioserotype isolated was 3 
variant/O:3, followed by 1B/O:8 and 1A/O:5. The results showed that healthy grower 
pig is an important reservoir of Y. enterocolitica biotype 3 variant/O:3 harbouring 
virulence genes. Besides, food such as raw pork meat, liver and intestine might serve as 
important transmission agents of virulent Y. enterocolitica for humans. The virulence 
genes are not only present in the pathogenic biotypes but also in the non-pathogenic 
biotype 1A. PFGE subtyping clearly differentiated the Y. enterocolitica isolates with 
different bioserotypes and origin from each other, indicating the isolates are genetically 
diverse. However, the isolates were highly clonal within each bioserotype. This may 
due to limitation in the current cultures collection. The increment in the resistance rates 
of nalidixic acid, tetracycline and streptomycin and the existence of multidrug-resistant 
Y. enterocolitica in food and pigs are of public concern and should be monitored in 
future surveillance studies. Improper food handling and processing may cause cross 
contamination of this pathogen to humans. More research is needed in understanding 
the possible route of transmission of Y. enterocolitica in human yersiniosis in Malaysia. 
The performance of the CIN agar was increased through the modification made in this 
study. Bacteria such as H2S-producing Citrobacter freundii, C. braakii, Enterobacter 
cloacae, Aeromonas hydrophila, and Providencia rettgeri which were indistinguishable 
on CIN agar each now had distinct colony appearances on the modified CIN. In 
addition, Morganella morganii can be differentiated too. The modified CIN may be 
useful for routine surveillance for the presence of Y. enterocolitica in raw pork meat and 
for those with microbiota such as H2S-producing C. freundii, C. braakii, E. cloacae, A. 
hydrophila, P. rettgeri, and M. morganii as it able to reduce false positive.  
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ENRICHMENT BROTHS 
1. Phosphate buffered saline (PBS) 
PBS (Oxoid, Germany, BR0014)    10 tablets 
dH2O        1 L 
The tablets were dissolved well and autoclaved for 10 min at 115 ˚C. 
 
2. Yersinia selective enrichment broth according to OSSMER (YSEO) 
YSEO (Merck, Germany)     38.7 g 
dH2O        1 L 
The suspension was gently brought to boil to dissolve completely. It was then 
autoclaved at 121˚C for 15min. The solution were kept in dark at the refrigerator 
temperature (at 4˚C) and used within 7 days. 
 
3. Irgasan-ticarcillin-potassium chlorate (ITC) broth  
ITC broth base (Fluka, Germany)    76 g 
dH2O        970 ml  
Ticarcillin supplement (Fluka 17778)    1 vial 
(Dissolved in 2 ml sterile dH2O) 
Potassium chlorate supplement (Fluka 17777)  1 vial 
Seventy-six gram ITC broth base was suspended in 970 ml dH2O. Medium was heated 
to dissolve completely, sterilized by autoclaving at 121°C for 15 minutes, cooled to 45-
50°C. One vial of each ticarcillin supplement (Fluka 17778) and potassium chlorate 
supplement (Fluka 17777) added aseptically, and mixed well before dispensing in 
sterile tubes. The solution were kept in dark at the refrigerator temperature (at 4˚C) and 
used within 7 days. 
 
 
DIFFERENTIAL AGARS 
1. Yersinia Selective Supplement/ CIN agar 
CIN agar base (Oxoid, cat no: CM0653)   29 g 
dH2O        500 ml 
CIN selective supplement (Oxoid, cat no: SR0109)   1 vial 
(Dissolved in ethanol : sterile dH2O= 1:1) 
Twenty-nine gram of CIN agar base was suspended in 500ml of dH2O and boiled gently 
to dissolve completely. Agar was sterilised by autoclaving at 121°C for 15 minutes. 
Agar was allowed to cool to approximately 50°C and 1 vial of CIN selective 
supplement (SR0109) was aseptically added into the agar, mixed gently and poured into 
sterile Petri dishes. The plates were kept in dark at the refrigerator temperature (at 4˚C) 
and used within 7 days. 
 
2. Modified CIN agar 
The following supplements were added into the CIN agar base, pH adjusted to pH 7.4 ± 
0.02 before autoclave and CIN selective supplement was added: 
a) 1% L-arginine (Sigma, Germany) 
b) 0.8 g/l ferric ammonium citrate (BDH Prolabo, UK) 
c) 6.8 g/l sodium thiosulfate (BDH Prolabo) 
d) 2.0 g/l DL-phenylalanine (Sigma) 
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NON-SELECTIVE AGARS 
1. Brain Heart Infusion (BHI) Agar  
BHI agar (Oxoid)       52 g  
dH2O        1 L  
The suspension was gently brought to boil to dissolve completely. It was then 
autoclaved at 121˚C for 15min. It was cooled down to 45-50˚C and was dispensed into 
Petri dishes. The plates were kept at the refrigerator temperature (at 4˚C). 
 
2. Mueller-Hinton II agar 
MH agar (BD)       21.0 g  
dH2O        1 L  
The suspension was gently brought to boil to dissolve completely. It was then 
autoclaved at 121˚C for 15min. It was cooled down to 45-50˚C and about 20-25 ml was 
dispensed into Petri dishes. The plates were kept at the refrigerator temperature (at 4 
˚C). 
 
 
MEDIA FOR BIOCHEMICAL TESTS 
1. Simmons’ citrate agar 
Simmons’ citrate agar powder (Oxoid)   23.0 g 
dH2O        1 L  
Twenty-three g of Simmons’ Citrate powder was suspended in 1L of distilled water, 
boiled to dissolve. It was then autoclaved at 121˚C for 15min. It was cooled down to 45-
50˚C and about 20-25 ml was dispensed into Petri dishes. The plates were kept at the 
refrigerator temperature (at 4 ˚C). 
 
2. Urea agar base 
Urea agar base (Oxoid)     2.4 g 
dH2O        95 ml  
The suspension was gently brought to boil to dissolve completely. It was then 
autoclaved at 121˚C for 15min. It was cooled down to 50˚C and 5 ml of filter-sterilized 
40% urea solution (Sigma) was mixed well into the warm agar base and immediately 
dispensed into Petri dishes (20-25 ml). The plates were kept at the refrigerator 
temperature (at 4 ˚C). 
 
 
MEDIA FOR BIOGROUPING 
1. Lipase test agar (Tween 80 agar) 
 Peptone (Oxoid)      10 g 
 NaCl        5 g 
 CaCl2·H2O       0.1 g 
 Agar        15 g 
 dH2O        1 L 
The suspension was gently brought to boil to dissolve completely. It was then 
autoclaved at 121˚C for 15 min. It was cooled down to 45-50˚C and 1% Tween 80 
(sterilized by autoclaving at 121°C for 15 minutes) was added, mixed well and 
dispensed into Petri dishes. The plates were kept at the refrigerator temperature (at 4˚C). 
 
2. Bile esculine agar 
Bile esculine agar (Oxoid)     44.5g 
dH2O        1 L 
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The suspension was gently brought to boil to dissolve completely. It was then 
autoclaved at 121˚C for 15 min. It was cooled down to 45-50˚C and was dispensed into 
Petri dishes. The plates were kept in dark at the refrigerator temperature (at 4˚C). 
 
3. Phenol red agar 
 Phenol red agar base      30 g 
 dH2O        1 L 
The suspension was gently brought to boil to dissolve completely. It was then 
autoclaved at 121˚C for 15 min. . It was cooled down to 45-50˚C and was dispensed 
into Petri dishes. The plates were kept at the refrigerator temperature (at 4˚C). Phenol 
red agar was used together with the following carbohydrate discs for carbohydrate 
fermentation: 
a) Salicin carbohydrate disc (Fluka, 92971) 
b) Xylose carbohydrate disc (Fluka, 07411) 
c) Trehalose carbohydrate disc (Fluka, 92961) 
 
4. Pyrazinamidase agar 
 Tryptic soy agar (Difco)     30 g 
 Pyrazine-carboxamide (Sigma)    1 g 
 0.2 M Tris-maleate buffer (pH 6)    1 L 
The suspension was gently brought to boil to dissolve completely. About 5 ml 
dispensed into (160 × 16 mm) test tubes, autoclaved at 121˚C for 15 min and slanted for 
cooling. Slants were kept at the refrigerator temperature (at 4˚C). 
  
5. β-D-Glucosidase 
0.1 g 4-nitrophenyl-β-D-glucopyranoside (Sigma) was added to 100 ml 0.666 M 
NaH2PO4 (pH 6.0, Sigma), dissolved, and then filter-sterilized. The solution was kept in 
dark at the refrigerator temperature (at 4˚C). 
 
6. DNase test agar with Toluidine blue  
 DNase test agar with Toluidine blue (BD)   42 g 
 dH2O        1 L 
The suspension was gently brought to boil to dissolve completely. It was then 
autoclaved at 121˚C for 15 min. It was cooled down to 45-50˚C and was dispensed into 
Petri dishes. The plates were kept at the refrigerator temperature (at 4˚C). 
 
7. MRVP broth (Oxoid) 
 MRVP broth (Oxoid)      17 g 
 dH2O        1 L 
The suspension was gently brought to boil to dissolve completely, dispensed into test 
tubes and then autoclaved at 121˚C for 15 min. The solution was kept at the refrigerator 
temperature (at 4˚C). 
 
  
APPENDIX I   MEDIA 
 
131 
 
PHENOTYPIC VIRULENCE TESTS 
1. MRVP broth (Oxoid) – refer above 
 
2. CR-MOX agar  
 MOX agar (Fluka)      46.75 g 
 dH2O        1 L 
The suspension was gently brought to boil to dissolve completely. It was then 
autoclaved at 121˚C for 15min. It was cooled down to 55˚C and the following solutions 
were added: 
a) 10 ml of 20% D-galactose solution (filter-sterilized by 0.2 µm membrane 
filter) 
b) 5 ml of 1% Congo red solution (sterilized by autoclaving at 121°C for 15 
minutes) 
Agar was mixed well and dispensed into Petri dishes. The plates were kept in dark at the 
refrigerator temperature (at 4˚C). 
 
APPENDIX II   CHEMICALS AND REAGENTS 
 
132 
 
APPENDIX II CHEMICALS AND REAGENTS 
 
1. API 20 E reagent kit (bio-Mérieux® SA, France) 
 James reagent, TDA reagent, VP(1+2) reagent, NIT(1+2) reagent, Zn powder 
 
2. Mineral oil (bio-Mérieux® SA, France) 
 
3. 3% Potassium Hydroxide (KOH) solution 
KOH pellet       3 g 
Sterile ddH2O       top up to 100 ml 
KOH pellet was mixed well and used immediately. 
 
4. 85 µg/ml Crystal violet 
Crystal violet       0.085 g 
Sterile ddH2O       100 ml 
Reagent powder was mixed well and stored at 28 °C. 
 
5. α-Naphthol Reagent 
α-Naphthol       5 g 
Sterile ddH2O       top up to 100 ml 
Reagent powder was mixed well and stored at 4 °C. 
 
6. 40% KOH solution 
KOH pellet       40 g 
Sterile ddH2O       top up to 100 ml 
KOH pellet was mixed well and used immediately. 
 
7. 1% iron (II) ammonium sulphate solution 
Iron (II) ammonium sulphate (BDH) powder   1 g 
Sterile ddH2O       100 ml 
Reagent powder was mixed well and used immediately after preparation. 
 
8. 1.5 % agarose gel 
 Agarose powder      1.5 g 
 0.5× TBE buffer      100 ml 
Agarose powder was mixed well and boiled to dissolve. Molten agarose was cooled 
down to 50-55 °C before the gel was casted. 
 
9. 2 % agarose gel 
Agarose powder      2 g 
 0.5× TBE buffer      100 ml 
Agarose powder was mixed well and boiled to dissolve. Molten agarose was cooled 
down to 50-55 °C before the gel was casted. 
 
10. 0.9 % agarose gel 
Agarose powder      1.8 g 
 0.5× TBE buffer      200 ml 
Agarose powder was mixed well and boiled to dissolve. Molten agarose was cooled 
down to 50-55 °C before the gel was casted. 
 
  
APPENDIX II   CHEMICALS AND REAGENTS 
 
133 
 
11. 1% Seakem Gold agarose 
 Seakem Gold agarose powder    1 g 
 1× TE buffer       100 ml 
Agarose powder was mixed well and boiled to dissolve. Molten agarose was kept in 55 
°C water bath while waiting for PFGE plug preparation. 
 
12. 1 % PFGE gel 
 Agarose powder (type 1, Sigma-Aldrich)   1.5 g 
 0.5× TBE buffer      100 ml 
Agarose powder was mixed well and boiled to dissolve. Molten agarose was cooled 
down to 50-55 °C before the gel was casted. 
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APPENDIX III BUFFERS AND SOLUTIONS 
 
1. 0.25% potassium hydroxide (KOH): 0.50% sodium chloride (NaCl) solution 
 NaCl        5 g 
 KOH        2.5 g 
 ddH2O        1 L 
The solution was filter-sterilised (0.2 µm filter) or sterilised at 121 °C for 15 min. 
Stored at the refrigerator temperature (at 4˚C) and used within 7 days. 
 
2. 3% KOH solution 
 KOH pellets       3 g 
 ddH2O        100 ml 
KOH pellets were dissolved completely and used immediately for String test. 
 
3. 0.85% Saline  
NaCl         0.85 g  
dH2O        100 ml  
The solution was sterilized by at 121 °C for 15 min and stored at 28 °C. 
 
4. 10× Tris-borated EDTA (TBE), pH 8.3  
Trizma base        121.2 g   
Orthoboric/Boric acid      61.8 g  
EDTA        0.745 g  
ddH2O        1 L  
The above ingredients were dissolved in 500 ml of ddH2O by stirring on the heated 
stirrer plate. pH was adjusted to 8.3 and top up to 1 L and autoclaved at 121˚C for 15 
min.  
 
5. 0.5× Tris-borate EDTA (TBE)  
10× TBE        50 ml  
dH2O        950 ml  
50 ml of 10× TBE was aliquoted into clean Schott bottle and top up to 1 L by using the 
dH2O.  
 
6. 1M Tris, pH 8.0 (Molecular weight = 121.14 g)  
Tris         36.342 g  
dH2O        250 ml  
36.342 g of Tris powder were dissolved in 250 ml of ddH2O by stirring on the heated 
stirrer plate. pH was adjusted to 8.0 and top up to 300 ml and autoclaved at 121˚C; 15 
psi for 15 min.  
 
7. 0.5 M EDTA, pH 8.0 (Molecular weight = 372.24 g) 
EDTA        55.83 g  
dH2O        250 ml  
55.83 g of EDTA powder were dissolved in 250 ml of ddH2O by stirring on the heated 
stirrer plate. pH was adjusted to 8.0 and top up to 300 ml and autoclaved at 121˚C; 15 
psi for 15 min.  
 
8. Tris-EDTA (TE) buffer (10 mM Tris; 1 mM EDTA; pH 8.0)  
 Tris, pH 8.0        10 ml  
0.5M EDTA, pH 8.0       2 ml  
Top up with ddH2O to 1000 ml, and autoclaved 121˚C; 15 psi for 15 min.  
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9. Cell Suspension Buffer (100 mM Tris; 100 mM EDTA; pH 8.0)  
1M Tris, pH 8.0       10 ml  
0.5M EDTA, pH 8.0       20 ml  
Top up with ddH2O to 100 ml. Autoclaved 121˚C; 15 psi for 15 min.  
 
10. 10% Sarcosyl (N-Lauryl-Sarcosine, Sodium Salt) (Molecular weight = 293.39 g)  
Sodium N-Lauryl-Sarcosinate solution    10 ml  
Top up with ddH2O to 100 ml. Autoclaved 121˚C; 15 psi for 15 min.  
 
11. Cell Lysis Buffer (50mM Tris; 50mM EDTA; pH 8.0; 1% Sarcosine)  
1M Tris, pH 8.0       25 ml  
0.5M EDTA, pH 8.0       50 ml  
10% Sarcosyl (N-Lauryl-Sarcosine, Sodium Salt)   50 ml  
Top up with ddH2O to 500 ml. Autoclaved 121˚C; 15 psi for 15 min.  
 
12. Proteinase K 20 mg/ml  
Proteinase K powder       100 mg  
Sterile ddH2O       5 ml 
Solution was mixed well and kept in ice while waiting to be used. The remaining 
solution was kept at -20 °C. 
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APPENDIX IV  BACKGROUND INFORMATION OF RAW PORK PRODUCTS 
No. Sampling date Sample code Sample Location 
Wet 
market 
Hawker 
stall 
Condition 
Biochemical 
tests 
PCR 
confirmation 
Post enrichment PCR detection 
    
 
   
  Overall YSEO ITC PBS 
1 7-Jun-10 M1 Raw Pork Meat Kuala Lumpur A stall 1 whole meat + + + - n.a. + 
2 7-Jun-10 M2 Raw Pork Meat Kuala Lumpur A stall 1 whole meat - - + - n.a. + 
3 7-Jun-10 M3 Raw Pork Meat Kuala Lumpur A stall 1 whole meat + + + - n.a. + 
4 14-Jun-10 I1 Raw Pork Intestine Kuala Lumpur B stall 1 minced - - + - n.a. + 
5 14-Jun-10 K1 Raw Pork Kidney Kuala Lumpur B stall 1 minced - - - - n.a. - 
6 14-Jun-10 S1 Raw Pork Skin Kuala Lumpur B stall 1 minced - - - - n.a. - 
7 14-Jun-10 E1 Pig's Ear Kuala Lumpur B stall 1 minced - - - - n.a. - 
8 14-Jun-10 T1 Pig's Throat Kuala Lumpur B stall 1 minced - - - - n.a. - 
9 14-Jun-10 F1 Pig's fat tissue Kuala Lumpur B stall 1 minced - - - - n.a. - 
10 10-Jul-10 M4 Raw Pork Meat Kuala Lumpur A stall 1 whole meat + - + - n.a. + 
11 10-Jul-10 M5 Raw Pork Meat Kuala Lumpur A stall 1 minced - - + + n.a. + 
12 10-Jul-10 M6 Raw Pork Meat Kuala Lumpur A stall 1 minced - - + - n.a. + 
13 10-Jul-10 M7 Raw Pork Meat Kuala Lumpur A stall 1 minced - - - - n.a. - 
14 10-Jul-10 I2 Raw Pork Intestine Kuala Lumpur A stall 2 minced - - + + n.a. - 
15 10-Jul-10 I3 Raw Pork Intestine Kuala Lumpur A stall 2 minced - - + - n.a. + 
16 10-Jul-10 D1 Raw Pork Heart Kuala Lumpur A stall 1 minced - - + + n.a. - 
17 10-Jul-10 D2 Raw Pork Heart Kuala Lumpur A stall 1 minced - - + + n.a. + 
18 10-Jul-10 L1 Raw Pork liver Kuala Lumpur A stall 1 minced - - + + n.a. - 
19 10-Jul-10 P1 Pig's paw Kuala Lumpur A stall 1 whole - - - - n.a. - 
20 2-Aug-10 M8 Raw Pork Meat Kuala Lumpur B stall 1 whole - - - - - - 
21 2-Aug-10 M9 Raw Pork Meat Kuala Lumpur B stall 1 whole - - + + - - 
22 2-Aug-10 M10 Raw Pork Meat Kuala Lumpur B stall 1 whole - - - - - - 
23 2-Aug-10 D3 Raw Pork Meat Kuala Lumpur B stall 1 minced - - - - - - 
24 2-Aug-10 S2 Raw Pork Skin Kuala Lumpur B stall 1 whole - - + - - + 
25 16-Aug-10 D4 Raw Pork heart Kuala Lumpur B stall 1 whole - - + + + - 
26 12-Sep-10 L2 Raw Pork Liver Kuala Lumpur A stall6 whole - - - - - - 
27 12-Sep-10 I4 Raw Pork Intestine Kuala Lumpur A stall6 whole - - - - - - 
28 12-Sep-10 S3 Raw Pork Skin Kuala Lumpur A stall2 whole - - - - - - 
29 12-Sep-10 M11 Raw Pork Meat Kuala Lumpur A stall6 whole - - + + + - 
30 20-Sep-10 M12 Raw Pork Meat Kuala Lumpur A stall 1 whole - - + + - - 
31 20-Sep-10 M13 Raw Pork Meat Kuala Lumpur A stall 1 whole + + + + - - 
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No. Sampling date Sample code Sample Location 
Wet 
market 
Hawker 
stall 
Condition 
Biochemical 
tests 
PCR 
confirmation 
Post enrichment PCR detection 
    
 
   
  Overall YSEO ITC PBS 
32 20-Sep-10 M14 Raw Pork Meat Kuala Lumpur A stall 2 whole - - + + + - 
33 20-Sep-10 M15 Raw Pork Meat Kuala Lumpur A stall 2 whole - - + + + + 
34 20-Sep-10 I5 Raw Pork Intestine Kuala Lumpur A stall6 whole - - + + - + 
35 20-Sep-10 I6 Raw Pork Intestine Kuala Lumpur A stall6 whole - - + - + + 
36 17-Jan-11 M16 Raw Pork Meat Kuala Lumpur A stall7 whole + + + + + + 
37 17-Jan-11 M17 Raw Pork Meat Kuala Lumpur A stall7 whole - - + + + + 
38 17-Jan-11 M18 Raw Pork Meat Kuala Lumpur A stall8 whole - - + + - + 
39 17-Jan-11 M19 Raw Pork Meat Kuala Lumpur A stall9 whole - - + + + + 
40 17-Jan-11 M20 Raw Pork Meat Kuala Lumpur A stall9 whole + - + + + + 
41 17-Jan-11 I7 Raw Pork Intestine Kuala Lumpur A stall10 whole - - + + + + 
42 15-Mar-11 K2 Raw Pork Kidney Perak C stall 11 whole - - - - - - 
43 15-Mar-11 K3 Raw Pork Kidney Perak C stall 11 whole - - + + - - 
44 15-Mar-11 S4 Raw Pork Skin Perak C stall 11 whole - - - - - - 
45 15-Mar-11 L3 Raw Pork Liver Perak C stall 11 whole - - + + - - 
46 15-Mar-11 K4 Pig's Kidney tissue Perak D stall 12 whole - - - - - - 
47 15-Mar-11 N1 Pig's nose Perak D stall 12 whole - - - - - - 
48 15-Mar-11 EB1 Pig's eye tissue Perak D stall 12 whole - - - - - - 
49 15-Mar-11 H1 Raw Pork heart Perak D stall 12 whole - - - - - - 
50 15-Mar-11 P2 pig's foot Perak D stall 12 whole - - - - - - 
51 27-Sep-10 PO1 Raw Pork Meat Pahang G stall 19 whole - - - - - - 
52 18-Jan-11 
YE032 (or 
S18/1-1) 
Raw Pork Liver Kuala Lumpur A stall 1 whole + + + - + - 
53 18-Jan-11 S18/1-2 Raw Pork liver Kuala Lumpur A stall 1 whole - - - - - - 
54 18-Jan-11 S18/1-3 Raw Pork Meat Kuala Lumpur A stall 1 whole - - + - - + 
55 18-Jan-11 S18/1-4 Raw Pork Meat Kuala Lumpur A stall 1 whole - - + - - + 
56 18-Jan-11 
YE036 (or 
S18/1-5) 
Raw Pork Meat Kuala Lumpur A stall 1 whole + + + + + - 
57 18-Jan-11 
YE037 (or 
S18/1-6) 
Raw Pork Intestine Kuala Lumpur A stall 1 whole + + + + - + 
58 18-Jan-11 S18/1-11 Raw Pork Meat Kuala Lumpur A stall 1 whole - - - - - - 
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APPENDIX V  BACKGROUND INFORMATION OF NON-PORCINE FOOD 
No. Sampling date Sample code Sample Location 
Wet 
market 
Hawker 
stall 
Condition 
Biochemical 
tests 
PCR 
confirmation 
Post enrichment PCR detection 
    
 
   
  Overall YSEO ITC PBS 
1 16-Aug-10 VG1 Water-cress Kuala Lumpur B stall 3 Fresh - - + + - + 
2 16-Aug-10 VG2 celery cabbage Kuala Lumpur B stall 3 Fresh - - + + - + 
3 16-Aug-10 VG3 Lettuce Kuala Lumpur B stall4 Fresh - - + + - - 
4 12-Sep-10 VG4 balsam pear Kuala Lumpur A stall5 
Fresh, 
internal 
content 
- - - - - - 
5 12-Sep-10 VG5 Cowpea Kuala Lumpur A stall4 Fresh - - - - - - 
6 12-Sep-10 VR1 Amaranth's root Kuala Lumpur A stall5 Fresh - - - - - - 
7 3-Sep-10 S3/9-1 China cabbage Selangor E stall 13 Fresh - - - - - - 
8 3-Sep-10 S3/9-2 Chinese broccoli (kai lan) Selangor E stall 13 
Slightly 
spoilt 
- - - - - - 
9 3-Sep-10 S3/9-3 Squid Selangor E stall 14 Fresh - - - - - - 
10 3-Sep-10 S3/9-4 Sweet potato Selangor E stall 13 Fresh, dry - - - - - - 
11 3-Sep-10 S3/9-5 China cabbage Selangor E stall 13 Fresh - - - - - - 
12 3-Sep-10 S3/9-6 China cabbage  Selangor E stall 13 Fresh - - - - - - 
13 6-Sep-10 S6/9-C1 Chicken Selangor F stall 15 Fresh - - + - - + 
14 6-Sep-10 S6/9-C2 Chicken Selangor F stall 15 Fresh - - + - - + 
15 6-Sep-10 S6/9-C3 Chicken Selangor F stall 15 Fresh - - + - - + 
16 6-Sep-10 S6/9-B1 Beef Selangor F stall 16 Fresh - - - - - - 
17 6-Sep-10 S6/9-B2 Beef Selangor F stall 16 Fresh - - - - - - 
18 6-Sep-10 S6/9-B3 Beef  Selangor F stall 16 Fresh - - + - - + 
19 6-Sep-10 S6/9-B4 Beef  Selangor F stall 16 Fresh - - + - - + 
20 7-Sep-10 S7/9-P1 Prawn Pahang G stall 17 Fresh - - - - - - 
21 7-Sep-10 
S7/9-F1 or 
YE015 
“Ikan kampong” Pahang G stall 17 
Slightly 
spoilt 
+ - + - - + 
22 7-Sep-10 S7/9-F2 “Ikan kampong” Pahang G stall 17 Fresh - - - - - - 
23 7-Sep-10 S7/9-F3 “Ikan patin” Pahang G stall 17 Fresh - - - - - - 
24 7-Sep-10 S7/9-C1 Chicken Pahang G stall 18 Fresh - - + - - + 
25 20-Sep-10 S20/9-V1 Spinach Selangor E stall 13 Spoilt - - - - - - 
26 20-Sep-10 S20/9-C1 Chicken (meat) Selangor E stall 21 Fresh - - - - - - 
27 20-Sep-10 S20/9-V2 China cabbage Selangor E stall 13 Spoilt - - - - - - 
28 20-Sep-10 S20/9-V3 Bitter gourd Selangor E stall 13 Fresh - - - - - - 
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  Overall YSEO ITC PBS 
29 20-Sep-10 S20/9-F4 Fish Selangor E stall 14 Fresh - - + - + - 
30 27-Sep-10 S27/9-T1 Tofu Pahang G stall 20  Fresh - - - - - - 
31 27-Sep-10 S27/9-S1 Squid Pahang G stall 14 Fresh - - - - - - 
32 27-Sep-10 S27/9-V1 Cauliflower Pahang G stall 13  Fresh - - - - - - 
33 27-Sep-10 S27/9-C1 Chicken Pahang G stall 18 Fresh - - - - - - 
34 27-Sep-10 S27/9-M1 Goat milk (pasteurized) Pahang G 
mini mart 
1 
 Fresh - - - - - - 
35 27-Sep-10 S27/9-T2 Tofu  Pahang G stall 20  Fresh - - - - - - 
36 27-Sep-10 S27/9-C2 Chicken (feet) Pahang G stall 18  Fresh - - - - - - 
37 18-Jan-11 S18/1-7 Cabbage Kuala Lumpur A stall 5  Fresh - - + - + + 
38 18-Jan-11 S18/1-8 Bitter Gourd Kuala Lumpur A stall 5 
A little 
mushy and 
spoilt 
- - + + + - 
39 18-Jan-11 S18/1-9 Brinjal Kuala Lumpur A stall 6 
Spoilt, 
worms 
observed 
- - + + + - 
40 18-Jan-11 S18/1-10 Lady’s Finger Kuala Lumpur A stall 6 Fresh - - - - - - 
41 24-Jan-11 S24/1-1 Beef Pahang G stall 22 Fresh - - + - - + 
42 24-Jan-11 S24/1-2 Chicken Pahang G stall 18  Fresh - - - - - - 
43 24-Jan-11 S24/1-3 Cockles Pahang G stall 14 Fresh - - - - - - 
44 24-Jan-11 S24/1-4 “Ikan kampong” Pahang G stall 14 Fresh - - + - + - 
45 24-Jan-11 S24/1-5 “Ikan patin” Pahang G stall 14 Fresh - - + - + - 
46 24-Jan-11 S24/1-6 Beef Pahang G stall 22 Fresh - - + - + - 
47 24-Jan-11 S24/1-7 Squid Pahang G stall 14 Fresh - - + - + - 
48 24-Jan-11 S24/1-8 Chicken Pahang G stall 18  Fresh - - + - + - 
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APPENDIX VI  BACKGROUND INFORMATION OF PIG FARMS AND PIG SAMPLES 
No. 
Sampling 
date 
Location Farm 
Animal 
No. 
Sample 
code 
Sample type Year old 
Health 
condition 
Biochemical 
tests 
PCR 
confirmation 
Post enrichment PCR detection 
 
 
       
  Overall ITC PBS 
1 6-Oct-10 Tanjung Sepat, Selangor A 1 TSP1a Nasal swab Weaner Healthy - - - - n.a. 
2 6-Oct-10 Tanjung Sepat, Selangor A 1 TSP1b Rectal swab Weaner Healthy - - - - n.a. 
3 6-Oct-10 Tanjung Sepat, Selangor A 1 TSP1c Tongue swab Weaner Healthy - - - - n.a. 
4 6-Oct-10 Tanjung Sepat, Selangor A 2 TSP2a Nasal swab Weaner Healthy - - - - - 
5 6-Oct-10 Tanjung Sepat, Selangor A 2 TSP2b Rectal swab Weaner Healthy - - + + - 
6 6-Oct-10 Tanjung Sepat, Selangor A 2 TSP2c Palate swab Weaner Healthy - - - - - 
7 6-Oct-10 Tanjung Sepat, Selangor A 3 TSP3a Nasal swab Weaner Healthy - - - - - 
8 6-Oct-10 Tanjung Sepat, Selangor A 3 TSP3b Rectal swab Weaner Healthy - - - - - 
9 6-Oct-10 Tanjung Sepat, Selangor A 3 TSP3c Palate swab Weaner Healthy - - - - - 
10 6-Oct-10 Tanjung Sepat, Selangor A 4 TSP4a Nasal swab Weaner Healthy - - - - n.a. 
11 6-Oct-10 Tanjung Sepat, Selangor A 4 TSP4b Rectal swab Weaner Healthy - - - - n.a. 
12 6-Oct-10 Tanjung Sepat, Selangor A 4 TSP4c Palate swab Weaner Healthy - - - - n.a. 
13 6-Oct-10 Tanjung Sepat, Selangor A 5 TSP5a Nasal swab Weaner Healthy - - - - - 
14 6-Oct-10 Tanjung Sepat, Selangor A 5 TSP5b Rectal swab Weaner Healthy - - - - - 
15 6-Oct-10 Tanjung Sepat, Selangor A 5 TSP5c Tongue swab Weaner Healthy - - - - - 
16 6-Oct-10 Tanjung Sepat, Selangor A 6 TSP6a Nasal swab Weaner Healthy - - - - - 
17 6-Oct-10 Tanjung Sepat, Selangor A 6 TSP6b Rectal swab Weaner Healthy - - - - - 
18 6-Oct-10 Tanjung Sepat, Selangor A 6 TSP6c Palate swab Weaner Healthy - - - - - 
19 6-Oct-10 Tanjung Sepat, Selangor A 7 TSP7a Nasal swab Weaner Healthy - - + - + 
20 6-Oct-10 Tanjung Sepat, Selangor A 7 TSP7b Rectal swab Weaner Healthy - - + - + 
21 6-Oct-10 Tanjung Sepat, Selangor A 7 TSP7c Palate swab Weaner Healthy - - + - + 
22 6-Oct-10 Tanjung Sepat, Selangor A 8 TSP8a Nasal swab Weaner Unhealthy - - + + - 
23 6-Oct-10 Tanjung Sepat, Selangor A 8 TSP8b Rectal swab Weaner Unhealthy - - - - - 
24 6-Oct-10 Tanjung Sepat, Selangor A 8 TSP8c Tonsil swab Weaner Unhealthy - - + - + 
25 6-Oct-10 Tanjung Sepat, Selangor A 9 TSP9a Nasal swab Weaner Unhealthy - - - - n.a. 
26 6-Oct-10 Tanjung Sepat, Selangor A 9 TSP9b Rectal swab Weaner Unhealthy - - - - n.a. 
27 6-Oct-10 Tanjung Sepat, Selangor A 9 TSP9c Tongue swab Weaner Unhealthy - - - - n.a. 
28 20-Oct-10 Tanjung Sepat, Selangor B 10 TSP10a nasal swab Weaner Unhealthy - - - - - 
29 20-Oct-10 Tanjung Sepat, Selangor B 10 TSP10b tongue swab Weaner Unhealthy - - - - - 
30 20-Oct-10 Tanjung Sepat, Selangor B 10 TSP10c rectal swab Weaner Unhealthy - - - - - 
31 20-Oct-10 Tanjung Sepat, Selangor B 11 TSP11a nasal swab Weaner Unhealthy - - - - - 
32 20-Oct-10 Tanjung Sepat, Selangor B 11 TSP11b tongue swab Weaner Unhealthy - - - - - 
33 20-Oct-10 Tanjung Sepat, Selangor B 11 TSP11c rectal swab Weaner Unhealthy - - + + - 
34 20-Oct-10 Tanjung Sepat, Selangor B 12 TSP12a nasal swab Weaner Unhealthy - - - - - 
35 20-Oct-10 Tanjung Sepat, Selangor B 12 TSP12b tongue swab Weaner Unhealthy - - - - - 
36 20-Oct-10 Tanjung Sepat, Selangor B 12 TSP12c rectal swab Weaner Unhealthy - - - - - 
37 20-Oct-10 Tanjung Sepat, Selangor B 13 TSP13a nasal swab Weaner Healthy - - - - - 
38 20-Oct-10 Tanjung Sepat, Selangor B 13 TSP13b tongue swab Weaner Healthy - - - - - 
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  Overall ITC PBS 
39 20-Oct-10 Tanjung Sepat, Selangor B 13 TSP13c rectal swab Weaner Healthy - - - - - 
40 20-Oct-10 Tanjung Sepat, Selangor B 14 TSP14a nasal swab Weaner Healthy - - - - - 
41 20-Oct-10 Tanjung Sepat, Selangor B 14 TSP14b tongue swab Weaner Healthy - - + + - 
42 20-Oct-10 Tanjung Sepat, Selangor B 14 TSP14c rectal swab Weaner Healthy - - - - - 
43 20-Oct-10 Tanjung Sepat, Selangor B 15 TSP15a nasal swab Weaner Healthy - - + + - 
44 20-Oct-10 Tanjung Sepat, Selangor B 15 TSP15b tongue swab Weaner Healthy - - - - - 
45 20-Oct-10 Tanjung Sepat, Selangor B 15 TSP15c rectal swab Weaner Healthy - - + + - 
46 20-Oct-10 Tanjung Sepat, Selangor B 16 TSP16a nasal swab Finisher Healthy - - - - - 
47 20-Oct-10 Tanjung Sepat, Selangor B 16 TSP16b tongue swab Finisher Healthy - - - - - 
48 20-Oct-10 Tanjung Sepat, Selangor B 16 TSP16c rectal swab Finisher Healthy - - - - - 
49 20-Oct-10 Tanjung Sepat, Selangor B 17 TSP17a nasal swab Finisher Healthy - - - - - 
50 20-Oct-10 Tanjung Sepat, Selangor B 17 TSP17b tongue swab Finisher Healthy - - - - - 
51 20-Oct-10 Tanjung Sepat, Selangor B 17 TSP17c rectal swab Finisher Healthy - - - - - 
52 20-Oct-10 Tanjung Sepat, Selangor B 18 TSP18a nasal swab Finisher Healthy - - - - - 
53 20-Oct-10 Tanjung Sepat, Selangor B 18 TSP18b tongue swab Finisher Healthy - - - - - 
54 20-Oct-10 Tanjung Sepat, Selangor B 18 TSP18c rectal swab Finisher Healthy - - - - - 
55 20-Oct-10 Tanjung Sepat, Selangor B 19 TSP19a nasal swab Finisher Healthy - - - - - 
56 20-Oct-10 Tanjung Sepat, Selangor B 19 TSP19b tongue swab Finisher Healthy - - - - - 
57 20-Oct-10 Tanjung Sepat, Selangor B 19 TSP19c rectal swab Finisher Healthy - - - - - 
58 20-Oct-10 Tanjung Sepat, Selangor B 20 TSP20a nasal swab Weaner Healthy - - - - - 
59 20-Oct-10 Tanjung Sepat, Selangor B 20 TSP20b tongue swab Weaner Healthy - - + + - 
60 20-Oct-10 Tanjung Sepat, Selangor B 20 TSP20c rectal swab Weaner Healthy - - + - + 
61 20-Oct-10 Tanjung Sepat, Selangor B 21 TSP21a nasal swab Weaner Unhealthy - - - - - 
62 20-Oct-10 Tanjung Sepat, Selangor B 21 TSP21b tonsil swab Weaner Unhealthy - - + - + 
63 20-Oct-10 Tanjung Sepat, Selangor B 21 TSP21d rectal swab Weaner Unhealthy - - - - - 
64 20-Oct-10 Tanjung Sepat, Selangor B 22 TSP22a nasal swab Weaner Unhealthy - - + - - 
65 20-Oct-10 Tanjung Sepat, Selangor B 22 TSP22b tonsil swab Weaner Unhealthy - - - - - 
66 20-Oct-10 Tanjung Sepat, Selangor B 22 TSP22d rectal swab Weaner Unhealthy - - - - - 
67 20-Oct-10 Tanjung Sepat, Selangor B 23 TSP23a nasal swab Weaner Unhealthy - - - - - 
68 20-Oct-10 Tanjung Sepat, Selangor B 23 TSP23b tonsil swab Weaner Unhealthy - - - - - 
69 20-Oct-10 Tanjung Sepat, Selangor B 23 TSP23d rectal swab Weaner Unhealthy - - - - - 
70 21-Mar-11 Tanjung Sepat, Selangor C 24 TSP24a nasal swab Piglet healthy - - - - - 
71 21-Mar-11 Tanjung Sepat, Selangor C 24 TSP24b tongue swab Piglet healthy - - - - - 
72 21-Mar-11 Tanjung Sepat, Selangor C 24 TSP24c rectal swab Piglet healthy - - - - - 
73 21-Mar-11 Tanjung Sepat, Selangor C 25 TSP25a nasal swab Piglet healthy - - - - - 
74 21-Mar-11 Tanjung Sepat, Selangor C 25 TSP25b tongue swab Piglet healthy - - - - - 
75 21-Mar-11 Tanjung Sepat, Selangor C 25 TSP25c rectal swab Piglet healthy - - - - - 
76 21-Mar-11 Tanjung Sepat, Selangor C 26 TSP26a nasal swab Piglet healthy - - - - - 
77 21-Mar-11 Tanjung Sepat, Selangor C 26 TSP26b tongue swab Piglet healthy - - - - - 
78 21-Mar-11 Tanjung Sepat, Selangor C 26 TSP26c rectal swab Piglet healthy - - - - - 
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  Overall ITC PBS 
79 21-Mar-11 Tanjung Sepat, Selangor C 27 TSP27a nasal swab Piglet healthy - - - - - 
80 21-Mar-11 Tanjung Sepat, Selangor C 27 TSP27b tongue swab Piglet healthy - - - - - 
81 21-Mar-11 Tanjung Sepat, Selangor C 27 TSP27c rectal swab Piglet healthy - - - - - 
82 21-Mar-11 Tanjung Sepat, Selangor C 28 TSP28a nasal swab Piglet Unhealthy - - - - - 
83 21-Mar-11 Tanjung Sepat, Selangor C 28 TSP28b tongue swab Piglet Unhealthy - - - - - 
84 21-Mar-11 Tanjung Sepat, Selangor C 28 TSP28c rectal swab Piglet Unhealthy - - - - - 
85 21-Mar-11 Tanjung Sepat, Selangor C 29 TSP29a nasal swab Piglet Unhealthy - - - - - 
86 21-Mar-11 Tanjung Sepat, Selangor C 29 TSP29b tongue swab Piglet Unhealthy - - - - - 
87 21-Mar-11 Tanjung Sepat, Selangor C 29 TSP29c rectal swab Piglet Unhealthy - - - - - 
88 21-Mar-11 Tanjung Sepat, Selangor C 30 TSP30a nasal swab Piglet Unhealthy - - - - - 
89 21-Mar-11 Tanjung Sepat, Selangor C 30 TSP30b tongue swab Piglet Unhealthy - - - - - 
90 21-Mar-11 Tanjung Sepat, Selangor C 30 TSP30c rectal swab Piglet Unhealthy - - - - - 
91 21-Mar-11 Tanjung Sepat, Selangor C 31 TSP31a nasal swab Piglet Unhealthy - - - - - 
92 21-Mar-11 Tanjung Sepat, Selangor C 31 TSP31b tongue swab Piglet Unhealthy - - - - - 
93 21-Mar-11 Tanjung Sepat, Selangor C 31 TSP31c rectal swab Piglet Unhealthy - - - - - 
94 21-Mar-11 Tanjung Sepat, Selangor C 32 TSP32a nasal swab Grower Unhealthy - - - - - 
95 21-Mar-11 Tanjung Sepat, Selangor C 32 TSP32b tongue swab Grower Unhealthy - - - - - 
96 21-Mar-11 Tanjung Sepat, Selangor C 32 TSP32c rectal swab Grower Unhealthy - - - - - 
97 21-Mar-11 Tanjung Sepat, Selangor C 33 TSP33a nasal swab Grower healthy - - - - - 
98 21-Mar-11 Tanjung Sepat, Selangor C 33 TSP33b tongue swab Grower healthy - - - - - 
99 21-Mar-11 Tanjung Sepat, Selangor C 33 TSP33c rectal swab Grower healthy - - - - - 
100 21-Mar-11 Tanjung Sepat, Selangor C 34 TSP34a nasal swab Grower Unhealthy - - - - - 
101 21-Mar-11 Tanjung Sepat, Selangor C 34 TSP34b tongue swab Grower Unhealthy - - - - - 
102 21-Mar-11 Tanjung Sepat, Selangor C 34 TSP34c rectal swab Grower Unhealthy - - - - - 
103 21-Mar-11 Tanjung Sepat, Selangor C 35 TSP35a nasal swab Grower healthy - - - - - 
104 21-Mar-11 Tanjung Sepat, Selangor C 35 TSP35b tongue swab Grower healthy - - - - - 
105 21-Mar-11 Tanjung Sepat, Selangor C 35 TSP35c rectal swab Grower healthy - - - - - 
106 21-Mar-11 Tanjung Sepat, Selangor C 36 TSP36a nasal swab Weaner Unhealthy - - - - - 
107 21-Mar-11 Tanjung Sepat, Selangor C 36 TSP36b tongue swab Weaner Unhealthy - - - - - 
108 21-Mar-11 Tanjung Sepat, Selangor C 36 TSP36c rectal swab Weaner Unhealthy - - - - - 
109 21-Mar-11 Tanjung Sepat, Selangor C 37 TSP37a nasal swab Weaner Unhealthy - - - - - 
110 21-Mar-11 Tanjung Sepat, Selangor C 37 TSP37b tongue swab Weaner Unhealthy - - - - - 
111 21-Mar-11 Tanjung Sepat, Selangor C 37 TSP37c rectal swab Weaner Unhealthy - - - - - 
112 21-Mar-11 Tanjung Sepat, Selangor C 38 TSP38a nasal swab Weaner Unhealthy - - - - - 
113 21-Mar-11 Tanjung Sepat, Selangor C 38 TSP38b tongue swab Weaner Unhealthy - - - - - 
114 21-Mar-11 Tanjung Sepat, Selangor C 38 TSP38c rectal swab Weaner Unhealthy - - - - - 
115 21-Mar-11 Tanjung Sepat, Selangor C 39 TSP39a nasal swab Weaner healthy - - - - - 
116 21-Mar-11 Tanjung Sepat, Selangor C 39 TSP39b tongue swab Weaner healthy - - - - - 
117 21-Mar-11 Tanjung Sepat, Selangor C 39 TSP39c rectal swab Weaner healthy - - - - - 
118 21-Mar-11 Tanjung Sepat, Selangor C 40 TSP40a nasal swab Weaner healthy - - - - - 
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  Overall ITC PBS 
119 21-Mar-11 Tanjung Sepat, Selangor C 40 TSP40b tongue swab Weaner healthy - - - - - 
120 21-Mar-11 Tanjung Sepat, Selangor C 40 TSP40c rectal swab Weaner healthy - - - - - 
121 21-Mar-11 Tanjung Sepat, Selangor C 41 TSP41a nasal swab Weaner healthy - - - - - 
122 21-Mar-11 Tanjung Sepat, Selangor C 41 TSP41b tongue swab Weaner healthy - - - - - 
123 21-Mar-11 Tanjung Sepat, Selangor C 41 TSP41c rectal swab Weaner healthy - - - - - 
124 21-Mar-11 Tanjung Sepat, Selangor C 42 TSP42a nasal swab Weaner Unhealthy - - - - - 
125 21-Mar-11 Tanjung Sepat, Selangor C 42 TSP42b tongue swab Weaner Unhealthy - - - - - 
126 21-Mar-11 Tanjung Sepat, Selangor C 42 TSP42c rectal swab Weaner Unhealthy - - - - - 
127 21-Mar-11 Tanjung Sepat, Selangor C 43 TSP43a nasal swab Weaner healthy - - - - - 
128 21-Mar-11 Tanjung Sepat, Selangor C 43 TSP43b tongue swab Weaner healthy - - - - - 
129 21-Mar-11 Tanjung Sepat, Selangor C 43 TSP43c rectal swab Weaner healthy - - - - - 
130 21-Mar-11 Tanjung Sepat, Selangor C 44 TSP44a nasal swab Weaner Unhealthy - - - - - 
131 21-Mar-11 Tanjung Sepat, Selangor C 44 TSP44b tongue swab Weaner Unhealthy - - - - - 
132 21-Mar-11 Tanjung Sepat, Selangor C 44 TSP44c rectal swab Weaner Unhealthy - - - - - 
133 21-Mar-11 Tanjung Sepat, Selangor C 45 TSP45a nasal swab Weaner Unhealthy - - - - - 
134 21-Mar-11 Tanjung Sepat, Selangor C 45 TSP45b tongue swab Weaner Unhealthy - - - - - 
135 21-Mar-11 Tanjung Sepat, Selangor C 45 TSP45c rectal swab Weaner Unhealthy - - - - - 
136 21-Mar-11 Tanjung Sepat, Selangor C 46 TSP46a nasal swab Weaner Unhealthy - - - - - 
137 21-Mar-11 Tanjung Sepat, Selangor C 46 TSP46b tongue swab Weaner Unhealthy - - - - - 
138 21-Mar-11 Tanjung Sepat, Selangor C 46 TSP46c rectal swab Weaner Unhealthy - - - - - 
139 21-Mar-11 Tanjung Sepat, Selangor C 47 TSP47a nasal swab Weaner Unhealthy - - - - - 
140 21-Mar-11 Tanjung Sepat, Selangor C 47 TSP47b tongue swab Weaner Unhealthy - - - - - 
141 21-Mar-11 Tanjung Sepat, Selangor C 47 TSP47c rectal swab Weaner Unhealthy - - - - - 
142 21-Mar-11 Tanjung Sepat, Selangor C 48 TSP48a nasal swab Finisher healthy - - - - - 
143 21-Mar-11 Tanjung Sepat, Selangor C 48 TSP48b tongue swab Finisher healthy - - - - - 
144 21-Mar-11 Tanjung Sepat, Selangor C 48 TSP48c rectal swab Finisher healthy - - - - - 
145 21-Mar-11 Tanjung Sepat, Selangor C 49 TSP49a nasal swab Finisher healthy - - - - - 
146 21-Mar-11 Tanjung Sepat, Selangor C 49 TSP49b tongue swab Finisher healthy - - - - - 
147 21-Mar-11 Tanjung Sepat, Selangor C 49 TSP49c rectal swab Finisher healthy - - - - - 
148 21-Mar-11 Tanjung Sepat, Selangor C 50 TSP50a nasal swab Finisher healthy - - - - - 
149 21-Mar-11 Tanjung Sepat, Selangor C 50 TSP50b tongue swab Finisher healthy - - - - - 
150 21-Mar-11 Tanjung Sepat, Selangor C 50 TSP50c rectal swab Finisher healthy - - - - - 
151 21-Mar-11 Tanjung Sepat, Selangor C 51 TSP51a nasal swab Finisher healthy - - - - - 
152 21-Mar-11 Tanjung Sepat, Selangor C 51 TSP51b tongue swab Finisher healthy - - - - - 
153 21-Mar-11 Tanjung Sepat, Selangor C 51 TSP51c rectal swab Finisher healthy - - - - - 
154 21-Mar-11 Tanjung Sepat, Selangor C 52 TSP52a nasal swab Finisher healthy - - - - - 
155 21-Mar-11 Tanjung Sepat, Selangor C 52 TSP52b tongue swab Finisher healthy - - - - - 
156 21-Mar-11 Tanjung Sepat, Selangor C 52 TSP52c rectal swab Finisher healthy - - - - - 
157 21-Mar-11 Tanjung Sepat, Selangor C 53 TSP53a nasal swab Finisher healthy - - - - - 
158 21-Mar-11 Tanjung Sepat, Selangor C 53 TSP53b tongue swab Finisher healthy - - - - - 
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  Overall ITC PBS 
159 21-Mar-11 Tanjung Sepat, Selangor C 53 TSP53c rectal swab Finisher healthy - - - - - 
160 29-Jun-11 Gopeng, Perak D 1 PP1a nasal swab Weaner Healthy - - - - - 
161 29-Jun-11 Gopeng, Perak D 1 PP1b tongue swab Weaner Healthy - - - - - 
162 29-Jun-11 Gopeng, Perak D 1 PP1c rectal swab Weaner Healthy - - - - - 
163 29-Jun-11 Gopeng, Perak D 2 PP2a nasal swab Weaner Healthy - - + + - 
164 29-Jun-11 Gopeng, Perak D 2 PP2b tongue swab Weaner Healthy - - - - - 
165 29-Jun-11 Gopeng, Perak D 2 PP2c rectal swab Weaner Healthy - - - - - 
166 29-Jun-11 Gopeng, Perak D 3 PP3a nasal swab Weaner Healthy - - + + - 
167 29-Jun-11 Gopeng, Perak D 3 PP3b tongue swab Weaner Healthy - - - - - 
168 29-Jun-11 Gopeng, Perak D 3 PP3c rectal swab Weaner Healthy - - - - - 
169 29-Jun-11 Gopeng, Perak D 4 PP4a nasal swab Weaner Healthy - - - - - 
170 29-Jun-11 Gopeng, Perak D 4 PP4b tongue swab Weaner Healthy - - - - - 
171 29-Jun-11 Gopeng, Perak D 4 PP4c rectal swab Weaner Healthy - - - - - 
172 29-Jun-11 Gopeng, Perak D 5 PP5a nasal swab Weaner Healthy - - - - - 
173 29-Jun-11 Gopeng, Perak D 5 PP5b tongue swab Weaner Healthy - - - - - 
174 29-Jun-11 Gopeng, Perak D 5 PP5c rectal swab Weaner Healthy - - - - - 
175 29-Jun-11 Gopeng, Perak D 6 PP6a nasal swab Weaner Healthy - - - - - 
176 29-Jun-11 Gopeng, Perak D 6 PP6b tongue swab Weaner Healthy - - - - - 
177 29-Jun-11 Gopeng, Perak D 6 PP6c rectal swab Weaner Healthy - - - - - 
178 29-Jun-11 Gopeng, Perak D 7 PP7a nasal swab Weaner Healthy - - - - - 
179 29-Jun-11 Gopeng, Perak D 7 PP7b tongue swab Weaner Healthy - - - - - 
180 29-Jun-11 Gopeng, Perak D 7 PP7c rectal swab Weaner Healthy - - + + - 
181 29-Jun-11 Gopeng, Perak D 8 PP8a nasal swab Weaner Healthy - - - - - 
182 29-Jun-11 Gopeng, Perak D 8 PP8b tongue swab Weaner Healthy - - - - - 
183 29-Jun-11 Gopeng, Perak D 8 PP8c rectal swab Weaner Healthy - - - - - 
184 29-Jun-11 Gopeng, Perak D 9 PP9a nasal swab Grower Unhealthy - - - - - 
185 29-Jun-11 Gopeng, Perak D 9 PP9b tongue swab Grower Unhealthy - - - - - 
186 29-Jun-11 Gopeng, Perak D 9 PP9c rectal swab Grower Unhealthy - - - - - 
187 29-Jun-11 Gopeng, Perak D 10 PP10a nasal swab Grower Unhealthy - - - - - 
188 29-Jun-11 Gopeng, Perak D 10 PP10b tongue swab Grower Unhealthy - - - - - 
189 29-Jun-11 Gopeng, Perak D 10 PP10c rectal swab Grower Unhealthy - - - - - 
190 29-Jun-11 Gopeng, Perak D 11 PP11a nasal swab Grower Unhealthy - - - - - 
191 29-Jun-11 Gopeng, Perak D 11 PP11b tongue swab Grower Unhealthy - - - - - 
192 29-Jun-11 Gopeng, Perak D 11 PP11c rectal swab Grower Unhealthy - - - - - 
193 29-Jun-11 Gopeng, Perak D 12 PP12a nasal swab Grower Unhealthy - - - - - 
194 29-Jun-11 Gopeng, Perak D 12 PP12b tongue swab Grower Unhealthy - - - - - 
195 29-Jun-11 Gopeng, Perak D 12 PP12c rectal swab Grower Unhealthy - - + + - 
196 29-Jun-11 Gopeng, Perak D 13 PP13a nasal swab Weaner Unhealthy - - - - - 
197 29-Jun-11 Gopeng, Perak D 13 PP13b tongue swab Weaner Unhealthy - - - - - 
198 29-Jun-11 Gopeng, Perak D 13 PP13c rectal swab Weaner Unhealthy - - - - - 
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199 29-Jun-11 Gopeng, Perak D 14 PP14a nasal swab Weaner Unhealthy - - - - - 
200 29-Jun-11 Gopeng, Perak D 14 PP14b tongue swab Weaner Unhealthy - - - - - 
201 29-Jun-11 Gopeng, Perak D 14 PP14c rectal swab Weaner Unhealthy - - - - - 
202 29-Jun-11 Gopeng, Perak D 15 PP15a nasal swab Weaner Unhealthy - - - - - 
203 29-Jun-11 Gopeng, Perak D 15 PP15b tongue swab Weaner Unhealthy - - - - - 
204 29-Jun-11 Gopeng, Perak D 15 PP15c rectal swab Weaner Unhealthy - - - - - 
205 29-Jun-11 Gopeng, Perak D 16 PP16a nasal swab Weaner Unhealthy - - - - - 
206 29-Jun-11 Gopeng, Perak D 16 PP16b tongue swab Weaner Unhealthy - - + + - 
207 29-Jun-11 Gopeng, Perak D 16 PP16c rectal swab Weaner Unhealthy - - - - - 
208 29-Jun-11 Gopeng, Perak D 17 PP17a nasal swab Grower Healthy - - - - - 
209 29-Jun-11 Gopeng, Perak D 17 PP17b tongue swab Grower Healthy - - - - - 
210 29-Jun-11 Gopeng, Perak D 17 PP17c rectal swab Grower Healthy - - - - - 
211 29-Jun-11 Gopeng, Perak D 18 PP18a nasal swab Grower Healthy - - - - - 
212 29-Jun-11 Gopeng, Perak D 18 PP18b tongue swab Grower Healthy - - - - - 
213 29-Jun-11 Gopeng, Perak D 18 PP18c rectal swab Grower Healthy - - - - - 
214 29-Jun-11 Gopeng, Perak D 19 PP19a nasal swab Grower Healthy - - - - - 
215 29-Jun-11 Gopeng, Perak D 19 PP19b tongue swab Grower Healthy - - - - - 
216 29-Jun-11 Gopeng, Perak D 19 PP19c rectal swab Grower Healthy - - - - - 
217 29-Jun-11 Gopeng, Perak D 20 PP20a nasal swab Grower Healthy - - - - - 
218 29-Jun-11 Gopeng, Perak D 20 PP20b tongue swab Grower Healthy - - - - - 
219 29-Jun-11 Gopeng, Perak D 20 PP20c rectal swab Grower Healthy - - - - - 
220 29-Jun-11 Sungai Siput, Perak E 21 PP21a nasal swab Weaner Healthy - - - - - 
221 29-Jun-11 Sungai Siput, Perak E 21 PP21b tongue swab Weaner Healthy - - - - - 
222 29-Jun-11 Sungai Siput, Perak E 21 PP21c rectal swab Weaner Healthy - - - - - 
223 29-Jun-11 Sungai Siput, Perak E 22 PP22a nasal swab Weaner Healthy - - - - - 
224 29-Jun-11 Sungai Siput, Perak E 22 PP22b tongue swab Weaner Healthy - - - - - 
225 29-Jun-11 Sungai Siput, Perak E 22 PP22c rectal swab Weaner Healthy - - - - - 
226 29-Jun-11 Sungai Siput, Perak E 23 PP23a nasal swab Weaner Healthy - - - - - 
227 29-Jun-11 Sungai Siput, Perak E 23 PP23b tongue swab Weaner Healthy - - - - - 
228 29-Jun-11 Sungai Siput, Perak E 23 PP23c rectal swab Weaner Healthy - - - - - 
229 29-Jun-11 Sungai Siput, Perak E 24 PP24a nasal swab Weaner Healthy - - - - - 
230 29-Jun-11 Sungai Siput, Perak E 24 PP24b tongue swab Weaner Healthy - - - - - 
231 29-Jun-11 Sungai Siput, Perak E 24 PP24c rectal swab Weaner Healthy - - - - - 
232 29-Jun-11 Sungai Siput, Perak E 25 PP25a nasal swab Weaner Healthy - - - - - 
233 29-Jun-11 Sungai Siput, Perak E 25 PP25b tongue swab Weaner Healthy - - - - - 
234 29-Jun-11 Sungai Siput, Perak E 25 PP25c rectal swab Weaner Healthy - - - - - 
235 29-Jun-11 Sungai Siput, Perak E 26 PP26a nasal swab Weaner Healthy - - - - - 
236 29-Jun-11 Sungai Siput, Perak E 26 PP26b tongue swab Weaner Healthy - - - - - 
237 29-Jun-11 Sungai Siput, Perak E 26 PP26c rectal swab Weaner Healthy - - - - - 
238 29-Jun-11 Sungai Siput, Perak E 27 PP27a nasal swab Weaner Healthy - - - - - 
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239 29-Jun-11 Sungai Siput, Perak E 27 PP27b tongue swab Weaner Healthy - - - - - 
240 29-Jun-11 Sungai Siput, Perak E 27 PP27c rectal swab Weaner Healthy - - - - - 
241 29-Jun-11 Sungai Siput, Perak E 28 PP28a nasal swab Weaner Healthy - - - - - 
242 29-Jun-11 Sungai Siput, Perak E 28 PP28b tongue swab Weaner Healthy - - - - - 
243 29-Jun-11 Sungai Siput, Perak E 28 PP28c rectal swab Weaner Healthy - - - - - 
244 29-Jun-11 Sungai Siput, Perak E 29 PP29a nasal swab Weaner Unhealthy - - - - - 
245 29-Jun-11 Sungai Siput, Perak E 29 PP29b tongue swab Weaner Unhealthy - - - - - 
246 29-Jun-11 Sungai Siput, Perak E 29 PP29c rectal swab Weaner Unhealthy - - - - - 
247 29-Jun-11 Sungai Siput, Perak E 30 PP30a nasal swab Weaner Unhealthy - - - - - 
248 29-Jun-11 Sungai Siput, Perak E 30 PP30b tongue swab Weaner Unhealthy - - - - - 
249 29-Jun-11 Sungai Siput, Perak E 30 PP30c rectal swab Weaner Unhealthy - - - - - 
250 29-Jun-11 Sungai Siput, Perak E 31 PP31a nasal swab Weaner Unhealthy - - - - - 
251 29-Jun-11 Sungai Siput, Perak E 31 PP31b tongue swab Weaner Unhealthy - - - - - 
252 29-Jun-11 Sungai Siput, Perak E 31 PP31c rectal swab Weaner Unhealthy - - - - - 
253 29-Jun-11 Sungai Siput, Perak E 32 PP32a nasal swab Weaner Unhealthy - - - - - 
254 29-Jun-11 Sungai Siput, Perak E 32 PP32b tongue swab Weaner Unhealthy - - - - - 
255 29-Jun-11 Sungai Siput, Perak E 32 PP32c rectal swab Weaner Unhealthy - - - - - 
256 29-Jun-11 Sungai Siput, Perak E 33 PP33a nasal swab Weaner Unhealthy - - - - - 
257 29-Jun-11 Sungai Siput, Perak E 33 PP33b tongue swab Weaner Unhealthy - - - - - 
258 29-Jun-11 Sungai Siput, Perak E 33 PP33c rectal swab Weaner Unhealthy - - - - - 
259 29-Jun-11 Sungai Siput, Perak E 34 PP34a nasal swab Weaner Unhealthy - - - - - 
260 29-Jun-11 Sungai Siput, Perak E 34 PP34b tongue swab Weaner Unhealthy - - - - - 
261 29-Jun-11 Sungai Siput, Perak E 34 PP34c rectal swab Weaner Unhealthy - - - - - 
262 29-Jun-11 Sungai Siput, Perak E 35 PP35a nasal swab Weaner Unhealthy - - - - - 
263 29-Jun-11 Sungai Siput, Perak E 35 PP35b tongue swab Weaner Unhealthy - - - - - 
264 29-Jun-11 Sungai Siput, Perak E 35 PP35c rectal swab Weaner Unhealthy - - - - - 
265 29-Jun-11 Sungai Siput, Perak E 36 PP36a nasal swab Weaner Unhealthy - - - - - 
266 29-Jun-11 Sungai Siput, Perak E 36 PP36b tongue swab Weaner Unhealthy - - - - - 
267 29-Jun-11 Sungai Siput, Perak E 36 PP36c rectal swab Weaner Unhealthy - - - - - 
268 29-Jun-11 Sungai Siput, Perak E 37 PP37a nasal swab Grower Healthy - - - - - 
269 29-Jun-11 Sungai Siput, Perak E 37 PP37b tongue swab Grower Healthy - - - - - 
270 29-Jun-11 Sungai Siput, Perak E 37 PP37c rectal swab Grower Healthy - - - - - 
271 29-Jun-11 Sungai Siput, Perak E 38 PP38a nasal swab Grower Healthy - - - - - 
272 29-Jun-11 Sungai Siput, Perak E 38 PP38b tongue swab Grower Healthy - - - - - 
273 29-Jun-11 Sungai Siput, Perak E 38 PP38c rectal swab Grower Healthy - - + - + 
274 29-Jun-11 Sungai Siput, Perak E 39 PP39a nasal swab Grower Healthy - - - - - 
275 29-Jun-11 Sungai Siput, Perak E 39 PP39b tongue swab Grower Healthy - - - - - 
276 29-Jun-11 Sungai Siput, Perak E 39 PP39c rectal swab Grower Healthy - - - - - 
277 29-Jun-11 Sungai Siput, Perak E 40 PP40a nasal swab Grower Healthy - - - - - 
278 29-Jun-11 Sungai Siput, Perak E 40 PP40b tongue swab Grower Healthy - - - - - 
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279 29-Jun-11 Sungai Siput, Perak E 40 PP40c rectal swab Grower Healthy - - - - - 
280 30-Jun-11 Sungai Siput, Perak F 41 PP41a nasal swab Weaner Healthy - - - - - 
281 30-Jun-11 Sungai Siput, Perak F 41 PP41b tongue swab Weaner Healthy - - - - - 
282 30-Jun-11 Sungai Siput, Perak F 41 PP41c rectal swab Weaner Healthy - - - - - 
283 30-Jun-11 Sungai Siput, Perak F 42 PP42a nasal swab Weaner Healthy - - - - - 
284 30-Jun-11 Sungai Siput, Perak F 42 PP42b tongue swab Weaner Healthy - - - - - 
285 30-Jun-11 Sungai Siput, Perak F 42 PP42c rectal swab Weaner Healthy - - - - - 
286 30-Jun-11 Sungai Siput, Perak F 43 PP43a nasal swab Weaner Healthy - - - - - 
287 30-Jun-11 Sungai Siput, Perak F 43 PP43b tongue swab Weaner Healthy - - + + + 
288 30-Jun-11 Sungai Siput, Perak F 43 PP43c rectal swab Weaner Healthy - - - - - 
289 30-Jun-11 Sungai Siput, Perak F 44 PP44a nasal swab Weaner Healthy - - - - - 
290 30-Jun-11 Sungai Siput, Perak F 44 PP44b tongue swab Weaner Healthy - - - - - 
291 30-Jun-11 Sungai Siput, Perak F 44 PP44c rectal swab Weaner Healthy - - - - - 
292 30-Jun-11 Sungai Siput, Perak F 45 PP45a nasal swab Weaner Healthy - - + + + 
293 30-Jun-11 Sungai Siput, Perak F 45 PP45b tongue swab Weaner Healthy - - - - - 
294 30-Jun-11 Sungai Siput, Perak F 45 PP45c rectal swab Weaner Healthy - - - - - 
295 30-Jun-11 Sungai Siput, Perak F 46 PP46a nasal swab Weaner Healthy - - + + + 
296 30-Jun-11 Sungai Siput, Perak F 46 PP46b tongue swab Weaner Healthy - - + + + 
297 30-Jun-11 Sungai Siput, Perak F 46 PP46c rectal swab Weaner Healthy - - - - - 
298 30-Jun-11 Sungai Siput, Perak F 47 PP47a nasal swab Weaner Healthy - - + + + 
299 30-Jun-11 Sungai Siput, Perak F 47 PP47b tongue swab Weaner Healthy - - + + + 
300 30-Jun-11 Sungai Siput, Perak F 47 PP47c rectal swab Weaner Healthy - - + + - 
301 30-Jun-11 Sungai Siput, Perak F 48 PP48a nasal swab Weaner Healthy - - + - + 
302 30-Jun-11 Sungai Siput, Perak F 48 PP48b tongue swab Weaner Healthy - - + + + 
303 30-Jun-11 Sungai Siput, Perak F 48 PP48c rectal swab Weaner Healthy - - - - - 
304 30-Jun-11 Sungai Siput, Perak F 49 PP49a nasal swab Weaner Unhealthy - - + - + 
305 30-Jun-11 Sungai Siput, Perak F 49 PP49b tongue swab Weaner Unhealthy - - + + + 
306 30-Jun-11 Sungai Siput, Perak F 49 PP49c rectal swab Weaner Unhealthy - - - - - 
307 30-Jun-11 Sungai Siput, Perak F 50 PP50a nasal swab Weaner Unhealthy - - + + + 
308 30-Jun-11 Sungai Siput, Perak F 50 PP50b tongue swab Weaner Unhealthy - - + + + 
309 30-Jun-11 Sungai Siput, Perak F 50 PP50c rectal swab Weaner Unhealthy - - + + - 
310 30-Jun-11 Sungai Siput, Perak F 51 PP51a nasal swab Weaner Unhealthy - - + + + 
311 30-Jun-11 Sungai Siput, Perak F 51 PP51b tongue swab Weaner Unhealthy - - + + + 
312 30-Jun-11 Sungai Siput, Perak F 51 PP51c rectal swab Weaner Unhealthy - - - - - 
313 30-Jun-11 Sungai Siput, Perak F 52 PP52a nasal swab Weaner Unhealthy - - + + + 
314 30-Jun-11 Sungai Siput, Perak F 52 PP52b tongue swab Weaner Unhealthy - - - - - 
315 30-Jun-11 Sungai Siput, Perak F 52 PP52c rectal swab Weaner Unhealthy - - + - / 
316 30-Jun-11 Sungai Siput, Perak F 53 PP53a nasal swab Weaner Unhealthy - - - - - 
317 30-Jun-11 Sungai Siput, Perak F 53 PP53b tongue swab Weaner Unhealthy - - + + + 
318 30-Jun-11 Sungai Siput, Perak F 53 PP53c rectal swab Weaner Unhealthy - - + + + 
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319 30-Jun-11 Sungai Siput, Perak F 54 PP54a nasal swab Weaner Unhealthy - - + + + 
320 30-Jun-11 Sungai Siput, Perak F 54 PP54b tongue swab Weaner Unhealthy - - + + + 
321 30-Jun-11 Sungai Siput, Perak F 54 PP54c rectal swab Weaner Unhealthy - - - - - 
322 30-Jun-11 Sungai Siput, Perak F 55 PP55a nasal swab Weaner Unhealthy - - + - + 
323 30-Jun-11 Sungai Siput, Perak F 55 PP55b tongue swab Weaner Unhealthy - - + - + 
324 30-Jun-11 Sungai Siput, Perak F 55 PP55c rectal swab Weaner Unhealthy - - - - - 
325 30-Jun-11 Sungai Siput, Perak F 56 PP56a nasal swab Weaner Unhealthy - - - - - 
326 30-Jun-11 Sungai Siput, Perak F 56 PP56b tongue swab Weaner Unhealthy - - - - - 
327 30-Jun-11 Sungai Siput, Perak F 56 PP56c rectal swab Weaner Unhealthy - - - - - 
328 30-Jun-11 Sungai Siput, Perak F 57 PP57a nasal swab Sow Healthy - - - - - 
329 30-Jun-11 Sungai Siput, Perak F 57 PP57b tongue swab Sow Healthy - - - - - 
330 30-Jun-11 Sungai Siput, Perak F 57 PP57c rectal swab Sow Healthy - - - - - 
331 30-Jun-11 Sungai Siput, Perak F 58 PP58a nasal swab Sow Healthy - - - - - 
332 30-Jun-11 Sungai Siput, Perak F 58 PP58b tongue swab Sow Healthy - - - - - 
333 30-Jun-11 Sungai Siput, Perak F 58 PP58c rectal swab Sow Healthy - - - - - 
334 30-Jun-11 Sungai Siput, Perak F 59 PP59a nasal swab Finisher Healthy - - + - + 
335 30-Jun-11 Sungai Siput, Perak F 59 PP59b tongue swab Finisher Healthy - - + - + 
336 30-Jun-11 Sungai Siput, Perak F 59 PP59c rectal swab Finisher Healthy - - - - - 
337 30-Jun-11 Sungai Siput, Perak F 60 PP60a nasal swab Finisher Healthy - - + + + 
338 30-Jun-11 Sungai Siput, Perak F 60 PP60b tongue swab Finisher Healthy - - + - + 
339 30-Jun-11 Sungai Siput, Perak F 60 PP60c rectal swab Finisher Healthy - - + - + 
340 24-Sep-11 Sungai Jawi, Penang G 1 PPN1a nasal swab Weaner Healthy - - - - - 
341 24-Sep-11 Sungai Jawi, Penang G 1 PPN1b tongue swab Weaner Healthy - - - - - 
342 24-Sep-11 Sungai Jawi, Penang G 1 PPN1c rectal swab Weaner Healthy - - - - - 
343 24-Sep-11 Sungai Jawi, Penang G 2 PPN2a nasal swab Weaner Healthy - - - - - 
344 24-Sep-11 Sungai Jawi, Penang G 2 PPN2b tongue swab Weaner Healthy - - - - - 
345 24-Sep-11 Sungai Jawi, Penang G 2 PPN2c rectal swab Weaner Healthy - - - - - 
346 24-Sep-11 Sungai Jawi, Penang G 3 PPN3a nasal swab Grower Healthy - - - - - 
347 24-Sep-11 Sungai Jawi, Penang G 3 PPN3b tongue swab Grower Healthy - - - - - 
348 24-Sep-11 Sungai Jawi, Penang G 3 PPN3c rectal swab Grower Healthy - - - - - 
349 24-Sep-11 Sungai Jawi, Penang G 4 PPN4a nasal swab Grower Healthy - - - - - 
350 24-Sep-11 Sungai Jawi, Penang G 4 PPN4b tongue swab Grower Healthy - - - - - 
351 24-Sep-11 Sungai Jawi, Penang G 4 PPN4c rectal swab Grower Healthy - - - - - 
352 24-Sep-11 Sungai Jawi, Penang G 5 PPN5a nasal swab Weaner Unhealthy - - - - - 
353 24-Sep-11 Sungai Jawi, Penang G 5 PPN5b tongue swab Weaner Unhealthy - - - - - 
354 24-Sep-11 Sungai Jawi, Penang G 5 PPN5c rectal swab Weaner Unhealthy - - - - - 
355 24-Sep-11 Sungai Jawi, Penang G 6 PPN6a nasal swab Weaner Unhealthy - - - - - 
356 24-Sep-11 Sungai Jawi, Penang G 6 PPN6b tongue swab Weaner Unhealthy - - - - - 
357 24-Sep-11 Sungai Jawi, Penang G 6 PPN6c rectal swab Weaner Unhealthy - - - - - 
358 24-Sep-11 Sungai Jawi, Penang G 7 PPN7a nasal swab Weaner Healthy - - - - - 
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359 24-Sep-11 Sungai Jawi, Penang G 7 PPN7b tongue swab Weaner Healthy - - - - - 
360 24-Sep-11 Sungai Jawi, Penang G 7 PPN7c rectal swab Weaner Healthy - - - - - 
361 24-Sep-11 Sungai Jawi, Penang G 8 PPN8a nasal swab Weaner Healthy - - - - - 
362 24-Sep-11 Sungai Jawi, Penang G 8 PPN8b tongue swab Weaner Healthy - - - - - 
363 24-Sep-11 Sungai Jawi, Penang G 8 PPN8c rectal swab Weaner Healthy - - - - - 
364 24-Sep-11 Sungai Jawi, Penang G 9 PPN9a nasal swab Weaner Healthy - - - - - 
365 24-Sep-11 Sungai Jawi, Penang G 9 PPN9b tongue swab Weaner Healthy - - - - - 
366 24-Sep-11 Sungai Jawi, Penang G 9 PPN9c rectal swab Weaner Healthy - - - - - 
367 24-Sep-11 Sungai Jawi, Penang G 10 PPN10a nasal swab Weaner Healthy - - - - - 
368 24-Sep-11 Sungai Jawi, Penang G 10 PPN10b tongue swab Weaner Healthy - - + + - 
369 24-Sep-11 Sungai Jawi, Penang G 10 PPN10c rectal swab Weaner Healthy - - - - - 
370 24-Sep-11 Sungai Jawi, Penang G 11 PPN11a nasal swab Weaner Healthy - - - - - 
371 24-Sep-11 Sungai Jawi, Penang G 11 PPN11b tongue swab Weaner Healthy - - - - - 
372 24-Sep-11 Sungai Jawi, Penang G 11 PPN11c rectal swab Weaner Healthy - - - - - 
373 24-Sep-11 Sungai Jawi, Penang G 12 PPN12a nasal swab Weaner Healthy - - - - - 
374 24-Sep-11 Sungai Jawi, Penang G 12 PPN12b tongue swab Weaner Healthy - - - - - 
375 24-Sep-11 Sungai Jawi, Penang G 12 PPN12c rectal swab Weaner Healthy - - - - - 
376 24-Sep-11 Sungai Jawi, Penang G 13 PPN13a nasal swab Weaner Healthy - - - - - 
377 24-Sep-11 Sungai Jawi, Penang G 13 PPN13b tongue swab Weaner Healthy - - - - - 
378 24-Sep-11 Sungai Jawi, Penang G 13 PPN13c rectal swab Weaner Healthy - - - - - 
379 24-Sep-11 Sungai Jawi, Penang G 14 PPN14a nasal swab Weaner Healthy - - - - - 
380 24-Sep-11 Sungai Jawi, Penang G 14 PPN14b tongue swab Weaner Healthy - - - - - 
381 24-Sep-11 Sungai Jawi, Penang G 14 PPN14c rectal swab Weaner Healthy - - - - - 
382 24-Sep-11 Sungai Jawi, Penang G 15 PPN15a nasal swab Grower Healthy - - - - - 
383 24-Sep-11 Sungai Jawi, Penang G 15 PPN15b tongue swab Grower Healthy - - - - - 
384 24-Sep-11 Sungai Jawi, Penang G 15 PPN15c rectal swab Grower Healthy - - - - - 
385 24-Sep-11 Sungai Jawi, Penang G 16 PPN16a nasal swab Grower Healthy - - - - - 
386 24-Sep-11 Sungai Jawi, Penang G 16 PPN16b tongue swab Grower Healthy - - - - - 
387 24-Sep-11 Sungai Jawi, Penang G 16 PPN16c rectal swab Grower Healthy - - - - - 
388 24-Sep-11 Kg. Selamat, Penang H 21 PPN21a nasal swab Weaner Healthy - - - - - 
389 24-Sep-11 Kg. Selamat, Penang H 21 PPN21b tongue swab Weaner Healthy - - - - - 
390 24-Sep-11 Kg. Selamat, Penang H 21 PPN21c rectal swab Weaner Healthy - - - - - 
391 24-Sep-11 Kg. Selamat, Penang H 22 PPN22a nasal swab Weaner Healthy - - - - - 
392 24-Sep-11 Kg. Selamat, Penang H 22 PPN22b tongue swab Weaner Healthy - - - - - 
393 24-Sep-11 Kg. Selamat, Penang H 22 PPN22c rectal swab Weaner Healthy - - - - - 
394 24-Sep-11 Kg. Selamat, Penang H 23 PPN23a nasal swab Weaner Unhealthy - - - - - 
395 24-Sep-11 Kg. Selamat, Penang H 23 PPN23b tongue swab Weaner Unhealthy - - - - - 
396 24-Sep-11 Kg. Selamat, Penang H 23 PPN23c rectal swab Weaner Unhealthy - - - - - 
397 24-Sep-11 Kg. Selamat, Penang H 24 PPN24a nasal swab Weaner Unhealthy - - - - - 
398 24-Sep-11 Kg. Selamat, Penang H 24 PPN24b tongue swab Weaner Unhealthy - - - - - 
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399 24-Sep-11 Kg. Selamat, Penang H 24 PPN24c rectal swab Weaner Unhealthy - - - - - 
400 24-Sep-11 Kg. Selamat, Penang H 25 PPN25a nasal swab Weaner Healthy - - - - - 
401 24-Sep-11 Kg. Selamat, Penang H 25 PPN25b tongue swab Weaner Healthy - - - - - 
402 24-Sep-11 Kg. Selamat, Penang H 25 PPN25c rectal swab Weaner Healthy - - - - - 
403 24-Sep-11 Kg. Selamat, Penang H 26 PPN26a nasal swab Weaner Healthy - - - - - 
404 24-Sep-11 Kg. Selamat, Penang H 26 PPN26b tongue swab Weaner Healthy - - - - - 
405 24-Sep-11 Kg. Selamat, Penang H 26 PPN26c rectal swab Weaner Healthy - - - - - 
406 24-Sep-11 Kg. Selamat, Penang H 27 PPN27a nasal swab Weaner Healthy - - - - - 
407 24-Sep-11 Kg. Selamat, Penang H 27 PPN27b tongue swab Weaner Healthy - - - - - 
408 24-Sep-11 Kg. Selamat, Penang H 27 PPN27c rectal swab Weaner Healthy - - - - - 
409 24-Sep-11 Kg. Selamat, Penang H 28 PPN28a nasal swab Weaner Unhealthy - - - - - 
410 24-Sep-11 Kg. Selamat, Penang H 28 PPN28b tongue swab Weaner Unhealthy - - - - - 
411 24-Sep-11 Kg. Selamat, Penang H 28 PPN28c rectal swab Weaner Unhealthy - - - - - 
412 24-Sep-11 Kg. Selamat, Penang H 29 PPN29a nasal swab Weaner Healthy - - + + - 
413 24-Sep-11 Kg. Selamat, Penang H 29 PPN29b tongue swab Weaner Healthy - - + + - 
414 24-Sep-11 Kg. Selamat, Penang H 29 PPN29c rectal swab Weaner Healthy - - + + - 
415 24-Sep-11 Kg. Selamat, Penang H 30 PPN30a nasal swab Weaner Unhealthy - - - - - 
416 24-Sep-11 Kg. Selamat, Penang H 30 PPN30b tongue swab Weaner Unhealthy - - - - - 
417 24-Sep-11 Kg. Selamat, Penang H 30 PPN30c rectal swab Weaner Unhealthy - - - - - 
418 24-Sep-11 Kg. Selamat, Penang H 31 PPN31a nasal swab Weaner Unhealthy - - - - - 
419 24-Sep-11 Kg. Selamat, Penang H 31 PPN31b tongue swab Weaner Unhealthy - - - - - 
420 24-Sep-11 Kg. Selamat, Penang H 31 PPN31c rectal swab Weaner Unhealthy - - - - - 
421 24-Sep-11 Kg. Selamat, Penang H 32 PPN32a nasal swab Weaner Healthy - - - - - 
422 24-Sep-11 Kg. Selamat, Penang H 32 PPN32b tongue swab Weaner Healthy - - - - - 
423 24-Sep-11 Kg. Selamat, Penang H 32 PPN32c rectal swab Weaner Healthy - - - - - 
424 24-Sep-11 Kg. Selamat, Penang H 33 PPN33a nasal swab Weaner Unhealthy - - - - - 
425 24-Sep-11 Kg. Selamat, Penang H 33 PPN33b tongue swab Weaner Unhealthy - - - - - 
426 24-Sep-11 Kg. Selamat, Penang H 33 PPN33c rectal swab Weaner Unhealthy - - - - - 
427 24-Sep-11 Kg. Selamat, Penang H 34 PPN34a nasal swab Weaner Healthy - - - - - 
428 24-Sep-11 Kg. Selamat, Penang H 34 PPN34b tongue swab Weaner Healthy - - - - - 
429 24-Sep-11 Kg. Selamat, Penang H 34 PPN34c rectal swab Weaner Healthy - - - - - 
430 24-Sep-11 Kg. Selamat, Penang H 35 PPN35a nasal swab Weaner Healthy - - - - - 
431 24-Sep-11 Kg. Selamat, Penang H 35 PPN35b tongue swab Weaner Healthy - - - - - 
432 24-Sep-11 Kg. Selamat, Penang H 35 PPN35c rectal swab Weaner Healthy - - - - - 
433 24-Sep-11 Kg. Selamat, Penang H 36 PPN36a nasal swab Weaner Healthy - - - - - 
434 24-Sep-11 Kg. Selamat, Penang H 36 PPN36b tongue swab Weaner Healthy - - - - - 
435 24-Sep-11 Kg. Selamat, Penang H 36 PPN36c rectal swab Weaner Healthy - - - - - 
436 24-Sep-11 Kg. Selamat, Penang H 37 PPN37a nasal swab Grower Healthy - - + + - 
437 24-Sep-11 Kg. Selamat, Penang H 37 PPN37b tongue swab Grower Healthy - - - - - 
438 24-Sep-11 Kg. Selamat, Penang H 37 PPN37c rectal swab Grower Healthy - - - - - 
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439 24-Sep-11 Kg. Selamat, Penang H 38 PPN38a nasal swab Grower Healthy - - + + - 
440 24-Sep-11 Kg. Selamat, Penang H 38 PPN38b tongue swab Grower Healthy - - - - - 
441 24-Sep-11 Kg. Selamat, Penang H 38 PPN38c rectal swab Grower Healthy - - - - - 
442 24-Sep-11 Kg. Selamat, Penang H 39 PPN39a nasal swab Grower Healthy - - + + - 
443 24-Sep-11 Kg. Selamat, Penang H 39 PPN39b tongue swab Grower Healthy - - + + - 
444 24-Sep-11 Kg. Selamat, Penang H 39 PPN39c rectal swab Grower Healthy - - - - - 
445 24-Sep-11 Kg. Selamat, Penang H 40 PPN40a nasal swab Grower Healthy - - + + - 
446 24-Sep-11 Kg. Selamat, Penang H 40 PPN40b tongue swab Grower Healthy - - + + - 
447 24-Sep-11 Kg. Selamat, Penang H 40 PPN40c rectal swab Grower Healthy - - + + - 
448 24-Sep-11 Kg. Selamat, Penang I 41 PPN41a nasal swab Weaner Healthy - - - - - 
449 24-Sep-11 Kg. Selamat, Penang I 41 PPN41b tongue swab Weaner Healthy - - - - - 
450 24-Sep-11 Kg. Selamat, Penang I 41 PPN41c rectal swab Weaner Healthy - - - - - 
451 24-Sep-11 Kg. Selamat, Penang I 42 PPN42a nasal swab Weaner Healthy - - - - - 
452 24-Sep-11 Kg. Selamat, Penang I 42 PPN42b tongue swab Weaner Healthy - - + + - 
453 24-Sep-11 Kg. Selamat, Penang I 42 PPN42c rectal swab Weaner Healthy - - - - - 
454 24-Sep-11 Kg. Selamat, Penang I 43 PPN43a nasal swab Weaner Unhealthy - - - - - 
455 24-Sep-11 Kg. Selamat, Penang I 43 PPN43b tongue swab Weaner Unhealthy - - + + - 
456 24-Sep-11 Kg. Selamat, Penang I 43 PPN43c rectal swab Weaner Unhealthy - - - - - 
457 24-Sep-11 Kg. Selamat, Penang I 44 PPN44a nasal swab Weaner Unhealthy - - - - - 
458 24-Sep-11 Kg. Selamat, Penang I 44 PPN44b tongue swab Weaner Unhealthy - - - - - 
459 24-Sep-11 Kg. Selamat, Penang I 44 PPN44c rectal swab Weaner Unhealthy - - - - - 
460 24-Sep-11 Kg. Selamat, Penang I 45 PPN45a nasal swab Weaner Unhealthy - - - - - 
461 24-Sep-11 Kg. Selamat, Penang I 45 PPN45b tongue swab Weaner Unhealthy - - - - - 
462 24-Sep-11 Kg. Selamat, Penang I 45 PPN45c rectal swab Weaner Unhealthy - - - - - 
463 24-Sep-11 Kg. Selamat, Penang I 46 PPN46a nasal swab Weaner Healthy - - - - - 
464 24-Sep-11 Kg. Selamat, Penang I 46 PPN46b tongue swab Weaner Healthy - - - - - 
465 24-Sep-11 Kg. Selamat, Penang I 46 PPN46c rectal swab Weaner Healthy - - - - - 
466 24-Sep-11 Kg. Selamat, Penang I 47 PPN47a nasal swab Weaner Healthy - - + + - 
467 24-Sep-11 Kg. Selamat, Penang I 47 PPN47b tongue swab Weaner Healthy - - - - - 
468 24-Sep-11 Kg. Selamat, Penang I 47 PPN47c rectal swab Weaner Healthy - - - - - 
469 24-Sep-11 Kg. Selamat, Penang I 48 PPN48a nasal swab Weaner Healthy - - - - - 
470 24-Sep-11 Kg. Selamat, Penang I 48 PPN48b tongue swab Weaner Healthy - - - - - 
471 24-Sep-11 Kg. Selamat, Penang I 48 PPN48c rectal swab Weaner Healthy - - + + - 
472 24-Sep-11 Kg. Selamat, Penang I 49 PPN49a nasal swab Grower Unhealthy - - - - - 
473 24-Sep-11 Kg. Selamat, Penang I 49 PPN49b tongue swab Grower Unhealthy - - - - - 
474 24-Sep-11 Kg. Selamat, Penang I 49 PPN49c rectal swab Grower Unhealthy - - - - - 
475 24-Sep-11 Kg. Selamat, Penang I 50 PPN50a nasal swab Grower healthy - - - - - 
476 24-Sep-11 Kg. Selamat, Penang I 50 PPN50b tongue swab Grower Healthy - - - - - 
477 24-Sep-11 Kg. Selamat, Penang I 50 PPN50c rectal swab Grower Healthy - - + + - 
478 24-Sep-11 Kg. Selamat, Penang I 51 PPN51a nasal swab Grower Healthy - - - - - 
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479 24-Sep-11 Kg. Selamat, Penang I 51 PPN51b tongue swab Grower Healthy - - - - - 
480 24-Sep-11 Kg. Selamat, Penang I 51 PPN51c rectal swab Grower Healthy - - + + - 
481 24-Sep-11 Kg. Selamat, Penang I 52 PPN52a nasal swab Grower Healthy - - + + - 
482 24-Sep-11 Kg. Selamat, Penang I 52 PPN52b tongue swab Grower Healthy - - - - - 
483 24-Sep-11 Kg. Selamat, Penang I 52 PPN52c rectal swab Grower Healthy - - - - - 
484 24-Sep-11 Kg. Selamat, Penang I 53 PPN53a nasal swab Grower Healthy + + + + + 
485 24-Sep-11 Kg. Selamat, Penang I 53 PPN53b tongue swab Grower Healthy - - - - - 
486 24-Sep-11 Kg. Selamat, Penang I 53 PPN53c rectal swab Grower Healthy - - - - - 
487 24-Sep-11 Kg. Selamat, Penang I 54 PPN54a nasal swab Grower Healthy - - - - - 
488 24-Sep-11 Kg. Selamat, Penang I 54 PPN54b tongue swab Grower Healthy - - - - - 
489 24-Sep-11 Kg. Selamat, Penang I 54 PPN54c rectal swab Grower Healthy - - + + - 
490 24-Sep-11 Kg. Selamat, Penang I 55 PPN55a nasal swab Grower Healthy + + + + + 
491 24-Sep-11 Kg. Selamat, Penang I 55 PPN55b tongue swab Grower Healthy + + + + + 
492 24-Sep-11 Kg. Selamat, Penang I 55 PPN55c rectal swab Grower Healthy + + + + + 
493 24-Sep-11 Kg. Selamat, Penang I 56 PPN56a nasal swab Grower Healthy + + + + + 
494 24-Sep-11 Kg. Selamat, Penang I 56 PPN56b tongue swab Grower Healthy + + + + + 
495 24-Sep-11 Kg. Selamat, Penang I 56 PPN56c rectal swab Grower Healthy + + + + + 
APPENDIX VIII   BIOCHEMICAL TESTS, API 20E AND BIOGROUPING 
 
153 
 
 
APPENDIX VII PRELIMINARY BIOCHEMICAL TESTS 
 
 
1. Gram determination by using KOH string test (3% KOH solution) 
Fresh bacteria culture was picked with sterile pipette tip and suspended in 20 µl 3%  
KOH. Pipette tip was lifted after 60 s. 
 
 Interpretation:  
a, uninoculated 
b, Gram negative (bacteria string, Y. enterocolitica ATCC 9610) 
c, Gram positive (no bacteria string, Listeria monocytogenes ATCC 7644) 
 
2. Citrate test (Simmon’s citrate agar) 
A fresh single well-isolated colony was picked from NA and was streaked on the 
surface of the slant. The tube was incubated at 37±2ºC for 18-24 hours. Colour 
changes was observed 
Representative photo of citrate test Interpretation 
 
a, citrate positive (agar turned blue, C. 
freundii) 
b, citrate negative (agar unchanged, Y. 
enterocolitica ATCC 9610) 
c, uninoculated. 
 
 
3. Oxidase test (N,N,N’,N’-tetramethyl-p-phenylenediamine solution) 
A fresh single well-isolated colony was picked from NA by a sterile toothpick and 
touched onto a piece of filter paper that contained oxidase reagent. Colour changed 
to purple within 10 sec indicated positive; 10-60 sec indicated delayed positive; and 
more than 60 sec considered as negative. 
Representative photo of oxidase test Interpretation 
 
a, uninoculated 
b, oxidase negative bacterium (colour 
unchanged, Y. enterocolitica ATCC 9610) 
c, oxidase positive bacterium (colony turned 
blue, Vibrio cholera) 
 
4. Urease test  
Representative photo of urease test Interpretation 
 
a, urease positive (agar turned pink, Y. 
enterocolitica ATCC 9610) 
 
b, urease negative (agar unchanged, E. coli 
ATCC 25922) 
 
c, uninoculated 
 
a b c 
a b 
c 
a b c 
a 
b 
c 
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APPENDIX VIII API 20E, DUPLEX PCR AND API50CH  
 
1. API 20E identification kit 
Fresh culture (18-24 hours) was diluted using sterile 0.85% NaCl solution and 0.5 
McFarland was achieved. The cell culture was inoculated into wells of API 20E strip 
according to the instruction shown in API 20E manual and incubated at 37±2ºC and 
result was taken within 18-24 hours. After incubation of 37±2ºC, the results on the strip 
were referred to interpretation table for the identification. There were reagents needed to 
be added before the results were recorded. For examples, TDA test: one drop of TDA 
reagent was added. Dark brown colour showed positive result; IND test: one drop of 
JAMES reagent was added. Pink colour indicated positive result; VP test: one drop of 
α-napthtol was added and followed by one drop of 40% KOH solution. Pink or red 
colour formation after 10 min showed positive result. Identification software was used 
and results were coded into the Numerical profile before the database process by 
computer. 
 
2. Summary of biochemical reactions of Y. enterocolitica on API 20E 
identification kit. 
Tests Results 
Positive Negative Y. 
enterocolitica 
Ortho nitrophenyl-β-
galactosidase (ONPG) 
Yellow Colourless + 
Arginine dihydrolase (ADH) Red – orange Yellow - 
Lysine decarboxylase (LDC) Red – orange Yellow - 
Ornithine decarboxylase (ODC) Red – orange Yellow +/- 
Citrate utilization (CIT) Blue Light green - 
H2S production (H2S) Black Colourless - 
Urease production (URE) Red – orange Yellow + 
Tryptophane deaminase (TDA) Brown – red Yellow - 
Indole production (IND) Red Yellow +/- 
Voges-Proskauer (VP) Light red – red Colourless +/- 
Gelatinase production (GEL) Black  - 
D-Glucose (GLU) Yellow Blue – green + 
D-Mannitol (MAN) Yellow Blue – green + 
Inositol (INO) Yellow Blue – green +/- 
D-Sorbitol (SOR) Yellow Blue – green + 
L-Rhamnose (RHA) Yellow Blue – green - 
D-Sacharose (SAC) Yellow Blue – green + 
D-Melibiose (MEL) Yellow Blue – green +/- 
Amygdalin (AMY) Yellow Blue – green +/- 
L-Arabinose (ARA) Yellow Blue – green + 
Oxidase (OX) Violet – blue Colourless - 
NO2 production/reduction to N2 
gas (NO3 – NO2) 
Red Yellow + 
+, positive; -, negative. 
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3. Raw Data for API 20E, Duplex PCR and API50CH of Y. enterocolitica 
No. Isolates Name 
API 20E PCR 
API 50CH (ID, %) 
code % 
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1 PCM-PPN53a-1 1114523 99.7% + - - + - - + - - - - + + - + - + - + + - + + - 
2 PCM-PPN53a-2 1114523 99.7% + - - + - - + - - - - + + - + - + - + + - + + - 
3 PCM-PPN53a-3 1014522 93.9% + - - - - - + - - - - + + - + - + - - + - + + - 
4 PCM-PPN53a-4 1114523 99.7% + - - + - - + - - - - + + - + - + - + + - + + - 
5 PCM-PPN53a-K1 1014522 93.9% + - - - - - + - - - - + + - + - + - - + - + + - 
6 PCM-PPN53a-K2 1014522 93.9% + - - - - - + - - - - + + - + - + - - + - + + - 
7 PCM-PPN53a-K3 1114523 99.7% + - - + - - + - - - - + + - + - + - + + - + + - 
8 PCM-PPN53a-K4 1014522 93.9% + - - - - - + - - - - + + - + - + - - + - + + - 
9 DCM-PPN55a-1 1114523 99.7% + - - + - - + - - - - + + - + - + - + + - + + - 
10 DCM-PPN55a-2 1014522 93.9% + - - - - - + - - - - + + - + - + - - + - + + - 
11 DCM-PPN55a-3 1114523 99.7% + - - + - - + - - - - + + - + - + - + + - + + - 
12 DCM-PPN55a-4 1014522 93.9% + - - - - - + - - - - + + - + - + - - + - + + - 
13 PCM-PPN55a-1 1104523 95.7% + - - - - - + - - - - + + - + - + - + + - + + - 
14 PCM-PPN55a-2 1014522 93.9% + - - - - - + - - - - + + - + - + - - + - + + - 
15 PCM-PPN55a-3 1014522 93.9% + - - - - - + - - - - + + - + - + - - + - + + - 
16 PCM-PPN55a-4 1014522 93.9% + - - - - - + - - - - + + - + - + - - + - + + - 
17 PCM-PPN55a-K1 1114523 99.7% + - - + - - + - - - - + + - + - + - + + - + + - 
18 PCM-PPN55a-K2 1014522 93.9% + - - - - - + - - - - + + - + - + - - + - + + - 
19 PCM-PPN55a-K3 1014523 93.9% + - - - - - + - - - - + + - + - + - + + - + + - 
20 PCM-PPN55a-K4 1014522 93.9% + - - - - - + - - - - + + - + - + - - + - + + - 
21 PCM-PPN55b-1 1114522 99.9% + - - + - - + - - - - + + - + - + - - + - + + - 
22 PCM-PPN55b-2 1114523 99.7% + - - + - - + - - - - + + - + - + - + + - + + - 
23 PCM-PPN55b-3 1014522 93.9% + - - - - - + - - - - + + - + - + - - + - + + - 
24 PCM-PPN55b-4 1014522 93.9% + - - - - - + - - - - + + - + - + - - + - + + - 
25 PCM-PPN55b-K1 1014522 93.9% + - - - - - + - - - - + + - + - + - - + - + + - 
26 PCM-PPN55b-K2 1014522 93.9% + - - - - - + - - - - + + - + - + - - + - + + - 
27 PCM-PPN55b-K3 1014522 93.9% + - - - - - + - - - - + + - + - + - - + - + + - 
28 PCM-PPN55b-K4 1014522 93.9% + - - - - - + - - - - + + - + - + - - + - + + - 
29 PCM-PPN55c-1 1114523 99.7% + - - + - - + - - - - + + - + - + - + + - + + - 
30 PCM-PPN55c-2 1014522 93.9% + - - - - - + - - - - + + - + - + - - + - + + - 
31 PCM-PPN55c-3 1014522 93.9% + - - - - - + - - - - + + - + - + - - + - + + - 
32 PCM-PPN55c-4 1014522 93.9% + - - - - - + - - - - + + - + - + - - + - + + - 
33 PCM-PPN55c-K1 1014522 93.9% + - - - - - + - - - - + + - + - + - - + - + + - 
34 PCM-PPN55c-K2 1114523 99.7% + - - + - - + - - - - + + - + - + - + + - + + - 
35 PCM-PPN55c-K3 1014522 93.9% + - - - - - + - - - - + + - + - + - - + - + + - 
36 PCM-PPN55c-K4 1014522 93.9% + - - - - - + - - - - + + - + - + - - + - + + - 
37 PCM-PPN56a-1 1014523 96.4% + - - - - - + - - - - + + - + - + - + + - + + - 
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38 PCM-PPN56a-2 1014522 93.9% + - - - - - + - - - - + + - + - + - - + - + + - 
39 PCM-PPN56a-3 1014522 93.9% + - - - - - + - - - - + + - + - + - - + - + + - 
40 PCM-PPN56a-4 1014522 93.9% + - - - - - + - - - - + + - + - + - - + - + + - 
41 PCM-PPN56a-K1 1114523 99.7% + - - + - - + - - - - + + - + - + - + + - + + - 
42 PCM-PPN56a-K2 1114523 99.7% + - - + - - + - - - - + + - + - + - + + - + + - 
43 PCM-PPN56a-K3 1014522 93.9% + - - - - - + - - - - + + - + - + - - + - + + - 
44 PCM-PPN56a-K4 1014522 93.9% + - - - - - + - - - - + + - + - + - - + - + + - 
45 DCM-PPN56b-21 1114522 99.9% + - - + - - + - - - - + + - + - + - - + - + + - 
46 DCM-PPN56b-22 1014522 93.9% + - - - - - + - - - - + + - + - + - - + - + + - 
47 DCM-PPN56b-23 1114523 99.7% + - - + - - + - - - - + + - + - + - + + - + + - 
48 DCM-PPN56b-24 1114523 99.7% + - - + - - + - - - - + + - + - + - + + - + + - 
49 PCM-PPN56b-1 1014522 93.9% + - - - - - + - - - - + + - + - + - - + - + + - 
50 PCM-PPN56b-2 1014522 93.9% + - - - - - + - - - - + + - + - + - - + - + + - 
51 PCM-PPN56b-3 1014522 93.9% + - - - - - + - - - - + + - + - + - - + - + + - 
52 PCM-PPN56b-4 1014522 93.9% + - - - - - + - - - - + + - + - + - - + - + + - 
53 PCM-PPN56b-K1 1014522 93.9% + - - - - - + - - - - + + - + - + - - + - + + - 
54 PCM-PPN56b-K2 1014522 93.9% + - - - - - + - - - - + + - + - + - - + - + + - 
55 PCM-PPN56b-K3 1004522 94.9% + - - - - - + - - - - + + - + - + - - + - + + - 
56 PCM-PPN56b-K4 1014522 93.9% + - - - - - + - - - - + + - + - + - - + - + + - 
57 DCM-PPN56c-21 1114523 99.7% + - - + - - + - - - - + + - + - + - + + - + + - 
58 DCM-PPN56c-22 1114523 99.7% + - - + - - + - - - - + + - + - + - + + - + + - 
59 DCM-PPN56c-23 1014522 93.9% + - - - - - + - - - - + + - + - + - - + - + + - 
60 DCM-PPN56c-24 1014522 93.9% + - - - - - + - - - - + + - + - + - - + - + + - 
61 PCM-PPN56c-1 1114523 99.7% + - - + - - + - - - - + + - + - + - + + - + + - 
62 PCM-PPN56c-2 1014522 93.9% + - - - - - + - - - - + + - + - + - - + - + + - 
63 PCM-PPN56c-3 1014522 93.9% + - - - - - + - - - - + + - + - + - - + - + + - 
64 PCM-PPN56c-4 1014522 93.9% + - - - - - + - - - - + + - + - + - - + - + + - 
65 PCM-PPN56c-5 1014522 93.9% + - - - - - + - - - - + + - + - + - - + - + + - 
66 PCM-PPN56c-6 1014522 93.9% + - - - - - + - - - - + + - + - + - - + - + + - 
67 PCM-PPN56c-7 1114523 99.7% + - - + - - + - - - - + + - + - + - + + - + + - 
68 PCM-PPN56c-8 1014522 93.9% + - - - - - + - - - - + + - + - + - - + - + + - 
69 PCM-PPN56c-K1 1014522 93.9% + - - - - - + - - - - + + - + - + - - + - + + - 
70 PCM-PPN56c-K2 1014522 93.9% + - - - - - + - - - - + + - + - + - - + - + + - 
71 PCM-PPN56c-K3 1014522 93.9% + - - - - - + - - - - + + - + - + - - + - + + - 
72 PCM-PPN56c-K4 1114522 99.9% + - - + - - + - - - - + + - + - + - - + - + + - 
73 PC-M1-K1 1014522 93.9% + - - - - - + - - - - + + - + - + - - + - + + - 
74 PC-M1-K2 1014522 93.9% + - - - - - + - - - - + + - + - + - - + - + + - 
75 PC-M1-K3 1014522 93.9% + - - - - - + - - - - + + - + - + - - + - + + - 
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76 PC-M1-K4 1014522 93.9% + - - - - - + - - - - + + - + - + - - + - + + - 
77 PC-M1-K5 1014522 93.9% + - - - - - + - - - - + + - + - + - - + - + + - 
78 PC-M1-K11 1014522 93.9% + - - - - - + - - - - + + - + - + - - + - + + - 
79 PC-M1-K12 1014522 93.9% + - - - - - + - - - - + + - + - + - - + - + + - 
80 PC-M1-K13 1014522 93.9% + - - - - - + - - - - + + - + - + - - + - + + - 
81 PC-M3-6 1014522 93.9% + - - - - - + - - - - + + - + - + - - + - + + - 
82 PC-M3-K11 1014522 93.9% + - - - - - + - - - - + + - + - + - - + - + + - 
83 PC-M3-K12 1014522 93.9% + - - - - - + - - - - + + - + - + - - + - + + - 
84 PC-M13-K13 1014522 93.9% + - - - - - + - - - - + + - + - + - - + - + + - 
85 S18/1-C-O-6a 1014523 99.7% + - - - - - + - - - - + + - + - + - + + - + + - 
86 S18/1-C-I-10-4-6a 1014523 99.7% + - - - - - + - - - - + + - + - + - + + - + + - 
87 S18/1-C-O-6b 1014523 99.7% + - - - - - + - - - - + + - + - + - + + - + + - 
88 S18/1-C-O-5-6b 1014523 99.7% + - - - - - + - - - - + + - + - + - + + - + + - 
89 S18/1-C-I-4-6b 1154523 92.3% + - - + - - + - - - - + + - + - + - + + - + + - 
90 S18/1-C-O-6c 1014523 99.7% + - - - - - + - - - - + + - + - + - + + - + + - 
91 S18/1-C-O-6d 1154523 92.3% + - - + - - + - + - - + + - + - + - + + - + + - 
92 S18/1-C-O-5-6e 1114523 99.7% + - - + - - + - - - - + + - + - + - + + - + + - 
93 S18/1-C-O-1a 1154723  92.5% + - - + - - + - + - - + + + + - + - + + - + - - 
94 S18/1-C-O-K-5b 1154523  92.3% + - - + - - + - + - - + + - + - + - + + - + - - 
95 S18/1-C-O-5c 1155523 98.3% + - - + - - + - + + - + + - + - + - + + - + - - 
96 PC-M16-2 1155723 98.3% + - - + - - + - + + - + + + + - + - + + - + - - 
97 PC-M16-5 1155723 98.3% + - - + - - + - + + - + + + + - + - + + - + - - 
98 PC-M16-10 1154723 92.5% + - - + - - + - + - - + + + + - + - + + - + - - 
99 YE015f-CPK 1155563 99.4% + - - + - - + - + + - + + - + - + + + + - - - Y. intermedia, 99.9% 
100 YE015c-CPK 1155563 99.4% + - - + - - + - + + - + + - + - + + + + - - - Y. intermedia, 99.9% 
101 PC-M5-K11 1155563 99.4% + - - + - - + - + + - + + - + - + + + + - - - Y. intermedia, 99.9% 
102 PC-M5-K12 1155563 99.4% + - - + - - + - + + - + + - + - + + + + - - - Y. intermedia, 99.9% 
105 PC-M16-4 1155723 98.3% + - - + - - + - + + - + + + + - + - + + - - - Y. frederiksenii, 55.3% 
106 PC-M16-6 1155723 98.3% + - - + - - + - + + - + + + + - + - + + - - - Y. frederiksenii, 55.3% 
107 PC-M20-3 1155563 99.4% + - - + - - + - + + - + + - + - + + + + - - - Y. intermedia, 99.9% 
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APPENDIX IX BIOROUPING AND SEROTYPING 
 
(A) Biochemical tests of biogrouping 
 
1. β- D-Glucosidase test 
Fresh culture (18-24 hours) was diluted using sterile 0.85% NaCl solution and 3 
McFarland was achieved. 0.75 ml culture suspension was added into 0.25 ml of β- 
D-Glucosidase test medium and incubated at 30 °C for 16-20 h. 
 
Representative photo 
of β- D-Glucosidase 
test 
 
   
Representing 
bacterium 
Uninoculated Y. enterocolitica 
ATCC 9610 
L. monocytogenes 
ATCC 7644 
Interpretation 
 
Uninoculated Negative (colourless) Positive (yellow) 
 
2. Esculine test 
Fresh culture (18-24 hours) was streaked onto bile esculine agar. Plates were 
incubated at 25-28 °C for 24 h. 
 
Representative photo of bile esculine agar Interpretation 
 
a, positive (brown diffused pigment), 
Enterococcus faecalis ATCC 29212 
 
b, negative (no pigment), Y. enterocolitica 
ATCC 9610 
 
c, uninoculated 
 
3. Salicin, xylose, trehalose test 
Fresh culture (18-24 hours) was diluted using sterile 0.85% NaCl solution and 0.5 
McFarland was achieved. Culture was lawned onto phenol red agar and the 
carbohydrate discs were dispensed onto the surface of the inoculated agar. Plates 
were incubated at 25-28 °C for 24 h. 
 
Interpretation Phenol red agar 
(uninoculated) 
Phenol red agar 
with salicin disc 
Phenol red agar 
with xylose disc 
Phenol red agar 
with trehalose 
disc 
Positive 
    
Negative 
    
  
a 
b 
c 
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4. Lipase (Tween-esterase) test 
Fresh culture (18-24 hours) was streaked onto lipase test agar. Plates were 
incubated at 25-28 °C and the plates were examined after 2 and 5 days. 
 
Representative 
photo of lipase 
test agar 
   
Representing 
bacterium 
Uninoculated Y. enterocolitica ATCC 
9610 
Escherichia coli ATCC 
25922 
Interpretation 
 
Uninoculated Positive (opaque halo 
surrounding streaking) 
Negative (no opaque 
halo observed) 
 
5. DNAse test 
Fresh culture (18-24 hours) was streaked onto DNAse test agar. Plates were 
incubated at 25-28 °C for 24 h. 
 
Representative photo of DNase test agar with 
Toluidine blue  
Interpretation 
 
 
 
 
 
 
 
 
a, negative (growth without zones), Y. 
enterocolitica bioserotype 3 variant/O:3 (PC-
M1-K1) 
b, negative (growth without zones), Y. 
enterocolitica ATCC 9610 
c, positive (growth with rose-pink zone), 
Serratia marcescens (YC-M2-4) 
d, uninoculated 
 
6. Indole test 
Fresh culture (18-24 hours) was stabbed into SIM medium (Oxoid) and the tube 
were incubated at 25-28 °C for 24 h. After incubation, 0.5 ml Indole reagent 
(Sigma) was added. Immediate development of red colour indicates a positive test. 
 
Representative photo 
of Voges-Prokauer test 
 
   
Representing 
bacterium 
Uninoculated Citrobacter freundii 
(YC-K1-3) 
E. coli ATCC 25922 
Interpretation Uninoculated Negative (yellow) Positive (red) 
 
  
a 
b 
d 
c 
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7. Pyrazinamidase test 
Fresh culture (18-24 hours) was streaked onto slant’s surface. Slant was were 
incubated at 25-28 °C for 48 h. Slant surface was flooded with 1 ml of freshly 
prepared 1% iron (II) ammonium sulphate solution. Slant was read after 15 min. 
 
Representative photo 
of pyrazinamidase 
test 
 
   
Representing 
bacterium 
Uninoculated Y. enterocolitica 
ATCC 9610 
Enterococcus faecalis 
ATCC 29212 
Interpretation Uninoculated Negative (colourless) Positive (brown color) 
 
8. Voges-Prokauer test 
Fresh culture (18-24 hours) was inoculated into MRVP broth and the tubes were 
incubated at 25-28 °C for 24 h. After incubation, 0.6 ml of α-naphtol reagent was 
added, mixed gently and then 0.2 ml of 40% KOH reagent was added. Tube was 
shaken gently for 30 s and allowed to slant to allow maximum oxygen expose for 
15 min. Development of red colour indicates a positive test.  
 
Representative photo 
of Voges-Prokauer test 
 
   
Representing 
bacterium 
Uninoculated Salmonella enteric 
ATCC 10376 
Y. enterocolitica 
ATCC 9610 
Interpretation 
 
Uninoculated Negative (dark 
brown/colour of α-
naphtol reagent 
remained) 
Positive (red) 
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APPENDIX IX  RAW DATA FOR BIOTYPING AND SEROTYPING 
No. Isolates Name 
Biobhemical tests 
Biotype 
 Antisera 
Serotype 
L
ip
a
se
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X
y
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β
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a
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V
P
 
D
N
A
se
 
 O:3 O:5 O:8 O:9 
O:1 
and 
O:2 
1 PCM-PPN53a-1 - - - - + + + - - - - 3 variant (VP-) 
 
+ - - - - O:3 
2 PCM-PPN53a-2 - - - - + + + - - - - 3 variant (VP-) 
 
+ - - - - O:3 
3 PCM-PPN53a-3 - - - - + + + - - - - 3 variant (VP-) 
 
+ - - - - O:3 
4 PCM-PPN53a-4 - - - - + + + - - - - 3 variant (VP-) 
 
+ - - - - O:3 
5 PCM-PPN53a-K1 - - - - + + + - - - - 3 variant (VP-) 
 
+ - - - - O:3 
6 PCM-PPN53a-K2 - - - - + + + - - - - 3 variant (VP-) 
 
+ - - - - O:3 
7 PCM-PPN53a-K3 - - - - + + + - - - - 3 variant (VP-) 
 
+ - - - - O:3 
8 PCM-PPN53a-K4 - - - - + + + - - - - 3 variant (VP-) 
 
+ - - - - O:3 
9 DCM-PPN55a-1 - - - - + + + - - - - 3 variant (VP-) 
 
+ - - - - O:3 
10 DCM-PPN55a-2 - - - - + + + - - - - 3 variant (VP-) 
 
+ - - - - O:3 
11 DCM-PPN55a-3 - - - - + + + - - - - 3 variant (VP-) 
 
+ - - - - O:3 
12 DCM-PPN55a-4 - - - - + + + - - - - 3 variant (VP-) 
 
+ - - - - O:3 
13 PCM-PPN55a-1 - - - - + + + - - - - 3 variant (VP-) 
 
+ - - - - O:3 
14 PCM-PPN55a-2 - - - - + + + - - - - 3 variant (VP-) 
 
+ - - - - O:3 
15 PCM-PPN55a-3 - - - - + + + - - - - 3 variant (VP-) 
 
+ - - - - O:3 
16 PCM-PPN55a-4 - - - - + + + - - - - 3 variant (VP-) 
 
+ - - - - O:3 
17 PCM-PPN55a-K1 - - - - + + + - - - - 3 variant (VP-) 
 
+ - - - - O:3 
18 PCM-PPN55a-K2 - - - - + + + - - - - 3 variant (VP-) 
 
+ - - - - O:3 
19 PCM-PPN55a-K3 - - - - + + + - - - - 3 variant (VP-) 
 
+ - - - - O:3 
20 PCM-PPN55a-K4 - - - - + + + - - - - 3 variant (VP-) 
 
+ - - - - O:3 
21 PCM-PPN55b-1 - - - - + + + - - - - 3 variant (VP-) 
 
+ - - - - O:3 
22 PCM-PPN55b-2 - - - - + + + - - - - 3 variant (VP-) 
 
+ - - - - O:3 
23 PCM-PPN55b-3 - - - - + + + - - - - 3 variant (VP-) 
 
+ - - - - O:3 
24 PCM-PPN55b-4 - - - - + + + - - - - 3 variant (VP-) 
 
+ - - - - O:3 
25 PCM-PPN55b-K1 - - - - + + + - - - - 3 variant (VP-) 
 
+ - - - - O:3 
26 PCM-PPN55b-K2 - - - - + + + - - - - 3 variant (VP-) 
 
+ - - - - O:3 
27 PCM-PPN55b-K3 - - - - + + + - - - - 3 variant (VP-) 
 
+ - - - - O:3 
28 PCM-PPN55b-K4 - - - - + + + - - - - 3 variant (VP-)  + - - - - O:3 
29 PCM-PPN55c-1 - - - - + + + - - - - 3 variant (VP-)  + - - - - O:3 
30 PCM-PPN55c-2 - - - - + + + - - - - 3 variant (VP-)  + - - - - O:3 
31 PCM-PPN55c-3 - - - - + + + - - - - 3 variant (VP-)  + - - - - O:3 
32 PCM-PPN55c-4 - - - - + + + - - - - 3 variant (VP-)  + - - - - O:3 
33 PCM-PPN55c-K1 - - - - + + + - - - - 3 variant (VP-)  + - - - - O:3 
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No. Isolates Name 
Biobhemical tests 
Biotype 
 Antisera 
Serotype 
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 O:3 O:5 O:8 O:9 
O:1 
and 
O:2 
34 PCM-PPN55c-K2 - - - - + + + - - - - 3 variant (VP-) 
 
+ - - - - O:3 
35 PCM-PPN55c-K3 - - - - + + + - - - - 3 variant (VP-) 
 
+ - - - - O:3 
36 PCM-PPN55c-K4 - - - - + + + - - - - 3 variant (VP-) 
 
+ - - - - O:3 
37 PCM-PPN56a-1 - - - - + + + - - - - 3 variant (VP-) 
 
+ - - - - O:3 
38 PCM-PPN56a-2 - - - - + + + - - - - 3 variant (VP-) 
 
+ - - - - O:3 
39 PCM-PPN56a-3 - - - - + + + - - - - 3 variant (VP-) 
 
+ - - - - O:3 
40 PCM-PPN56a-4 - - - - + + + - - - - 3 variant (VP-) 
 
+ - - - - O:3 
41 PCM-PPN56a-K1 - - - - + + + - - - - 3 variant (VP-) 
 
+ - - - - O:3 
42 PCM-PPN56a-K2 - - - - + + + - - - - 3 variant (VP-) 
 
+ - - - - O:3 
43 PCM-PPN56a-K3 - - - - + + + - - - - 3 variant (VP-) 
 
+ - - - - O:3 
44 PCM-PPN56a-K4 - - - - + + + - - - - 3 variant (VP-) 
 
+ - - - - O:3 
45 DCM-PPN56b-21 - - - - + + + - - - - 3 variant (VP-) 
 
+ - - - - O:3 
46 DCM-PPN56b-22 - - - - + + + - - - - 3 variant (VP-) 
 
+ - - - - O:3 
47 DCM-PPN56b-23 - - - - + + + - - - - 3 variant (VP-) 
 
+ - - - - O:3 
48 DCM-PPN56b-24 - - - - + + + - - - - 3 variant (VP-) 
 
+ - - - - O:3 
49 PCM-PPN56b-1 - - - - + + + - - - - 3 variant (VP-) 
 
+ - - - - O:3 
50 PCM-PPN56b-2 - - - - + + + - - - - 3 variant (VP-) 
 
+ - - - - O:3 
51 PCM-PPN56b-3 - - - - + + + - - - - 3 variant (VP-) 
 
+ - - - - O:3 
52 PCM-PPN56b-4 - - - - + + + - - - - 3 variant (VP-) 
 
+ - - - - O:3 
53 PCM-PPN56b-K1 - - - - + + + - - - - 3 variant (VP-) 
 
+ - - - - O:3 
54 PCM-PPN56b-K2 - - - - + + + - - - - 3 variant (VP-) 
 
+ - - - - O:3 
55 PCM-PPN56b-K3 - - - - + + + - - - - 3 variant (VP-) 
 
+ - - - - O:3 
56 PCM-PPN56b-K4 - - - - + + + - - - - 3 variant (VP-)  + - - - - O:3 
57 DCM-PPN56c-21 - - - - + + + - - - - 3 variant (VP-)  + - - - - O:3 
58 DCM-PPN56c-22 - - - - + + + - - - - 3 variant (VP-)  + - - - - O:3 
59 DCM-PPN56c-23 - - - - + + + - - - - 3 variant (VP-)  + - - - - O:3 
60 DCM-PPN56c-24 - - - - + + + - - - - 3 variant (VP-)  + - - - - O:3 
61 PCM-PPN56c-1 - - - - + + + - - - - 3 variant (VP-)  + - - - - O:3 
62 PCM-PPN56c-2 - - - - + + + - - - - 3 variant (VP-)  + - - - - O:3 
63 PCM-PPN56c-3 - - - - + + + - - - - 3 variant (VP-)  + - - - - O:3 
64 PCM-PPN56c-4 - - - - + + + - - - - 3 variant (VP-)  + - - - - O:3 
65 PCM-PPN56c-5 - - - - + + + - - - - 3 variant (VP-)  + - - - - O:3 
66 PCM-PPN56c-6 - - - - + + + - - - - 3 variant (VP-)  + - - - - O:3 
67 PCM-PPN56c-7 - - - - + + + - - - - 3 variant (VP-)  + - - - - O:3 
68 PCM-PPN56c-8 - - - - + + + - - - - 3 variant (VP-)  + - - - - O:3 
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No. Isolates Name 
Biobhemical tests 
Biotype 
 Antisera 
Serotype 
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 O:3 O:5 O:8 O:9 
O:1 
and 
O:2 
69 PCM-PPN56c-K1 - - - - + + + - - - - 3 variant (VP-)  + - - - - O:3 
70 PCM-PPN56c-K2 - - - - + + + - - - - 3 variant (VP-)  + - - - - O:3 
71 PCM-PPN56c-K3 - - - - + + + - - - - 3 variant (VP-)  + - - - - O:3 
72 PCM-PPN56c-K4 - - - - + + + - - - - 3 variant (VP-) 
 
+ - - - - O:3 
73 PC-M1-K1 - - - - + + + - - - - 3 variant (VP-) 
 
+ - - - - O:3 
74 PC-M1-K2 - - - - + + + - - - - 3 variant (VP-) 
 
+ - - - - O:3 
75 PC-M1-K3 - - - - + + + - - - - 3 variant (VP-) 
 
+ - - - - O:3 
76 PC-M1-K4 - - - - + + + - - - - 3 variant (VP-) 
 
+ - - - - O:3 
77 PC-M1-K5 - - - - + + + - - - - 3 variant (VP-) 
 
+ - - - - O:3 
78 PC-M1-K11 - - - - + + + - - - - 3 variant (VP-) 
 
+ - - - - O:3 
79 PC-M1-K12 - - - - + + + - - - - 3 variant (VP-) 
 
+ - - - - O:3 
80 PC-M1-K13 - - - - + + + - - - - 3 variant (VP-) 
 
+ - - - - O:3 
81 PC-M3-6 - - - - + + + - - - - 3 variant (VP-) 
 
+ - - - - O:3 
82 PC-M3-K11 - - - - + + + - - - - 3 variant (VP-) 
 
+ - - - - O:3 
83 PC-M3-K12 - - - - + + + - - - - 3 variant (VP-) 
 
+ - - - - O:3 
84 PC-M13-K13 - - - - + + + - - - - 3 variant (VP-)  + - - - - O:3 
85 S18/1-C-O-6a - - - - + + + - - - - 3 variant (VP-)  + - - - - O:3 
86 S18/1-C-I-10-4-6a - - - - + + + - - - - 3 variant (VP-)  + - - - - O:3 
87 S18/1-C-O-6b - - - - + + + - - - - 3 variant (VP-)  + - - - - O:3 
88 S18/1-C-O-5-6b - - - - + + + - - - - 3 variant (VP-)  + - - - - O:3 
89 S18/1-C-I-4-6b - - - - + + + - - - - 3 variant (VP-)  + - - - - O:3 
90 S18/1-C-O-6c - - - - + + + - - - - 3 variant (VP-)  + - - - - O:3 
91 S18/1-C-O-6d - - - - + + + - - - - 3 variant (VP-)  + - - - - O:3 
92 S18/1-C-O-5-6e - - - - + + + - - - - 3 variant (VP-)  + - - - - O:3 
93 S18/1-C-O-1a + - - + + + + + - - - 1B  - - + - - O:8 
94 S18/1-C-O-K-5b + - - + + + + + - - - 1B  - - + - - O:8 
95 S18/1-C-O-5c + - - + + + + + - - - 1B  - - + - - O:8 
96 PC-M16-2 + + + + + + + + + + - 1A  - + - - - O:5 
97 PC-M16-5 + + + + + + + + + + - 1A  - + - - - O:5 
98 PC-M16-10 + + + + + + + + + + - 1A  - + - - - O:5 
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APPENDIX X NCBI BLAST RESULTS 
 
Strain: PC-M1-K1; target gene: Yersinia enterocolitica 16S rRNA gene 
 
Strain: PC-M1-K1; target gene: ail gene 
 
Strain: PC-M1-K1, target gene: virF gene 
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Strain: PC-M1-K1; target gene: rbfC gene 
 
Strain: IP135; target gene: fepD gene 
 
Strain: IP135; target gene: hreP gene 
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Strain: IP102; target gene: fes gene 
 
 
Strain: IP135; target gene: sat gene 
 
Strain: IP102; target gene: fepA gene 
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Strain: IP102; target gene: ystB gene 
 
Strain: IP11105; target gene: inv gene 
 
Strain: IP383; target gene: yadA gene 
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Strain: IP11105; target gene: ymoA gene 
 
 
Strain: PC-M1-K1; target gene: myfA gene 
 
 
Strain: IP102; target gene: tccC gene 
Yersinia enterocolitica strain T83 biotype 1A putative lysR-family transcriptional regulatory proteins, putative insecticidal 
toxin complex protein (tcbA), putative insecticidal toxin complex protein (tcaC), putative phage-related proteins, putative 
exported protein, putative insecticidal toxin complex protein (tccC), putative DNA gyrase modulator, and putative carbon-
nitrogen hydrolase genes, complete cds 
Sequence ID: gb|AY647257.1|  Length: 20157Number of Matches: 1 
 
APPENDIX VIII   PHENOTYPIC VIRULENCE PLASMID TESTS 
 
169 
 
APPENDIX XI PHENOTYPIC VIRULENCE PLASMID TESTS 
 
1. Autoagglutination 
Cultures were inoculated into two tubes of MR-VP broth (Oxoid). One tube was 
incubated at 37°C and the other was incubated at 25 °C. After 18 to 24 h, the tubes 
were observed for agglutination, with care taken not to shake or disturb the sediment 
at the bottom and along the sides of the tube. Strains which carried virulence 
plasmid agglutinated at 37 °C but not 25 °C. Strains that lack the virulence plasmid 
do not agglutinate at either temperature. Strains that agglutinated at both 
temperatures were considered "rough". 
Representative photo of 
autoagglutination test using 
MRVP broth 
   
Representative bacteria Uninoculated Y. enterocolitica 
bioserotype 
3 variant/O:3 (PC-M1-
K1) at 37 °C 
Y. enterocolitica 
bioserotype 
3 variant/O:3 (PC-M1-
K1) at 25 °C 
Interpretation Uninoculated Clumping Turbid 
 
2. Calcium dependency and Congo red binding 
CR-MOX agar (Fluka) that allowed visualization of calcium-dependent growth and 
uptake of Congo red dye on the same plate were used. Fresh Y. enterocolitica 
isolates (16-18 h) were streaked onto CR-MOX agar plates, incubated at 37 °C, and 
for 24- 48 h. A predominance tiny red colony is indicative of a positive response for 
both Congo red binding and calcium dependency.  
Representative photo of 
CR-MOX plate 
40× light microscope Interpretation 
 
- Uninoculated 
  
Positive 
(red tiny 
colonies) 
Representing bacterium: Y. enterocolitica bioserotype 3 variant/O:3 (PC-M1-K1)  
  
Negative 
(white 
colonies) 
Representing bacterium: Y. enterocolitica bioserotype 1A/O:5 (PC-M16-2)  
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3. Crystal violet binding 
Crystal violet binding on the same CR-MOX agar was performed by flooding the 
plate with 85 µg/ml crystal violet, allowed to stand for 2 min, and the dye was 
decanted. Plates were observed with stereo microscope at 40 × magnification. 
Positive isolates displayed as small and intensely purple colonies. 
 
Representative photo of CR-MOX 
plate, flooded with 85 µg/ml crystal 
violet solution 
Observation under 40× light 
microscope 
Interpretation 
 
 
Positive 
(intensly 
purple 
colonies) 
 
 
Representing bacterium: Y. enterocolitica bioserotype 3 variant/O:3 (PC-M1-K1)  
  
Negative 
(bacteria 
colonies did 
not stained by 
crystal violet) 
Representing bacterium: Y. enterocolitica bioserotype 1A/O:5 (PC-M16-2)  
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APPENDIX XII  ANTIMICROBIAL SUSCEPTIBILITY PROFILES OF Y. enterocolitica ISOLATES 
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% S % I % R 
Cefuroxime, 30µg S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S I I 93.8 30 6.3 2 0.0 0 
Cefotaxime, 30µg S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S 100.0 32 0.0 0 0.0 0 
Ceftazidime, 30µg S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S 100.0 32 0.0 0 0.0 0 
Ceftriaxone, 30µg S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S 100.0 32 0.0 0 0.0 0 
Nalidixic acid, 30µg R R R R R R R R R R R R R R R R R R R R S S S S S S S S S S S S 37.5 12 0.0 0 62.5 20 
Ciprofloxacin, 5 µg S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S 100.0 32 0.0 0 0.0 0 
Levofloxacin, 5 µg S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S 100.0 32 0.0 0 0.0 0 
Trimethoprim, 5 µg S S I S S S S S S S S S S S S S S S S S S S S S S S S S S S S S 96.9 31 3.1 1 0.0 0 
Trimethoprim-sulphamethoxazole, 25 µg S S S S S S S S S S S S S S S S S S S S I R I S S S S S S S S S 90.6 29 6.3 2 3.1 1 
Streptomycin, 10 µg S S S S S I S S S S I S S S S S I S I S R R R R R R R S S S S S 65.6 21 12.5 4 21.9 7 
Kanamycin, 30µg S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S 100.0 32 0.0 0 0.0 0 
Amikacin, 30µg S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S 100.0 32 0.0 0 0.0 0 
Gentamicin, 10 µg S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S 100.0 32 0.0 0 0.0 0 
Neomycin, 10 µg S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S 100.0 32 0.0 0 0.0 0 
Netilmicin, 30µg S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S 100.0 32 0.0 0 0.0 0 
Ampicillin, 10 µg R R R R R R R R R R R R R R R R R R R I R R R R R R R S S S R R 9.4 3 3.1 1 87.5 28 
Ticarcilin, 75 µg R R R R R R R R I R R R R R R R R I R I R R R R R R I S S S R R 9.4 3 12.5 4 78.1 25 
Tetracycline, 30µg R R R R R R R R R R R R R R R R R R R R S S S S S S S S S S S S 37.5 12 0.0 0 62.5 20 
Doxycycline, 30µg S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S 100.0 32 0.0 0 0.0 0 
Amoxicillin-clavulanic acid, 30µg I S S S S R S S S S R S I S S S S S S S I S I S S S S S S S R S 78.1 25 12.5 4 9.4 3 
Aztreonam, 30µg S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S 100.0 32 0.0 0 0.0 0 
Imipenem, 10 µg S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S 100.0 32 0.0 0 0.0 0 
Polymyxin B, 300 µg S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S 100.0 32 0.0 0 0.0 0 
Chloroamphenicol, 30µg S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S 100.0 32 0.0 0 0.0 0 
Clindamycin, 2 µg R R R R R R R R R R R R R R R R R R R R R R R I I I I R R R R R 0.0 0 12.5 4 87.5 28 
Enrofloxacin, 5 µg S S S S S S S S S S S S I S S S S S S S S S S S S S S S S S S S 96.9 31 3.1 1 0.0 0 
Amoxicillin, 25 µg R R R R R R R R I R R R R R R R R R R I R R R R R R R S S S R R 9.4 3 6.3 2 84.4 27 
Spetinomycin, 100 µg S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S 100.0 32 0.0 0 0.0 0 
Colistin, 10 µg S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S S 100.0 32 0.0 0 0.0 0 
Total R 6 6 6 6 6 7 6 6 4 6 7 6 6 6 6 6 6 5 6 3 5 6 5 4 4 4 3 1 1 1 5 4 
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APPENDIX XIII BACTERIAL COUNTS FOR MODIFICATION AND  
IMPROVEMENT OF CIN AGAR 
 
1. The cfu counts of IP383, IP135, ATCC 9610 and PC-M16-2 on CIN, modified 
CIN and LBA. 
Bacterial 
strains 
Agar plates 
Replicate (cfu count) 
A
v
er
a
g
e 
 
(c
fu
 c
o
u
n
t)
 
D
il
u
ti
o
n
 
fa
ct
o
r 
cfu/ml
a
 
1 2 3 4 5 6 
IP 383  CIN
b
 (ae
c
) 197 257 83 102 83 127 142 10
6
 1.42×10
8
 
mCIN
d
 (ae) 120 137 130 130 131 134 130 10
6
 1.30×10
8
 
mCIN (mic
e
) 123 170 73 120 124 122 122 10
6
 1.22×10
8
 
LBA
f
 148 235 104 116 83 88 129 10
6
 1.29×10
8
 
IP 135 CIN (ae) 81 82 92 132 95 96 96 10
6
 9.63×10
7
 
mCIN (ae) 59 71 82 97 100 82 82 10
6
 8.18×10
7
 
mCIN (mic) 76 70 75 99 78 95 82 10
6
 8.22×10
7
 
LBA 88 96 92 119 90 113 100 10
6
 9.97×10
7
 
ATCC 9610 CIN (ae) 84 137 86 68 71 89 89 10
6
 8.92×10
7
 
mCIN (ae) 99 85 90 69 63 104 85 10
6
 8.50×10
7
 
mCIN (mic) 70 85 90 82 88 95 85 10
6
 8.50×10
7
 
LBA 107 136 133 91 77 61 101 10
6
 1.01×10
8
 
PC-M16-2 CIN (ae) 206 281 233 272 186 259 240 10
6
 2.40×10
8
 
mCIN (ae) 237 244 228 241 198 271 237 10
6
 2.37×10
8
 
mCIN (mic) 242 212 209 265 195 268 232 10
6
 2.32×10
8
 
LBA 217 223 195 265 174 229 217 10
6
 2.17×10
8
 
a cfu/ml=cfu/total dilution factor; bCIN, Cefsulodin-Irgasan-Novobiocin; cae, aerobic; d mCIN, modified CIN; e mic, microaerophilic; 
fLBA, Luria-Bertani agar 
 
 
2. The cfu counts of IP135 and background microflora plated on LBA. 
Bacterial 
strains 
Replicate (cfu) Average 
(cfu) 
Dilution 
factor 
cfu/ml 
1 2 3 4 5 6 
IP135 222 191 235 317 249 246 243 10
6
 2.43×10
8
 
Microbiota 
in the meat 
sample 
95 105 n.a. n.a. n.a. n.a. 100 10
5
 1.00×10
7
 
 
 
 
